Yaya tsawon lokacin da alamun suka ci gaba?
Kuma duk wani ciwon kirji ya kamata a bi da shi ta wannan hanyar musamman a shekarunka
Kuma akwai zazzabi a cikinta.
Kuma abin da ya kamata a duba shi ne yawan cholesterol da ke cikin jininka.
kuma kana da zazzabi a yanzu?
kuma kana da ciwon kirji a yanzu?
Kuma banda wannan, kuna da wahalar numfashi?
Kuma za ku iya gaya mini wasu alamun da kuka samu tare da waɗannan alamun?
kuma yadda high ne zazzabi
Kuma ni ma na yi tari.
Kuma ina da ɗan sanyi da tari.
Kuma na yi ciwon kirji sosai yau
kuma shi ne daidai lokacin da za a allergic zazzabi
Kuma ya samu ciwon kirji
Kuma ina ganin ina da ɗan zazzabi
Kuma ina so ku kwatanta wannan ciwon kirji.
kuma suna da zazzabi kadan.
da kuma tarihin ciwon sukari
kuma ka san ni kirji ji kamar zai fashe
kuma ka san mutane coughing a kan ni a duk tsawon lokacin
kuma kana da ciwon kirji
kuma ka ce akwai wani ji na matsawa a kan kirji
wani a cikin iyalinku da ke da ciwon zuciya ciwon zuciya bugun zuciya high cholesterol high jini
Shin akwai wasu alamun ko kuma matsaloli da kuka lura da su game da ciwon tsoka?
Akwai wani da yake da ciwo kamar ku a gida da ke da irin wannan bayyanar?
Shin kuna da wasu alamun cutar?
Shin kana da wani numfashi shãmaki?
Shin har yanzu kuna da ciwon kirji
Domin wannan ne lokacin mura
Amma kuma bai kamata mu manta da ciwon kirji da ke zuwa daga zuciya ba.
Amma matsalar da ta fi muhimmanci a yanzu ita ce ciwon kirji.
Amma ina da wahalar numfashi.
amma na san mutane da yawa coughing a kan ni
Amma dole ne mu ɗauki kowane ciwon kirji da muhimmanci.
Amma kana numfashi da kyau yanzu, ba ku?
Saboda ciwon kirji na manta da shi
Shin, ba ka ji kamar wani ya matsa ka kirji
Shin har yanzu yana jin kamar yana da numfashi
Shin suna da irin wannan ciwo da alamun?
Shin kuna da wasu matsaloli na kullum kamar hawan jini ko wani abu makamancin haka?
Shin kuna da wasu cututtuka na rashin lafiya na kullum kamar ciwon sukari?
Shin kuna da wani numfashi tare da ciwon kirji?
Shin kana da hawan jini?
Shin kana shan wahala daga numfashi tare da shi?
Shin kun san alamun da yake da su?
Kuna ganin wannan hoton?
sha ruwa da yawa a yau
Amma sai na yi gwajin ciwon sukari.
Amma kuma yana da irin wannan cututtuka kamar yadda nake da su.
Yaya zafin zafin jikinka yake?
Yaya hawan jini?
idan kana da zazzabi mai zafi
idan kana da zazzabi da zazzabi na ɗari biyu ko sama da haka
idan kana jin wata cuta ko wata cuta kana bukatar ƙarin bincike
Ina da zazzabi a daren jiya
Ina da ɗan zazzabi ma
Ina da zazzabi a daren jiya
Ina da ciwo mai zafi a nan a cikin kirji
Ina da ɗan wahalar numfashi kuma
Zan aika da hotuna zuwa gare ku
Ina da ɗan ciwon kirji a yau
Ina da ciwon kai da zazzabi a yau.
A ganina, sanyi ne.
Ina ganin wannan shi ne m mura
Shin yana jin kamar mutum mai nauyi yana zaune a kan kirjinka?
Dukkanin sun fara ne da ciwon kai da kuma zazzabi a daidai lokacin.
zafi a tsakiyar kirji
Yana da kamar ciwon kirji
Yana cikin kirjina
Yana tsakiyar kirjina
Yana tsakiyar kirji.
Ina jin zafi a kirji na
Ina matukar damuwa da ciwon kirji.
Ina so ka gaya mini ta hanyar kwatanta wannan kirji ciwo
kamar hawan jini ko ciwon sukari
kamar daidai a tsakiyar kirji
yanzu ga zazzabi za ka iya yi da Tachipirina Candy
Yanzu Mary Yaya tsawon lokacin da kake da alamun?
Yanzu ka ce kana da ciwon kirji
Wani lokaci ina jin ciwon kirji
Okay kana da wani sauran bayyanar cututtuka tare da wannan banda kawai ciwo
ko kuma wani yana zaune a kan kirjinka?
kamar zazzabi da tari da ciwon kai da kuma ciwon tsoka
daidai a tsakiyar kirji
Ka nuna mini a cikin wannan hoton inda kake jin zafi
Tun da kana da zazzabi
To, kana ganin wasu daga cikin waɗannan alamun suna da nasaba da yadda kake da ciki?
To, yaranka suna da irin wannan ciwon ne?
Ka gaya mini game da ciwon kirjinka
zazzabi ya tashi da dare
zazzabi da na sha a cikin kwanaki biyu da suka wuce
Jinin da ya gabata ya fara tashi
Wannan shi ne Dr. Porter a cikin ER.
Za ka iya gaya mani kadan game da ciwon kirjinka?
Ina jin zafi a gaban jikina a cikin kirji na
Ina da ciwo mai tsanani a kirji
lokacin da na ji ciwo a kirji
Mece ce raunin da kake ji a kirjinka?
Yaushe ne wannan ciwon kirji ya fara?
Ina kake jin zafi a kirjinka?
NS
Kana jin kamar numfashi ya yi maka wuya a cikin kirjinka.
Ka san ina da ciwon sukari da sauransu
Ka ce kana da wannan ciwon kirji
Haɗuwa mai yawa na cutar coronavirus (COVID-19) a Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma Burtaniya, 1 ga Janairu zuwa 15 ga Maris 2020
Cigaban kamuwa da cutar coronavirus (COVID-19) ya nuna irin wannan yanayin a cikin ƙasashen Tarayyar Turai/Yankin Tattalin Arzikin Turai da United Kingdom ya tabbatar da cewa, duk da cewa yana da matakai daban-daban dangane da ƙasa, cutar ta COVID-19 tana yaduwa cikin sauri a cikin dukkan ƙasashe.
Dangane da kwarewar da aka samu daga Italiya, jihohi, asibitoci da rukunin kula da gaggawa ya kamata su inganta shirye-shiryen su don karuwar adadin marasa lafiya da ke dauke da COVID-19 waɗanda za su buƙaci kulawar lafiya, musamman kulawar gaggawa.
A ranar 31 ga Disamba, 2019, an samu rahoton wani gungu na cutar huhu da ba a san asalinsa ba a Wuhan, Lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin ta ba da rahoton cewa, kwayar cutar coronavirus ce wacce yanzu ake kira da coronavirus acute respiratory syndrome 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 an sanya mata sunan cutar coronavirus (COVID-19).
Ya zuwa yanzu an tabbatar da cewa kusan kashi 80% na mutanen da ke da COVID-19 suna da rashin lafiya, watau kamuwa da numfashi tare da ko ba tare da ciwon huhu ba, kuma yawancin waɗannan marasa lafiya sun warke.
A cikin kusan kashi 14 cikin dari na cutar, COVID-19 ta zama mafi muni da ke buƙatar kulawar asibiti yayin da sauran kashi 6 cikin dari na cutar ta zama mai tsanani da ke buƙatar kulawa ta gaggawa.
Mutuwar marasa lafiya da ke asibiti saboda COVID-19 ya kai kashi 4 cikin dari.
A cikin wannan binciken, mun tantance yanayin hawan COVID-19 a kowace ƙasa ta Tarayyar Turai/Ƙasar Tattalin Arzikin Turai (EU/EEA) da kuma United Kingdom (UK) kuma mun kwatanta su da lardin Hubei na kasar Sin.
Mun kuma kwatanta adadin masu kamuwa da cutar COVID-19 a EU/EEA da kuma Birtaniya da na Italiya a ranar 31 ga Janairu zuwa 15 ga Maris, 2020.
Al'ummar EU/EEA da Birtaniya sun kamu da cutar COVID-19
Bayan China, COVID-19 ya sami ƙarin yaduwar ƙasa da kuma yanayin cutar COVID-19 a duk duniya a halin yanzu bisa ga yanayin ƙasar.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na Eurosurveillance 2020, Spiteri et al. sun ba da rahoton farkon tabbatar da cutar COVID-19 a Turai bisa ga bayanin WHO.
A EU/EEA, Faransa ta ba da rahoton farkon mutane uku da suka kamu da cutar a ranar 24 ga Janairu, 2020 a cikin waɗanda suka dawo daga Wuhan, lardin Hubei, China.
Ya zuwa ranar 15 ga Maris, 2020, an gano shari'o'in COVID-19 a duk ƙasashe 30 na EU/EEA da United Kingdom (UK), wanda tsakanin 31 ga Disamba, 2019 da kuma wannan kwanan wata, an sami shari'o'i 39,768 da mutuwar 1,727 da aka ruwaito, tare da 17,750 da mutuwar 1,441 daga Italiya kadai.
Samun adadin adadin mutane da suka kamu da cutar COVID-19
A Cibiyar Kula da Cututtuka ta Turai (ECDC), adadin mutanen da suka kamu da cutar COVID-19 a kowace ƙasa a duniya, wanda aka samo daga tushe na hukuma kamar Ma'aikatar Lafiya ta ƙasar, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, ana sabunta su kowace rana da karfe 8:00 na safe.
An yi amfani da wannan bayanan don kimanta yanayin COVID-19 a EU/EEA da Burtaniya, da kuma kwatanta shi da Italiya.
A matsayin wakili na yaduwar cutar COVID-19 mai aiki, mun ƙididdige adadin adadin adadin kwanaki 14 na COVID-19, saboda haka muna la'akari da hanyar COVID-19, a kowace EU/EEA da UK, a lokacin Janairu 1 zuwa Maris 15, 2020.
Mun kuma gabatar da adadin adadin masu kamuwa da cutar da aka ruwaito a kowace kasa a ranar 15 ga Maris, 2020 da karfe 8:00 na safe idan aka kwatanta da adadin masu kamuwa da cutar a Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a EU/EEA da UK
Yanayin a cikin kwanaki 14 na ƙididdigar adadin COVID-19 a cikin EU/EEA da UK ya bi yanayin a Hubei Province (China) (Hoto 1).
Ga EU/EEA da Burtaniya gabaɗaya, adadin COVID-19 ya fara ƙaruwa a ranar 21 ga Fabrairu sannan ya ƙaru sosai a ranar 28 ga Fabrairu, 2020 (Abubuwan da aka ƙara).
Wannan ya samo asali ne daga karuwar yawan wadanda suka kamu da cutar daga Italiya, amma duk sauran kasashen EU/EEA da kuma Burtaniya sun nuna irin wannan karuwar a kan adadin cutar COVID-19 (Additional Material).
Shafi na 2 ya nuna adadin adadin masu kamuwa da cutar COVID-19, a cikin EU/EEA da UK da kuma Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya jaddada cewa, har zuwa 15 ga Maris da karfe 8:00 na safe, sauran ƙasashe 15 na EU/EEA da Burtaniya sun ba da rahoton adadin adadin masu kamuwa da cutar kamar yadda Italiya ta yi makonni 3 ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin rahoton COVID-19 yana ƙaruwa cikin sauri a EU/EEA da kuma Birtaniya.
Yanayin yanayin COVID-19 da aka lura da shi yana nuna cewa cutar tana yaduwa a cikin sauri a duk ƙasashe.
Duk da cewa ƙasashe suna kan matakai daban-daban, bambancin da ke cikin martani na lafiyar jama'a na ƙasa da ma'anar yiwuwar shari'ar na iya bambanta a cikin ƙasashe da kuma ka'idoji daban-daban don zaɓar marasa lafiya waɗanda dole ne a gwada su don tabbatar da COVID-19, gami da gwajin biye.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana halin da ake ciki inda kashi 10% na marasa lafiya da ke dauke da cutar COVID-19 ke bukatar kulawa ta gaggawa kuma majiyoyin kafofin watsa labarai sun ruwaito cewa asibitoci da na'urorin kulawa ta gaggawa a yankin sun kai iyakar karfin su.
Bayanai kan shigar da COVID-19 a asibitoci da/ko na'urorin kulawa na gaggawa a halin yanzu suna nan a matakin EU/EEA don kashi 6% da 1% na shari'o'i, bi da bi (bayanai ba a nuna su ba).
Duk da haka, dole ne a tattara bayanan a cikin tsari don tallafawa bayanan sa ido na yau da kullun da ke mai da hankali kan adadin waɗanda aka ba da rahoton da kuma adadin mutuwar.
Binciken da aka gudanar a 2010-11 ya nuna bambancin da ke tsakanin wadatar gadajen kulawa da kulawa a Turai, tsakanin 29.2 a Jamus zuwa 4.2 gadaje ga kowane mazauna 100,000 a Portugal.
Wannan yana nufin cewa ƙasar tana da fiye da ƙasa da albarkatu fiye da Italiya (12.5 asibiti na asibiti da na kulawa na tsakiya don kowane mazauna 100,000 a 2010).
An samar da yanayin samfurin da ya danganci rashin wadatar kulawar lafiya, tare da kimantawa ga kowace EU/EEA da UK na yaduwar COVID-19 da aka kwantar a asibiti wanda ke da alaƙa da haɗarin > 90% fiye da ƙarfin gadajen kulawa, a cikin sabuntawa na shida na saurin kimanta haɗarin COVID-19 ta ECDC.
Tun da a yanzu haka an samu clusters a wasu yankuna a cikin EU/EEA da kuma Birtaniya, kuma asibitoci da na'urorin kula da gaggawa suna kula da yawan mutanen da ke cikin yankin, ya kamata a samar da bayanai game da masu kamuwa da cutar da kuma gadajen kula da gaggawa a Tatanama don na'urorin kula da gaggawa na matakin 2 (NUTS-2).
Kwarewa daga Italiya da kuma yanayin da ake ciki a wasu ƙasashe ya nuna cewa annobar COVID-19 tana yaduwa cikin sauri a EU/EEA da kuma Burtaniya.
Saboda haka, dole ne ƙasashe, asibitoci da rukunin kulawa ta gaggawa su shirya don yanayin watsawa na SARS-CoV-2 a cikin al'umma da kuma karuwar adadin marasa lafiya da ke kamuwa da COVID-19 waɗanda ke buƙatar kulawa ta kiwon lafiya, musamman kulawa ta gaggawa, kamar yadda ke faruwa a yankunan da ke fama da cutar a Italiya.
Kamar yadda aka jaddada a cikin sabon ƙimar haɗarin ECDC, hanzari, mai himma da cikakkiyar hanya tana da mahimmanci don rage saurin watsa SARS-CoV-2, tare da motsawa daga hanyar hanawa zuwa ragewa, saboda tsammanin saurin ƙaruwa a cikin adadin shari'o'in na iya ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, karɓa da daidaita martani yadda ya kamata idan ba a aiwatar da su ba da wuri.
Binciken hadarin da aka yi cikin gaggawa ya kuma lissafa matakan kiwon lafiya na jama'a don rage tasirin cutar.
Akwai ɗan gajeren lokacin da ƙasashe ke da damar ci gaba da haɓaka ƙoƙarin sarrafa su don rage yaduwar SARS-CoV-2 da rage matsin lamba kan kiwon lafiya.
Idan wannan ya gaza, yana yiwuwa tsarin kiwon lafiya na sauran ƙasashen EU/EEA zai fuskanci karuwar marasa lafiya da ke buƙatar kulawa mai mahimmanci a cikin kwanaki ko makonni masu zuwa.
Barkewar cutar Coronavirus 2019 (COVID-19), wanda cutar SARS ta haifar, ya kashe mutane sama da 3,000 kuma ya cutar da mutane sama da 80,000 a China da sauran sassan duniya, wanda hakan ya haifar da bala'i ga bil'adama.
Kamar yadda kwayar cutar ta SARS-CoV, wacce ta haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya yaduwa daga batutuwan kuma yana haifar da alamun bayyanar ta hanyar irin wannan hanyar.
Koyaya, COVID-19 yana da ƙarancin tsananin cutar da ƙarancin mutuwar SARS amma yana da saurin yaduwa kuma yana shafar tsofaffi fiye da matasa da maza fiye da mata.
Domin a san cewa ana yawan wallafa wannan sabon ciwo, an yi ƙoƙari a ba da cikakken bayani game da wannan ciwo da ake ci gaba da bincike a kai.
Za mu tattauna muhimman abubuwa game da cutar, da yadda ake kamuwa da ita, da yadda ake kamuwa da ita, da yadda ake gane ta, da yadda ake kula da ita, da yadda ake gane ta, da kuma yadda za a hana ta.
Ko da yake akwai tambayoyi da yawa da za a amsa, muna fatan cewa wannan bita zai taimaka wajen fahimtar da kuma kawar da wannan cuta mai barazana.
Bikin bazara a ranar 25 ga Janairu, 2020 ya zama abin tunawa da ba a zata ba ga mutanen China da aka bukaci su zauna a gida a lokacin hutun da makonni bayan haka saboda barkewar cutar kwayar cutar.
Kwayar cutar ta yi kama da kwayar cutar coronavirus (CoV) da ta haifar da barkewar cutar ta saurin numfashi (SARS) a 2003; saboda haka, Hukumar Lafiya ta Duniya (WHO) ta sanya mata suna SARS-CoV-2 a ranar 11 ga Fabrairu 2020 kuma ta sanya mata sunan cutar CoV Disease-19 (COVID-19).
Wannan annobar ta fara ne a Wuhan, China kuma ta bazu cikin sauri zuwa duk kasar da kusan wasu kasashe 50 a duniya.
Ya zuwa ranar 2 ga Maris, 2020, kwayar cutar ta haifar da sama da 80,000 na tabbatar da cutar COVID-19, tare da sama da marasa lafiya 40,000 da aka sallame su gida da kuma sama da marasa lafiya 3,000 da suka mutu.
WHO ta yi gargadin cewa COVID-19 shine "magabcin jama'a na 1" kuma yana da damar zama mai ƙarfi fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga takardu sama da 2000 game da COVID-19 gami da ilimin kwayar cuta, ilimin cututtuka, ilimin asali, ganewar asali da magani tun bayan rahoton farko a ranar 7 ga Janairu 2020 wanda ya ƙayyade kwayar cutar da aka ware daga wasu marasa lafiya.
Wannan bita ya yi ƙoƙari ya taƙaita ci gaban bincike a cikin sabon yanki da kuma ci gaba da sauri.
A lokacin da ya dace, za mu gwada COVID-19 da SARS da kuma wani cuta da ke haifar da CoV, ciwon numfashi na Gabas ta Tsakiya (MERS, wanda ya ɓarke a shekara ta 2012).
Za mu kuma tattauna abin da aka sani game da rigakafin cutar da kuma yadda za a iya gane ta, da kuma wasu muhimman tambayoyi.
CoVs an saba ganin su a matsayin masu cutarwa marasa lahani ga mutane, yawanci su ne ke haifar da kusan kashi 15% na mura ta yau da kullun 4.
Duk da haka, a wannan ƙarni, mun gano kwayar cutar mutum mai saurin kamuwa da cuta sau biyu, wato SARS-CoV da MERS-CoV, wanda ya haifar da barkewar annobar da ta samo asali a China a 2003 da Saudi Arabiya a 2012, kuma nan da nan ta bazu zuwa wasu ƙasashe da yawa tare da mummunan yanayin rashin lafiya da mutuwa.
Saboda haka, COVID-19 na yanzu shine annoba ta uku ta CoV a tarihin ɗan adam da aka rubuta.
Kamar yadda aka nuna a cikin Hoto na 1,1, an fara bayar da rahoton tarin cutar huhu da ba a san asalinsa ba daga Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta Kasa ta China.
Bayan kwana bakwai, an fitar da kwayar cutar.
A ranar 15 ga Janairu, 2020 an samu rahoton mutuwar mutum na farko daga Wuhan.
A halin yanzu, annobar ta bazu cikin sauri zuwa birane, larduna da ƙasashe makwabta.
A ranar 20 ga watan Janairu, an samu rahoton kamuwa da cuta a tsakanin ma'aikatan kiwon lafiya, wanda ke nuna cewa mutum-zuwa-mutum na iya faruwa.
A ranar 23 ga watan Janairu, an sanya dokar hana fita a birnin Wuhan, inda aka dakatar da dukkan ayyukan sufuri.
A ranar 24 ga Janairu binciken farko na asibiti kan cutar ya ruwaito cewa, daga cikin marasa lafiya 41 da aka tabbatar da su, 21 ne kawai suka yi hulɗa kai tsaye da kasuwar abincin teku ta Wuhan wanda ake ganin shine farkon fara kamuwa da cutar daga asalin dabbobi da ba a sani ba.
A ranar 30 ga watan Janairu, WHO ta ayyana cutar a matsayin gaggawa ta duniya.
A lokacin wannan rahoton, cutar ta bazu ko'ina cikin kasar Sin da kuma kusan wasu kasashe 50 a duniya (Shirya (Shirya 2).2).
Saboda yadda lamarin ke ci gaba da bunkasa, ba a san ko cutar za ta kai ko za ta yi tsanani ba.
A ranar 11 ga Fabrairu, 2020, nazarin cibiyoyi da yawa na marasa lafiya 8,866 ciki har da 4,021 waɗanda aka tabbatar da cutar COVID-19 sun ba da ƙarin bayani game da annobar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 na kamuwa da marasa lafiya a duk shekaru, amma mafi yawansu suna tsakanin shekaru 30-65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun haura shekaru 50, kaɗan ne ke ƙasa da shekaru 20 kuma mutane 14 ne kawai suka kamu da cutar da shekarunsu ba su kai 10 ba.
SARS-CoV-2 ya kamu da maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 na yaduwa a cikin gidajen abinci da ke da yawa a cikin da kewaye da Hubei.
COVID-19 yana ɗaukar matsakaicin kwanaki 5 (2-9) daga farkon zuwa ganewar asali.
Matsakaicin lokacin jinkiri shine kwanaki 4.8 (3.0-7.2).
Matsakaicin lokaci daga farawa zuwa mutuwa shine 9.5 (4.8-13) kwanaki.
Lambar haihuwa (R0) na asali shine 3.77 (95% CI: 3.51-4.05), kuma daidaitaccen RO shine 2.23-4.82.
Adadin mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin manyan motsi kafin bikin bazara a China.
Yawan mutuwar marasa lafiya tare da tabbatar da shari'ar shine 1.44% (95% CI: 1.10-1.86%), kuma daidaitaccen mutuwar ga dukkan marasa lafiya shine 3.06% (95% CI: 2.02-4.59%).
Abubuwa uku na farko da ke haifar da COVID-19 su ne jinsi (maza), shekaru (≥60) da kuma ciwon huhu mai tsanani.
CoVs wani ƙaramin kwayar cuta ne mai girma da ke ɗauke da zaren RNA guda ɗaya.
Ana iya rarraba kwayar cutar zuwa nau'i huɗu, wato, alpha, beta, gamma, da delta, a tsakanin dukkan alpha- da beta-CoVs da aka sani da cutar ɗan adam.
Spike (S) glycoprotein surface yana ɗaure ga masu karɓar ƙwayar cuta na angiotensin-modifying enzyme 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, kuma daga baya membrane fusion yana faruwa.
Ana sakin kwayar RNA ta kwayar cutar a cikin cytoplasm; bayan kwayar kwayar cutar ta kwayar cutar, RNA ta genomic tana tare da glycoprotein surface da kuma sunadaran nucleocapsid suna samar da kwayar da ke dauke da virion, wanda daga baya ya haɗu da membrane na plasma don sakin kwayar cutar.
An bayar da rahoton farkon kwayar cutar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV mai daukan fiye da kashi 99.98% na asalin kwayoyin halitta a cikin samfura 10 da aka samo daga wurin da cutar ta samo asali, Kasuwar Abinci na teku ta Huanan a Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV a kwayoyin halitta fiye da MERS-CoV.
Ta hanyar na'urar daukar hoto ta electron microscope, an gano SARS-CoV-2 a cikin mafi ƙanƙan ɓangaren epithelium na numfashin mutum.
An gano ACE2 na ɗan adam a matsayin mai karɓar SARS-CoV-2 da SARS-CoV.
Duk da haka, furotin S na SARS-CoV-2 yana da rauni sosai ga ACE2 fiye da SARS-CoV, wanda ya yi daidai da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 kuma na iya samar da sabon kwayar halitta mai sauƙin tsari wanda aka tsara ta orf3b da kuma kwayar halitta mai sauƙin tsari wanda aka tsara ta orf8.
orf3b don SARS-CoV-2 na iya taka rawa a cikin cutar kwayar cuta ta kwayar cuta kuma yana da bayanin IFNβ; duk da haka, orf8 ba shi da wani yanki ko yanayin aiki.
A ranar 18 ga Fabrairu, 2020, Zhou, et al., sun ba da rahoton cewa tsarin cyro-EM na ACE2 na ɗan adam gaba ɗaya yana da ƙuduri 2.9 Å a cikin hadaddun tare da mai ɗaukar amino acid B0AT1.
Sun gano cewa wannan hadaddun, wanda ke da buɗewa da rufewa, ya haɗu azaman dimer kuma ACE-BOAT2 hadaddun na iya haɗuwa da sunadarai biyu na S, wanda ke ba da tabbaci ga haɗuwa da kamuwa da cutar CoV.
B0AT1 na iya zama makasudin magani don tace magungunan hana kamuwa da cutar SARS-CoV-2.
Ƙarƙashin farko da na tsakiya
An san cewa SARS-CoV da MERS Cov sun samo asali ne daga bat da kuma an watsa su ga mutane ta hanyar fox da raƙumi, bi da bi.
Ta hanyar kwatanta SARS-CoV-2 da sauran CoVs, ana ganin bat ne asalin SARS-CoV-2 saboda sabon kwayar cutar tana da kama da kashi 96% na CoVs biyu kamar SARS daga bat da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Duk da haka, ba a san ainihin mahaɗan da ke taimaka wa kwayar cutar ta ƙetare shingen da ke hana ta kamuwa da mutane ba, kuma ba a bayyana hanyar da za ta iya yaduwa ba.
Ji, et al., sun ba da shawarar cewa macizai suna ɗaukar kwayar cutar daga bat zuwa ɗan adam wanda ya ƙunshi haɗuwa da homologous a cikin S protein.
A cewar binciken, masu bincike a Guangzhou, China sun ba da shawarar cewa tururuwa - dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi
Duk da haka, bambancin 1% da aka rarraba a cikin kwayoyin halittar biyu har yanzu babban bambanci ne; saboda haka, yanke shawara na ƙarshe don samar da hujjoji na zahiri yana jiran (Shirya (Fig.33).
Har yanzu ba a san yanayin kimiyyar SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa in vitro na tsawon sa'o'i 48 a cikin bushewar yanayi da kuma tsawon kwanaki 45 a ƙarƙashin 20 °C da zafi 40%-50%.
SARS-CoV-2 na iya samun irin wannan halayen.
An bayar da rahoton cewa SARS-CoV-2 yana da saukin kamuwa da hasken ultraviolet da zafi a 56 °C na tsawon minti 30; ether, 75% ethanol, chlorine-containing disinfectant, peracetic acid, chloroform, da sauran mai narkewa, amma ba chlorhexidine ba, na iya kashe kwayar cutar sosai.
Dukan yawan mutane ba su da rigakafi ga SARS-CoV-2 kuma saboda haka ana ganin su masu saukin kamuwa da cutar.
A halin yanzu, babu cikakken bincike da aka ruwaito game da martani na rigakafi ga SARS-CoV-2.
Saboda haka, za mu iya komawa ga binciken da aka yi a baya game da wasu CoVs, musamman SARS-CoV da MERS-CoV (Hoto (Hoto 4).4).
Gabaɗaya, bayan ƙwayoyin cuta sun shiga cikin kwayar cuta, kwayar cuta ta fara gano ta ta hanyar tsarin rigakafin kwayar cuta ta hanyar masu karɓar alamun ganewa (PRRs) gami da masu karɓar kamar su lectin nau'in C, masu karɓar kamar Tol (TLR), masu karɓar kamar NOD (NLR), da masu karɓar kamar RIG-I (RLR).
Duk da bambancin hanyoyin, kwayar cutar tana haifar da bayyanar abubuwan kumburi, tsufa na kwayoyin dendritic da kuma nau'in interferon type I (IFNs) wanda ke hana yaduwar kwayar cutar da kuma hanzarta phagocytosis na kwayar cutar.
Duk da haka, furotin N na SARS-CoV zai iya taimakawa kwayar cutar ta guje wa amsawar garkuwar jiki.
Ba da daɗewa ba bayan haka, rigakafin jikinmu ya soma yaƙi da cutar.
T lymphocytes ciki har da CD4+ da CD8+ T cells suna taka muhimmiyar rawa a cikin kariya.
CD4+ T cells suna motsa B cells su samar da ƙwayoyin cuta na musamman da kuma CD8+ T cells suna kashe kwayoyin cuta.
T-cell mai taimako tana samar da cytokines masu yaduwa don taimakawa cikin rigakafin.
Koyaya, CoVs na iya hana aikin T-cell ta hanyar haifar da apoptosis na T-cell.
Tsarin rigakafin jiki na ciki ciki har da masu kari kamar C3a da C5a da kuma antibodies suna da mahimmanci wajen yaƙi da kamuwa da kwayar cutar.
Misali, kwayoyin cutar da aka ware daga marasa lafiya da suka warke sun kawar da MERS-CoV.
A wani ɓangare kuma, yawan ƙwayar cuta da jikinmu yake yi yana jawo ƙwayoyin cuta masu yawa a jikinmu da ke iya sa mugun lalacewa ga huhu da sauran gabobin jiki, kuma a yanayi mafi muni, zai iya sa wasu gabobin jiki su kasa aiki ko kuma su mutu.
Cutar SARS-CoV-2, bisa ga farkon cluster, na iya shafar tsofaffi tare da comorbidities da mata masu juna biyu.
Ya zama gama gari ga waɗanda ke da babban adadin ƙwayoyin cuta ko kuma waɗanda ke da aikin rigakafi, suna da damar kamuwa da cutar fiye da sauran mutane.
An kiyasta matsakaicin lokacin rage cutar SARS-CoV-2 na kwanaki 1-14, yawanci kwanaki 3-7 bisa nazarin shari'o'i 425 na farko a Wuhan.
Duk da haka, nazarin mutane 1,099 ya nuna cewa tsawon lokacin da ake hana cutar ya kai kwanaki uku a matsakaici kuma ya kai daga kwanaki 0 zuwa 24.
Wani bincike na baya-bayan nan, kamar yadda aka ambata a sama, ya nuna cewa tsawon lokacin kwantar da hankali ya kasance kwanaki 4.8 (3.0-7.2) bisa alƙaluma na mutane 8,866.
Yana da muhimmanci hukumomin kiwon lafiya su daidaita lokacin keɓewa bisa ga lokacin da ya fi dacewa, tare da hana waɗanda suka kamu amma ba su da alamun cutar daga yada cutar ga wasu.
A matsayin al'ada, mutane da ke fama da cutar, ko kuma suka kamu da ita, yawanci suna bukatar su keɓe kansu na tsawon kwanaki 14.
Shin ya kamata a ƙara tsawon lokacin keɓewar zuwa kwanaki 24?
Zazzabi yawanci shine babban bayyanar cutar COVID-19, wanda zai iya kasancewa ba tare da wasu alamun ba kamar tari mai bushewa, numfashi mai wuya, ciwon tsoka, tashin hankali, ciwon kai, ciwon makogwaro, rhinorrhea, ciwon kirji, diarrhea, naƙuda da amai.
Wasu marasa lafiya suna fuskantar dyspnea da/ ko hypoxemia a cikin mako guda bayan farawar cutar.
A cikin mawuyacin yanayi, yanayin mai haƙuri yana ƙaruwa da sauri zuwa cututtukan numfashi na gaggawa, ɓarna, acidosis na metabolic da coagulopathy.
Marasa lafiya da ke da zazzabi da/ko cututtukan numfashi da kuma zazzabi mai tsanani, koda kuwa ba tare da wani rashin daidaito na hotunan huhu ba, ya kamata a yi musu gwajin kwayar cutar don ganewar asali.
Nazarin alƙaluma a ƙarshen Disamba 2019 ya nuna cewa yawan alamun cutar shine 98% don zazzabi, 76% don tari mai bushe, 55% don dyspnea, da 3% don diarrhea; 8% na marasa lafiya suna buƙatar taimakon numfashi.
An kuma bayar da rahoton irin wannan binciken a cikin wasu binciken biyu na baya-bayan nan na cluster na iyali da kuma cluster da ke haifar da yaduwar cutar daga mutane marasa alamun cutar.
Ta hanyar kwatantawa, binciken alƙaluma a cikin 2012 ya nuna cewa marasa lafiyar MERS-CoV suma suna da zazzabi (98%), tari mai bushe (47%), da dyspnea (55%) a matsayin manyan alamun su.
Duk da haka, kashi 80% na su na bukatar taimakon numfashi, fiye da marasa lafiya na COVID-19 kuma daidai da yawan cutar MERS fiye da COVID-19.
An kuma lura da ciwon hauka (26%) da ciwon makogwaro (21%) a cikin marasa lafiyar MERS.
A cikin marasa lafiya na SARS, an nuna cewa zazzabi (99%-100%), tari mai bushe (29%-75%), dyspnea (40%-42%), diarrhea (20-25%), da ciwon makogwaro (13-25%) sune manyan alamun cutar kuma an bukaci taimakon numfashi a cikin kimanin kashi 14%-20% na marasa lafiya.
Har zuwa 14 ga Fabrairu, yawan mutuwar COVID-19 ya kai kashi 2 cikin dari yayin da aka tabbatar da cewa akwai mutane 66,576 a duniya.
A kwatankwacin haka, mutuwar SARS har zuwa Nuwamba 2002 ya kai kashi 10% na 8,096 da aka tabbatar.
Ga MERS, bisa ga binciken alƙaluma a watan Yunin 2012, yawan mutuwar mutum ya kai kashi 37% na 2,494 da aka tabbatar da cutar.
Binciken farko ya ba da rahoton cewa R0 na SARS-CoV-2 ya kai 6.47 tare da kashi 95% na tabbacin (CI) na 5.71-7.23, yayin da R0 na SARS-CoV ya kai 2 zuwa 4.
Kwatanta tsakanin SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da bayyanar cututtuka, yawan mutuwa da RO na cutar an nuna su a cikin Table Table1.1.
Lambobin da ke sama sun nuna cewa SARS-CoV-2 yana da damar kamuwa da cutar fiye da MERS-CoV da SARS-CoV, amma ba shi da cutar da ke haifar da mutuwa.
Saboda haka, yana da ƙalubale sosai don sarrafa cutar SARS-CoV-2 fiye da MERS-CoV da SARS-CoV.
Cluster farawa sau da yawa yakan faru a cikin iyali ɗaya ko daga taro ɗaya ko kuma daga motoci kamar jirgin ruwa.
Marasa lafiya yawanci suna da tarihin tafiya ko zama a Wuhan ko wasu yankuna da ke fama da cutar ko kuma hulɗa da mutane ko marasa lafiya da suka kamu da cutar a cikin makonni biyu da suka gabata kafin fara cutar.
Duk da haka, an bayar da rahoton cewa marasa lafiya na iya ɗaukar kwayar cutar ba tare da wata alama ba fiye da makonni biyu kuma waɗanda suka warke waɗanda aka yarda su dawo daga asibiti na iya ɗaukar kwayar cutar kuma, wanda ke ba da gargadi don ƙara lokacin keɓewa.
Marasa lafiya suna da ƙarancin ƙwayoyin jini na farfajiyar jini (musamman lymphocytes) na al'ada ko raguwa a farkon matakin.
Misali, lymphopenia tare da ƙididdigar ƙwayoyin jini < 4×109/L gami da ƙididdigar lymphocytes < 1×109/L, da kuma ƙaruwa a matakan aspartate aminotransferase da viremia an gano su a cikin marasa lafiya 1,099 na COVID-19.
An samu ƙaruwar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
A cikin marasa lafiya da suka kamu da cutar, matakin D-dimer, wanda shine samfurin lalacewar fibrin a cikin jini, ya ƙaru, kuma ƙididdigar lymphocytes sun ragu sosai.
An gano rashin daidaito a cikin hotunan kirji a cikin yawancin marasa lafiya na COVID-19 kuma ana nuna shi ta hanyar inuwa mai haɗuwa ta hanyar haɗin gwiwa ko kuma ƙarancin gilashin ƙasa a cikin huhu.
Marasa lafiya galibi suna fama da cutar huhu, raunin huhu da kuma ciwon numfashi mai tsanani (ARDS).
Sa'ad da ARDS ta faru, kumburi da ba a iya sarrafawa, da kuma saurin samun ruwa da kuma ciwon tsoka suna shafan canjin gas sosai.
Rashin aiki na nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Saboda haka, munanan hotunan ƙirjin da aka yi a kan ƙirjin mutane sukan nuna cewa suna da ciwon zuciya sosai.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar COVID-19 ya nuna cewa pneumocytosis, samuwar membrane na hyaline da kuma shigar da kwayoyin lymphocytes na interstitial da kuma kwayoyin sinitium na multinucleate a cikin huhu na marasa lafiya da suka mutu daga cutar, daidai ne da cutar kamuwa da kwayar cutar da ARDS da kuma kama da cutar SARS da MERS.
Gano SARS-CoV-2 RNA ta hanyar halayen sarkar polymerase-reverse transcription (RT-PCR) an yi amfani da shi azaman babban ka'ida don gano COVID-19.
Koyaya, saboda yawan ƙarancin ƙarancin ƙarancin ƙarya, wanda zai iya haifar da annoba, an fara amfani da bayyanar asibiti don ganewar asali (wanda ba ya dogara da RT-PCR kawai) a China a ranar 13 ga Fabrairu, 2020.
Haka ma yake da cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar asibiti, gwajin gwaji da binciken radiology suna da mahimmanci kuma suna da mahimmanci don yin ingantaccen ganewar asali.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana wani tsari na amfani da fasahar SHERLOCK mai tushen CRISPR don gano SARS-CoV-2, wanda ke gano ɓangarorin SARS-CoV-2 RNA na roba a 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (10-100 kwafi a kowace microliter na shigarwa) ta amfani da tubalin ruwa a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki mai rikitarwa ba.
Muna fatan cewa wannan sabuwar dabara zata iya inganta ƙwarewa da sauƙin gaske idan aka tabbatar da ita a cikin samfurin asibiti.
Saboda rashin gogewa da sabon CoV, likitoci na iya samar da tallafi ga marasa lafiya na COVID-19, yayin da suke gwada magungunan da aka yi amfani da su ko aka ba da shawarar a baya don maganin sauran CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan kwayar cuta (Table (Table2).2).
Wannan magani ya hada da maganin da ake yi yanzu da kuma wanda ake iya yi da kwayoyin cutar, maganin hana rigakafi, maganin steroids, maganin plasma daga marasa lafiya da suka warke, maganin kasar Sin da kuma taimakon tunani.
An kuma ba da shawarar a yi amfani da jini daga marasa lafiya da suka warke.
Kamfanonin harhada magunguna suna ta fafutuka wajen samar da rigakafin cutar da kuma rigakafin cutar.
SARS-CoV-2 yawanci yana kaiwa ga huhu a matakin farko kuma yana iya kaiwa, a ƙananan matakan, wasu gabobin da ke samar da ACE2, kamar tsarin gastrointestinal da na koda.
Duk da haka, rashin aiki da kuma gazawar numfashi suna da babbar barazana ga marasa lafiya kuma sune manyan sanadin mutuwa.
Saboda haka, tallafin numfashi yana da mahimmanci don sauƙaƙe bayyanar cututtuka da ceton rai gami da maganin oxygen na gaba ɗaya, oxygen mai gudana, iska mai hanawa da iska mai hana iska dangane da tsananin cutar.
Marasa lafiya da ke da cututtukan numfashi masu tsanani suna buƙatar tallafawa ta hanyar oxygenation na membrane na waje (ECMO), ingantaccen fasahar zane-zane na cardiopulmonary da ake amfani da ita don magance rashin lafiyar zuciya ko numfashi.
Bugu da kari, kiyaye daidaiton electrolyte, rigakafi da maganin cututtukan sakandare da kuma girgizar sepsis, da kuma kare muhimman ayyukan gabobin jiki suma suna da mahimmanci ga masu cutar SARS-CoV-2.
An san cewa annobar cytokine ta samo asali ne daga yawan amsawar tsarin garkuwar jiki a cikin marasa lafiya na SARS da MERS.
Cytokine hawan shine nau'in amsawar kumburi na tsarin da aka nuna ta hanyar sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wannan cytokine yana sa ƙwayoyin cuta su saki ɗumbin adadin ƙwayoyin cuta masu 'yanci wanda shine babban dalilin ARDS da rashin aiki da gabobin jiki.
Ammunophenic yana da muhimmanci a maganin cututtukan cytokine, musamman ma ga marasa lafiya masu tsanani.
An yi amfani da maganin corticosteroid da tocilizumab, anti-IL6 monoclonal antibody, don magance matsalar cytokine.
Sauran maganin rigakafin rigakafin cututtukan cytokine sun hada da T-cell directed immune response modulation; IFN-γ, IL-1, da TNF blockade; JAK activation; blinatumomab; cytokine 4 siginar mai hanawa; da kuma HDAC activation.
Ana amfani da steroids, a matsayin maganin hana rigakafi, a cikin maganin SARS don rage tsananin lalacewar kumburi.
Duk da haka, steroids a manyan allurai ba su da amfani ga mummunan rauni na huhu a cikin marasa lafiya na SARS da COVID-19.
A gefe guda, steroids a cikin manyan allurai na iya haifar da mummunan sakamako, musamman osteonecrosis avascular, yana shafar yanayin ci gaba sosai.
Duk da haka, an ba da shawarar yin amfani da ƙananan magungunan corticosteroid na ɗan gajeren lokaci tare da taka tsantsan ga marasa lafiya masu cutar COVID-19.
A lokacin da ake rubuta wannan labarin, babu maganin rigakafi da aka tabbatar da inganci.
Duk da haka, an gano cewa shan remdesivir a cikin intravenous, wanda yake kwatankwacin nucleotide, ya yi tasiri a kan wani mara lafiya Ba'amurke da ya kamu da COVID-19.
Remdesivir wani sabon maganin rigakafi ne da Gilead ta fara kirkirarsa don maganin cututtukan da ke haifar da cutar Ebola da Marlburg.
Bayan haka, remdesivir ya kuma nuna yiwuwar kamuwa da wasu ƙwayoyin cuta masu amfani da RNA guda ɗaya ciki har da MERS da SARS.
Bisa ga wannan lura, Gilead ta ba da cakuda ga China don gudanar da gwaje-gwaje biyu a kan mutanen da ke dauke da cutar SARS-CoV-2, kuma ana jiran sakamakon.
Bugu da ƙari, baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin an ba da shawarar a matsayin yiwuwar magani ga marasa lafiya da ke da alamun cututtukan numfashi.
Diarrhea, amai, vomiting, cutar hanta da sauran illa na iya faruwa bayan maganin hadewar lopinavir/ritonavir.
Ya kamata a lura da hulɗar wannan magani tare da sauran magungunan da ake amfani da su ga marasa lafiya.
Plasma daga marasa lafiya da suka warke da kuma samar da kwayoyin cutar
Tattara jini daga marasa lafiya da suka warke daga cututtuka masu yaduwa don kula da wasu marasa lafiya da ke fama da irin wannan cutar ko don kare mutane masu lafiya daga kamuwa da cutar yana da dogon tarihi.
Gaskiya ne cewa, marasa lafiya da suka warke suna da ƙwayoyin cuta masu yawa a cikin jininsu.
Kwayoyin rigakafi sune immunoglobulin (Ig) da kwayoyin B ke samarwa don yaƙar ƙwayoyin cuta da sauran abubuwa na waje kuma yana gano ƙwayoyin ƙwayoyin cuta na musamman a cikin ƙwayoyin cuta sannan kuma ya kawar da su kai tsaye.
Bisa ga wannan, an tattara jini daga jinin wani rukunin marasa lafiya da suka warke daga COVID-19 kuma an yi wa marasa lafiya 10 allurar rigakafi.
A cikin sa'o'i 24 suka sami sauƙi, tare da rage kumburi da ƙwayar cutar da kuma ƙara yawan jini.
Duk da haka, ana bukatar tabbaci da bayani don a ba da shawarar irin wannan hanyar don amfani mai yawa kafin a samar da takamaiman maganin da ba a riga an tsara ba.
Bugu da ƙari, saboda tasirin maganin, wasu daga cikin abubuwan da ke tattare da cutar plasma dole ne a yi la'akari da su sosai.
Alal misali, ƙwayoyin cuta suna iya sa rigakafin ya yi tsattsauran ra'ayi kuma su sa a samu ciwon cytokine, wanda zai iya sa a yi mutuwa.
Yawan rigakafin a cikin jini yawanci yana da ƙanƙanta kuma bukatar jini tana da yawa don kula da marasa lafiya masu tsanani.
Yana da wuya a samu da kuma samar da rigakafin cutar nan take don yaƙi da annobar duniya.
Saboda haka, yana da mahimmanci kuma yana da amfani a ware kwayoyin B daga marasa lafiya da suka warke da kuma gano lambar kwayar halitta da ke yin kwafin kwayar cutar mai tasiri ko kuma tace kwayar cutar mai tasiri akan wasu muhimman sunadarai na kwayar cutar.
Ta wannan hanyar, za mu iya ƙara samar da ƙwayoyin cuta.
An yi amfani da TCM wajen magance cututtuka a ƙasar Sin na dubban shekaru.
Koyaya, tasirin ya dogara sosai akan haɗuwa da abubuwa daban-daban a cikin ƙira wanda ya bambanta bisa ga ganewar asali na cutar bisa ka'idar TCM.
Yawancin abubuwan da ke aiki ba a san su ba ko kuma sun kasance masu rikitarwa saboda yana da wuya a cire da kuma tabbatar da irin waɗannan abubuwan ko kuma haɗuwa da su.
A halin yanzu, saboda rashin takamaiman magani mai tasiri don COVID-19, TCM ya zama ɗayan manyan hanyoyin magani na madadin ga marasa lafiya tare da ƙananan alamun cutar ko kuma waɗanda suka warke daga matsanancin yanayi.
Misali, Shu Feng Jie Du da Lian Hua Qing Wen sun sami inganci wajen maganin COVID-19.
An ga mafi yawan adadin masu warkewa a kulawar marasa lafiya na COVID-19 a wasu larduna a kasar Sin da ke amfani da TCM a kashi 87% na marasa lafiyarsu, ciki har da Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei, wanda ke amfani da TCM a cikin kusan kashi 30% na marasa lafiya na COVID-19, yana da mafi ƙarancin adadin masu warkewa (13%).
Amma, wannan kwatancen ya yi kama da na baya-bayan nan saboda wasu abubuwan da suka shafi cutar kamar yawan marasa lafiya da kuma tsananin cutar da ake fama da su, dole ne a yi la'akari da su.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga wani bincike don kwatanta maganin maganin yammacin yamma (WM) kadai tare da hadewar WM da TCM.
Sun gano cewa lokacin da ake bukata don dawo da zafin jiki, kawar da alamun cutar da kuma kulawar asibiti ya yi gajarta a cikin rukunin WM+TCM fiye da na WM kadai.
Mafi ban mamaki, yawan yanayin bayyanar cututtuka ya zama mafi muni (daga m zuwa mai tsanani) ya kasance ƙasa da ƙasa ga ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (7.4% vs. 46.2%) kuma ƙananan mutuwar a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (8.8% vs. 39%).
Amma, amfanin da kuma amincin TCM suna jiran gwaji mai kyau a manyan wurare da kuma cibiyoyi da yawa.
Yana da ban sha'awa a kwatanta yadda ake yin maganin kuma a bayyana abin da ke cikin maganin TCM ko kuma a haɗa shi idan zai yiwu.
Marasa lafiya da ake zargi ko kuma aka tabbatar da cewa suna da COVID-19 galibi suna jin tsoron cutar mai saurin yaduwa da kuma iya haifar da mutuwar, yayin da waɗanda ke keɓewa kuma suna jin haushi, kaɗaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, hypoxia da tari da kuma illa na magani kamar rashin bacci da ake samu ta hanyar corticosteroids na iya haifar da tashin hankali da kuma damuwa na hankali.
A farkon fasalin annobar SARS, an kuma bayar da rahoton cututtukan da ke tattare da cutar ta rashin lafiyar kwakwalwa, ciki har da ciwon ciwon zuciya, tashin hankali, tashin hankali, halayen rashin hankali, hauka, har ma da kashe kansa.
Binciken tuntuɓar wajibi da keɓewa, a matsayin wani ɓangare na amsar lafiyar jama'a ga annobar COVID-19, na iya sa mutane su ji damuwa da laifi game da tasirin kamuwa da cuta, keɓewa da kuma wulakanci ga danginsu da abokansu.
Saboda haka, ya kamata a ba da kulawar lafiyar hankali ga marasa lafiya na COVID-19, waɗanda ake zargi da kuma mutanen da suka yi hulɗa da su da kuma jama'a da ke buƙatarsa.
Tallafin halayyar dan adam ya kamata ya hada da kafa kungiyoyin kula da lafiyar kwakwalwa da yawa, sadarwa mai kyau tare da sabuntawa akai-akai game da cutar SARS-CoV-2 da shirin magani da kuma amfani da na'urorin lantarki da aikace-aikacen kwararru don kauce wa kusanci da juna.
Alurar riga kafi mai inganci tana da mahimmanci don katse sarkar watsawa daga yankin dabbobin da mutane suka kamu da cutar zuwa ga rundunar da ke fama da cutar kuma yawanci yana dacewa da maganin rigakafi a cikin kula da annobar da cutar ta haifar.
An yi ƙoƙari ta hanyar haɓaka allurar rigakafin S-protein don samar da tsayayyen lokaci mai tasiri da kuma tsayayyen rigakafi da/ko rigakafi daga SARS-CoV.
An gwada rigakafin da ke rage yawan cutar kai tsaye a cikin dabbobi don SARS.
Duk da haka, ya kamata a tantance ingancin in vivo na wannan allurar rigakafin a cikin tsofaffi da kuma ƙirar ƙalubale mai haɗari da kariya daga kamuwa da kwayar cutar zoonotic kafin fara gwajin asibiti.
Wataƙila saboda SARS ta ƙare shekaru 17 da suka gabata kuma babu wani sabon yanayin da aka ba da rahoto tun daga lokacin.
Akasin haka, wasu lokuta da kuma tarin cututtuka na MERS sun ci gaba da faruwa a Gabas ta Tsakiya da kuma yaduwa zuwa wasu yankuna saboda ci gaba da samun zoonotic a yankunan da ke da iyaka.
An tsara dabarun allurar rigakafi don MERS ta amfani da kwayar cuta mara aiki, plasma na DNA, kwayar cuta, nanoparticles, kwayar cuta kamar kwayar cuta da kuma subunits na furotin da aka sake hadawa kuma an gwada wasu a cikin samfurin dabba.
Ci gaban ingantaccen rigakafin SARS-CoV-2 ga mutanen da ba su da rigakafi aiki ne da ake buƙata da gaggawa kuma yana da mahimmanci don sarrafa annobar da ke gudana.
Koyaya, yana da ƙalubale don shawo kan wahalar saboda dogon lokaci (matsakaici na watanni 18) da ake buƙata don haɓaka allurar rigakafi da bambancin CoV mai ƙarfi.
A matsayin sabuwar cuta, COVID-19 ta nuna cikakkiyar hanyar asibiti a cikin dubban marasa lafiya.
A yawancin lokaci, marasa lafiya suna iya warkewa a hankali ba tare da sake kamuwa da cutar ba.
Duk da haka, kamar SARS da MERS, COVID-19 kuma an danganta shi da yawan kamuwa da cuta da mutuwa a cikin marasa lafiya da ke da mummunan cuta.
Saboda haka, gina samfurin hangen nesa don cutar yana da mahimmanci ga hukumomin kiwon lafiya don fifita ayyukansu, musamman a yankunan da ke da karancin albarkatu.
Dangane da binciken asibiti da aka ruwaito zuwa yanzu, waɗannan abubuwan na iya shafar ko alaƙa da yanayin cutar COVID-19 (Tablo (Tablo33):
Shekara: Shekara ita ce muhimmiyar mahimmanci ga cutar SARS, wanda kuma gaskiya ne ga COVID-19.
COVID-19 yawanci yana faruwa ne a tsakanin shekaru 30-65 tare da kashi 47.7% na waɗanda ke da shekaru 50 a cikin binciken na 8,866 da aka ambata a sama.
Marasa lafiya da ke buƙatar kulawa mai ƙarfi sun fi saurin samun ɓoyayyun cututtuka da rikitarwa kuma sun fi waɗanda ba sa buƙatar su tsufa (a matsakaicin shekaru 66 da 51), suna ba da shawarar shekaru a matsayin yanayin hangen nesa don sakamakon marasa lafiyar COVID-19.
Jima'i: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka ambata a sama.
Haɗuwa da rikice-rikice: Marasa lafiya da ke da COVID-19 da ke buƙatar kulawa mai tsanani suna iya samun raunin zuciya mai tsanani da kuma arrhythmia.
Matsalar zuciya ita ce sanadin mutuwar marasa lafiya da cutar SARS.
An ba da rahoton cewa SARS-CoV-2 na iya ɗaure zuwa ACE2 mai kyau na colangiocytes, wanda zai iya haifar da rashin aikin hanta a cikin marasa lafiya COVID-19.
An lura cewa shekaru da cututtuka suna da alaƙa kuma suna iya shafan juna.
Binciken dakin gwaje-gwaje na rashin daidaito: Matakan C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko raunin nama kuma an ba da shawarar a matsayin mai yuwuwar yanayin cutar, amsawa ga magani da warkarwa ta ƙarshe.
An kuma ba da shawarar alaƙar ƙwayoyin CRP da tsananin cutar COVID-19.
Bugu da ƙari, ƙaruwar lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Ana fitar da wannan enzyme a yalwace a cikin gaɓoɓin jiki, musamman zuciya da hanta, kuma ana fitar da shi a lokacin da ake lalacewar nama.
Saboda haka, ya zama alama ta gargajiya don rashin aiki na zuciya ko hanta.
Babban bayyanar cututtuka: Ya kamata a yi la'akari da radiograph na kirji da ci gaban bayyanar cututtuka a kan lokaci tare da sauran batutuwa don hango sakamakon da rikitarwa na COVID-19.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids sune immunosuppressants waɗanda aka saba amfani dasu azaman ƙarin magani don cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Tun da aka yi amfani da maganin rigakafi mai yawa a cikin marasa lafiya masu cutar SARS, yawancin tsofaffin marasa lafiya suna fama da cutar osteonecrosis tare da nakasa rayuwa da kuma rashin ingancin rayuwa.
Saboda haka, idan ya cancanta, ya kamata a yi amfani da steroids a ƙananan allurai kuma na ɗan gajeren lokaci a cikin marasa lafiya na COVID-19.
Matsalar tunani: Kamar yadda aka ambata a sama, a lokacin annobar COVID-19 marasa lafiya da yawa sun sha wahala daga matsanancin damuwa saboda suna yawan fuskantar tsawan lokacin keɓewa da matsanancin rashin tabbas da kuma ganin mutuwar dangi da abokan marasa lafiya.
Yana da muhimmanci a ba da shawara ta dogon lokaci da kuma tallafi don taimakawa marasa lafiya su warke daga damuwa kuma su koma rayuwa ta al'ada.
Bisa ga binciken alƙaluma da aka yi a yanzu, COVID-19 ya bayyana yana da halaye daban-daban na annoba fiye da SARS.
Baya ga ninkawa a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya ninkawa cikin inganci a cikin ƙananan hanyoyin numfashi kuma yana haifar da ƙananan alamomi ko babu alamomi a farkon farkon kamuwa da cuta, kamar sauran CoVs da ke haifar da mura.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon lokaci ko lokacin hanawa na iya samar da adadin kwayar cutar yayin gudanar da ayyukan yau da kullun, yana mai da wahalar sarrafa annobar.
Duk da haka, ana ganin SARS-CoV yana faruwa ne a lokacin da mai cutar ya yi rashin lafiya, yayin da yawancin kamuwa da cutar ba sa faruwa a farkon lokaci.
Saboda haka, annobar COVID-19 ta yanzu ta fi ta SARS muni da wahalar sarrafawa.
An yi gagarumar yunkuri a kasar Sin, ciki har da dokar hana fita a Wuhan da biranen da ke kewaye da ita, da kuma keɓewar kusan dukkanin al'umma, da fatan kawo karshen yaduwar cutar SARS-CoV-2.
Duk da cewa wannan matakin ya yi wa tattalin arziki da sauran bangarori na kasar illa, adadin sabbin masu kamuwa da cutar ya ragu, wanda ke nuna cewa cutar ta barke.
Mafi yawan masu ra'ayin kirki sun ce za a kawo karshen annobar a karshen watan Maris kuma za a yi wani lokaci na raguwa na watanni uku zuwa hudu.
Amma, wasu masana ba su da bege.
Paul Hunter, et al., sun kiyasta cewa COVID-19, wanda ya fi SARS saurin yaduwa, ba zai ƙare ba a shekarar 2020.
Ira Longini, et al., sun kirkiro wani tsari na kimanta sakamakon annobar kuma sun nuna cewa SARS-CoV-2 na iya cutar da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin duka swabs na tsakiya da na makogwaro na marasa lafiya waɗanda suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kamuwa da cutar na iya zama maimaita fashewar cutar kamar mura.
Duk da haka, an sami tabbaci mai ƙarfi a cikin China dangane da raguwar sabbin lamuran, yana nuna cewa dabarun yanzu na iya yin tasiri.
An yi hasashen cewa cutar Ebola za ta iya kaiwa mutane miliyan daya da mutuwa miliyan daya da rabi.
Amma, tare da tsauraran matakan killacewa da keɓewa, an sami nasarar shawo kan cutar.
Saboda haka, kamar SARS-CoV, wataƙila cutar SARS-CoV-2 ta zama mai rauni kuma a ƙarshe ta ƙare ko kuma ta zama kwayar cuta mai ƙarancin cuta da ke tare da mutane.
An samar da kwatancen tsakanin annobar COVID-19 da SARS da MERS a ƙasa (Shirya (Shirya55).
SARS-CoV-2 yana da saukin kamuwa ta hanyar tari ko tari, kuma ana iya kamuwa da shi ta hanyar hulɗa kai tsaye da kayan da cutar ta ƙazantu da su.
An kuma gano wannan kwayar a cikin najasa, wanda hakan ya haifar da sabon yiwuwar yaduwar cutar daga najasa zuwa baki.
Wani bincike na kwanan nan kan mutane 138 ya ba da rahoton cewa kashi 41% na cutar na iya kasancewa sanadiyyar kamuwa da cutar nosocomial, ciki har da marasa lafiya 17 da ke da wasu cututtuka da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, dole ne a yi amfani da matakan kariya don kare mutane, musamman ma ma'aikatan kiwon lafiya, ma'aikatan zamantakewa, dangi, abokai, har ma da mutanen da ke kan titi da ke hulɗa da marasa lafiya ko kuma waɗanda ke da cutar.
Layin farko na kariya wanda za'a iya amfani dashi don rage haɗarin kamuwa da cuta shine sanya abin rufe fuska; amfani da abin rufe fuska na tiyata da abin rufe fuska na numfashi na N95 (jerin # 1860) yana taimakawa wajen sarrafa yaduwar kwayar cutar.
Abun rufe fuska na tiyata yana hana digo na ruwa daga mutane da ke iya kamuwa da cutar daga yaduwa ta hanyar iska ko mannewa da farfajiyar kayan, wanda hakan zai iya yaduwa ga wasu.
Koyaya, kawai nau'in N95 (jerin #1860s) zai iya karewa daga shan virion mai ƙarancin 10 zuwa 80 nm, tare da kawai 5% na virion wanda zai iya shiga cikin nau'in N95; SARS-CoV-2 ya yi kama da SARS-CoV daga girman girman girman da suke da shi duka a cikin kimanin 85 nm.
Tunda ƙwayoyin kwayar cutar na iya shiga cikin abin rufe fuska na tiyata guda biyar da aka saka tare, ma'aikatan kiwon lafiya da ke hulɗa kai tsaye da marasa lafiya dole ne su sanya abin rufe fuska na N95 (jerin #1860s) maimakon abin rufe fuska.
Bugu da ƙari ga sanya abin rufe fuska, ma'aikatan kiwon lafiya za su yi amfani da kayan kariya na mutum don rage haɗuwa da kwayar cutar.
Ƙari ga haka, za a iya samun ƙwayoyin cuta ta idanu.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2 duk da cewa ya sanya abin rufe fuska na N95; cutar ta iya shiga jikinsa ta hanyar idanun da ke fama da kumburi.
A wannan yanayin, ma'aikatan kiwon lafiya su sanya abin rufe fuska mai haske ko tabarau na tsaro yayin hulɗa da marasa lafiya.
Ga jama'a a yankunan da cutar ta shafa ko kuma za ta iya shafa, an shawarci dukkan mazauna yankin su wanke hannayensu da sabulun kashe cuta akai-akai, su zauna a gida kuma su rage hulɗa da mutanen da za su iya kamuwa da cutar.
Ana ganin nesa da mutum na tsawon kafa uku ne ya dace don nisantar da kansa daga marasa lafiya.
Wadannan matakan hanya ce mai inganci wajen rage hadarin kamuwa da cutar ban da hana yaduwar kwayar cutar.
Kodayake SARS-CoV-2 sabon kwayar cuta ne, babban homology ga SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu 2020 ya ba da gargaɗi ga China kamar yadda cutar SARS ta yi a 2003.
Koyaya, a ranar 19 ga Janairu, 2020, Daraktan Cibiyar Kula da Cututtuka da Cututtuka ta Wuhan ya yi ƙoƙari ya rage damuwar 'yan ƙasa ta hanyar cewa kwayar cutar ba ta da ƙarancin kamuwa da cuta da kuma iyakancewar haifuwa a cikin mutane kuma rigakafin cutar da hana shi ba matsala ba ne.
Wannan sakon ya sauƙaƙa damuwa a cikin jama'a, musamman a lokacin da duk ƙasar ke shirin bikin bazara, kuma ba za a iya karɓar shi ba don hana yaduwar cutar a Wuhan.
Hukumar kula da cututtuka a China na iya koyon darasi daga wannan kuma su inganta a nan gaba.
Misali, hukumomi masu dacewa (1) sun fi taka tsantsan wajen sanar da jama'a saboda kowane bayani da aka gabatar yana tasiri kan halayen jama'a da yanke shawara; (2) sun fi jin dadi da kuma amsawa ga bayanai na musamman da aka samu daga asibiti fiye da jiran rahoto na yau da kullun daga likitoci ko jami'ai; (3) sun fi tsauri wajen hana barkewar cutar fiye da kwantar da hankalin jama'a; da (4) gudanar da atisaye akai-akai don kara wayar da kan jama'a game da cutar ta annoba da kuma gwadawa da kuma inganta tsarin mayar da martani na jama'a akai-akai.
Cutar COVID-19 ta samo asali ne daga kwayar cutar SARS-CoV-2 da ta fara a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya yaɗu a duk ƙasar Sin da kuma kusan ƙasashe 50 a duniya a lokacin da nake rubuta wannan.
Tun da yake kwayar cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da na SARS, yaduwar COVID-19 ta haifar da jin cewa annobar SARS ta sake faruwa.
Duk da haka, akwai bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci wajen hana annobar da kuma kula da marasa lafiya.
COVID-19 ya shafi tsofaffi fiye da matasa kuma ya fi rinjayar maza fiye da mata, kuma tsananin cutar da mutuwar mutane sun fi tsofaffi fiye da matasa.
SARS yana da yawan mutuwar da ya fi na COVID-19 (10.91% vs. 1.44%).
Marasa lafiya na COVID-19 na iya yada kwayar cutar ba tare da samun wata alama ba yayin da masu cutar SARS ke yada kwayar cutar a cikin yanayin rashin lafiya, wanda ke haifar da wahalar hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana dalilin da yasa SARS-CoV-2 ke yaduwa cikin sauri da kuma yaduwa fiye da SARS-CoV.
Sakamakon gwajin RNA na SARS-CoV-2 na iya zama mara kyau ga marasa lafiya na COVID-19.
Duk da haka, waɗanda suka warke za su iya sake kamuwa da cutar.
Wannan binciken ya kara hadarin kamuwa da cutar kai tsaye.
Dangane da saurin ci gaba a cikin binciken COVID-19, wasu batutuwa masu mahimmanci har yanzu suna buƙatar a bincika, gami da:
Daga ina SARS-CoV-2 ya fito?
Ko da yake an gano kashi 96% na kwayoyin halittar SARS-CoV-2 da kuma CoVs biyu kamar SARS na bat, ba za mu iya kammala cewa SARS-CoV-2 ma daga bat ne ya fito ba.
Shin dabbobi ne suke watsa kwayar cutar daga gida, kamar su bat, zuwa ga mutane?
Idan ba mu san amsoshin tambayoyin farko da na biyu ba, ba za mu iya magance cutar ba, kuma za ta iya sake faruwa a kowane lokaci.
Ko da yake gwajin samfurin kwayoyin halitta da kuma nazarin kwayoyin sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, ta yaya kwayar cutar za ta iya shiga cikin ƙwayoyin iska kuma ta haifar da canje-canje na pathology?
Shin kwayar cutar tana da alaƙa da ƙwayoyin bayyana ACE2 a wasu gabobin jiki?
Idan ba tare da amsar wannan tambayar ba, ba za mu iya samun ganewar asali da kuma ingantaccen magani ba.
Har yaushe za a ci gaba da wannan annoba?
Ta yaya wannan kwayar cutar ta samu ci gaba ta hanyar kwayar halitta a tsakanin mutane?
Shin za ta zama annoba ta duniya, ta ƙare kamar SARS ko kuma za ta sake faruwa a kai a kai kamar mura?
Wannan yana da muhimmanci amma zai ɗauki lokaci kafin a sami amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Duk da haka, duk da irin tsadar da za a iya kashewa, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu mayar da rayuwarmu ga al'ada.
Tushen kwayar cutar coronavirus na mutum
Juyin halitta da kuma daidaitawa sun haifar da juyin halitta tare da coronavirus (CoV) da kuma manyan rundunoninsa, ciki har da mutane, tsawon dubban shekaru.
Kafin 2003, an san cewa kwayar cutar mutum (HCoV) biyu tana haifar da cututtuka masu saurin kamuwa da cuta, kamar mura.
Annobar cutar sankara ta SARS da ta MERS ta sauya ra'ayi kuma ta nuna yadda cutar HCoVs take da hatsari da kuma barazana ga rai.
Bayyanar SARS-CoV-2 a China a ƙarshen 2019 ya jawo hankalin CoV kuma ya ba mu mamaki game da sauƙin kamuwa da cuta amma ba shi da cutarwa kamar SARS-CoV.
Cutar HCoVs zoonosis ce kuma fahimtar asalin kwayar cutar HCoVs na iya taimaka mana.
Yawancin kwayar cutar HCoVs sun fito ne daga barbashi wanda ba shi da cutar.
An kuma san wani mai watsa shiri na matsakaici na wasu HCoVs.
Gano kwayar dabbobi yana da tasiri kai tsaye kan rigakafin cutar ɗan adam.
Binciken game da hulɗar mai watsa CoV a cikin dabbobi ya ba da damar fahimtar mahimmancin cutar CoV a cikin ɗan adam.
A cikin wannan binciken, mun gabatar da cikakken bayani game da ilimin da ake da shi game da kwayar cutar HCoV guda bakwai, tare da mai da hankali kan tarihin gano su da asalin zoonotic da watsawa tsakanin jinsuna.
Abin da ya fi muhimmanci shi ne, mun gwada kuma mun bambanta HCoVs daga mahangar juyin halitta na ƙwayoyin cuta da kuma sake haɗuwa da kwayoyin halitta.
An tattauna game da cutar COVID-19 a wannan mahallin.
Bugu da kari, an jaddada bukatar samun nasarar musayar masaukin baki da kuma tasirin juyin halittar kwayar cutar kan tsananin cutar.
Kwayar cuta ta coronavirus (CoV) tana cikin dangin Coronaviridae, wanda ya ƙunshi rukuni guda na ƙwayoyin cuta masu amfani da RNA masu amfani da jini.
Wannan kwayar halitta tana da tsawon tsakanin kilobase 26 zuwa 32 kuma ita ce mafi girma a cikin kwayar cutar RNA kuma an sanya mata suna "CoV" saboda siffar da take da ita kamar kambi a karkashin na'urar duba siginar lantarki.
A tsarin, CoVs suna da kwayoyin halittar da ba su da sashi da suka yi kama da juna.
An kiyasta cewa kashi biyu bisa uku na wannan kwayoyin suna da manyan manyan tsarin karatu guda biyu (ORF1a da ORF1b) wadanda suka yi aiki tare, wanda daga baya aka fassara zuwa pp1a da pp1ab polyprotein replicase.
Bayan haka, ana sarrafa polyprotein don samar da 16 da ba a tsara su ba, wanda ake kira nsp1~16.
Sauran kwayoyin sun hada da ORFs don sunadaran da aka tsara, ciki har da gashi (S), sheqa (E), membrane (M) da nucleoprotein (N).
Wasu sunadarai na musamman na sunadarai sun hada da wasu sunadarai na musamman na CoV.
Dangane da bambancin jerin sunadarai, CoVs an rarraba su zuwa nau'ikan hudu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), inda beta-CoVs suka ƙunshi yawancin HCoVs kuma an raba su zuwa jerin hudu (A, B, C da D).
Shaidar phylogenetic ta nuna cewa bat da beraye suna aiki a matsayin tushen kwayoyin zuwa mafi yawan alpha-CoVs da beta-CoVs, yayin da tsuntsaye su ne babban wurin ajiyar gamma-CoVs da delta-coVs.
A cikin dubban shekaru, CoVs sun sha kan nau'in rigakafi kuma wasu sun bayyana a matsayin muhimman cututtukan ɗan adam.
Ya zuwa yanzu, an gano kwayar cutar korona ta mutum guda bakwai.
Daga cikinsu akwai HCoV-229E da HCoV-NL63 wanda shine alpha-CoV.
Sauran beta-CoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, cutar sankarar hankula (SARS-CoV), cutar sankarar hankula ta Gabas ta Tsakiya (MERS-CoV) da kuma SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun rashin lafiya, kamar sanyi da/ko diarrhea.
A gefe guda, sabon SARS-CoV, MERS-CoV da SARS-CoV-2 sun kasance masu cutarwa sosai, suna haifar da kamuwa da cuta mai tsanani a cikin ƙananan hanyoyin numfashi a cikin marasa lafiya waɗanda ke da babban yiwuwar samun cututtukan cututtukan numfashi (ARDS) da kuma bayyanar extrapulmonary.
An ware kwayar HCoV-229E ta farko, B814, daga hanci na marasa lafiya da ke fama da mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin sani ta hanyar nazarin da aka yi game da HCoV-229E da HCoV-OC43, dukansu sun haifar da alamun rigakafin kai.
An yarda da ra'ayin cewa kamuwa da kwayar HCoV ba shi da haɗari har sai barkewar cutar SARS.
Yaduwar cutar SARS ta faru a 2003 kuma ta kasance daya daga cikin munanan lalacewar tarihi, ta cutar da mutane sama da 8,000 tare da yawan mutuwar mutane kusan 10%.
Shekaru goma bayan haka, annobar cutar MERS ta haifar da ci gaba da barkewar cutar a yankin Larabawa tare da yaduwar ta a wasu wurare a duniya.
Sabuwar kwayar cutar HCoV 2019 (2019-nCoV), daga baya aka sake masa suna SARS-CoV-2, ita ce ta haifar da annobar annobar cutar coronavirus ta 2010 (COVID-1), wacce ta yi sanadiyar mutuwar mutane 3,120 da kuma kamuwa da mutane 91,000 a ranar 3 ga Maris, 2020.
An yi gargadi kuma duniya ta shirya don fuskantar cutar SARS-CoV-2.
Dukkanin kwayar cutar HCoVs bakwai suna da asalin zoonotic daga bat, mice da dabbobi.
Akwai tabbaci mai yawa da ke nuna cewa HCoVs sun samo asali ne daga namomin kaza, inda kwayar cutar take da sauƙin daidaitawa kuma ba ta haifar da cuta ba amma tana nuna bambancin kwayoyin halitta.
Cutar COVID-2019 ta kawo babbar kalubale ta likita, kimiyya, zamantakewa da ɗabi'a ga China da sauran duniya.
Binciken asalin kwayar cutar HCoV ya ba da tsari don fahimtar tarihin halitta, motsawa da abubuwan da ke hana tsalle-tsalle na nau'in.
Hakanan yana iya jagorantar da sauƙaƙe binciken mai watsa labaran dabbobi, masu matsakaici da masu ɗaukar hoto don SARS-CoV-2, tare da mahimman abubuwan da ke tattare da hana yaduwar a nan gaba.
A cikin wannan bita mun gabatar da cikakken bayani game da asalin zoonotic, watsawa tsakanin jinsuna da kuma cutar HCoV.
Musamman, mun tsara kuma mun tattauna batun da aka saba da shi inda kwayar cutar HCoV ba ta da cutar a cikin ɗakunan ajiyar halitta amma ta zama mai cutar bayan kamuwa da nau'in zuwa sabon mai watsa shiri.
Mun kuma sake nazarin yanayin juyin HCoVs inda yawanci ana samun karuwar yaduwar cuta tare da raguwar cutar.
Sakamakon barkewar cutar SARS-CoV-2 da ke gudana an kuma tattauna shi a cikin wannan mahallin.
An san kwayar cutar dabbobi tun daga ƙarshen 1930s.
Kafin warewar farko na kwayar HCoV-229E B814 daga hancin masu fama da cutar sanyi, an ware CoVs daban-daban a cikin dabbobi da dama da suka kamu da cutar, ciki har da kaza, beraye, shanu, aladu, kuliyoyi da karnuka.
A cikin shekarun da suka gabata, an gano kwayar cutar HCoV guda bakwai.
Takaitaccen tarihin gano HCoV a cikin tsarin lokaci (Table 1) na iya ba da bayani da koyarwa.
An fara ware kwayar HCoV-229E daga cikin numfashi na marasa lafiya da ke fama da kamuwa da cuta a cikin numfashi na sama a 1966, kuma an sake tsara ta don girma a cikin layin kwayar cutar huhu WI-38.
Marasa lafiya da ke kamuwa da HCoV-229E suna nuna alamun cutar, ciki har da ciwon kai, tari, laushi da ciwon makogwaro, tare da zazzabi da tari da aka gani a cikin 10~20% na lokuta.
Daga baya a 1967, an ware HCoV-OC43 daga al'adun gabobin jiki sannan kuma an yi jerin abubuwan da ke cikin kwakwalwar linzamin kwamfuta.
Bayanan asibiti na kamuwa da HCoV-OC43 sun yi kama da kamuwa da HCoV-229E, wanda ba shi da bambanci daga kamuwa da wasu cututtukan cututtukan numfashi kamar su kwayar cutar mura A da rhinovirus.
Dukansu HCoV-229E da HCoV-OC43 suna yaduwa a duniya kuma suna da saurin yaduwa a lokacin hunturu a yankunan da ke da yanayin zafi.
Yawancin lokaci, tsawon lokacin da ake hana cutar da kuma cutar da ita ba su kai mako guda ba, sai kuma a yi rashin lafiya na tsawon makonni biyu.
Bisa ga binciken da aka yi kan masu sa kai na ɗan adam, mutane masu lafiya da suka kamu da HCoV-229E sun sami saurin kamuwa da cutar.
Wasu marasa lafiya da suka kamu da cutar sun nuna cewa suna da ciwon numfashi mai tsanani.
SARS, wanda kuma aka sani da atypical pneumonia, shi ne annoba ta farko da HCoV ya haifar da shi wanda aka rubuta shi a tarihin ɗan adam kuma mai maganin cutar shine SARS-CoV, HCoV na uku da aka gano.
An gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta haifar da kamuwa da cutar 8,096 da kuma mutuwar mutane 774, a kasashe da nahiyoyi da dama.
Baya ga super-spreader, an kiyasta cewa kowane yanayi na iya haifar da kusan yanayi biyu na biyu, tare da lokacin jinkiri tsakanin kwanaki 4 zuwa 7 kuma yanayin da ba shi da kwayar cutar ya bayyana a ranar 10 na cutar.
Marasa lafiya da ke dauke da SARS-CoV da farko suna nuna rashin tausayi, ciwon kai, zazzabi, zazzabi da sanyi, sannan kuma dyspnea, tari da kuma damuwa na numfashi a matsayin alamun bayyanar.
Lymphophenia, gwajin aikin hanta da ya ɓace da kuma ƙaruwa a cikin sinadarin creatine kinase, su ne abubuwan da ba su dace ba a cikin gwajin SARS.
An kuma lura da lalacewar alveolar difus, haɓakar ƙwayoyin epithelium da haɓaka macrophage a cikin marasa lafiya na SARS.
Kusan kashi 20-30% na marasa lafiya suna bukatar kulawa mai kyau da kuma na'ura mai aiki da iska.
Baya ga kamuwa da cutar ta hanyar numfashi, wasu gabobin jiki da suka hada da gastrointestinal tract, hanta da koda na iya kamuwa da cutar a cikin wannan mawuyacin hali, wanda yawanci yakan zo tare da tashin cytokine, wanda zai iya haifar da mutuwa musamman a cikin marasa lafiya masu rauni.
An fara ware kwayar cutar ne daga kwayar cutar huhu ta budewa da aka yi wa wani dan uwan wani mai cutar da ke tafiya zuwa Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an yi ƙoƙari sosai don binciken HCoV.
An ware HCoV-NL63 daga wani yaro mai wata 7 daga Netherlands a ƙarshen 2004.
Da farko an gano cewa cutar ta yadu a cikin yara, tsofaffi da kuma marasa lafiya masu rauni na numfashi.
Kasancewar tari, conjunctivitis, zazzabi da bronchiolitis na yau da kullun ne a cikin cututtukan da HCoV-NL63 ke haifarwa.
Wani bincike na 'yanci ya bayyana cewa an cire irin wannan kwayar cutar daga hanci na wani yaro mai wata takwas da ke fama da ciwon huhu a Netherlands.
Ko da yake an gano shi a Netherlands, amma a zahiri ya yadu a duk duniya.
An kiyasta cewa HCoV-NL63 shine ke haifar da kimanin kashi 4.7% na cututtukan numfashi na yau da kullun kuma lokacin mafi girma na cutar shine farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da cutar laringitis na hanawa, wanda kuma ake kira croup.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 da aka kwantar da shi a asibiti da ciwon huhu da kuma cutar sankarar bargo a Hong Kong.
Baya ga cutar huhu da kuma cutar sankarar bargo da ke kamuwa da ita a cikin al'umma, an kuma bayar da rahoton cewa HCoV-HKU1 yana da alaƙa da matsanancin tashin hankali na asma.
Kamar yadda HCoV-NL63, HCoV-229E da HCoV-OC43, HCoV-HKU1 ana samun su a duk duniya, suna haifar da rashin lafiya na numfashi.
Dukkanin HCoVs huɗu da aka kamu da su a cikin al'ummar sun daidaita da mutane kuma ba su da wataƙila ta hanyar canzawa zuwa cutar da ke haifar da cututtuka, kodayake haɗarin ya faru ne saboda ba a san dalilin ba saboda akwai ƙananan lokuta na cutar HCoV-NL63, wanda kwanan nan aka ba da rahoton cewa ya haifar da mummunan kamuwa da cutar numfashi a cikin China.
Gabaɗaya, lokacin da wannan HCoV ya sami damar yaduwa cikin inganci kuma ya kasance cikin jikin mutum, wannan kwayar cutar ma ta zama mai cutarwa ko rashin cutarwa.
An fara ware kwayar cutar MERS-CoV a shekarar 2012 daga huhu na wani mutum mai shekaru 60 da ke fama da ciwon huhu da kuma rashin aikin koda a Saudi Arabia.
Duk da cewa yawancin lab-tabbatattun shari'o'in sun fito ne daga Gabas ta Tsakiya, an samu rahoton shigo da shari'o'in tare da wasu lokuta na watsawa ta hanyar kusanci a kasashen Turai da Tunisia.
Wani kuma barkewar cutar ta biyu ya faru ne a Koriya ta Kudu a shekarar 2015 inda aka tabbatar da kamuwa da cutar mutum 186.
Bayyanar asibiti ga MERS tana kama da SARS, wanda ke nuna ci gaba da ciwon huhu mai tsanani.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da cutar MERS suna fama da rashin aikin koda, wanda har yanzu ya zama na musamman ga MERS a cikin cututtukan da HCoVs ke haifarwa.
Fiye da kashi 30 cikin ɗari na marasa lafiya suna nuna alamun ciwon ciki, kamar su diarrhea da kuma amai.
Ya zuwa 14 ga Fabrairu, 2020, sama da lambobi 2500 da aka tabbatar da su an bayar da rahoton su tare da mutuwar mutum 34.4%, wanda ya sanya MERS-CoV daya daga cikin cututtukan da suka fi addabar mutane.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano wani gungu na masu fama da cutar huhu da aka sani a baya dangane da kamuwa da cutar SARS-CoV-2 a Wuhan, Lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana annobar cutar numfashi ta SARS-CoV-2 a matsayin Matsalar Lafiya ta Duniya kuma ta sanya sunan cutar COVID-19.
Ya zuwa 3 ga Maris, 2020, an sami rahotanni 90,053 a duniya, tare da mutuwar mummunan yanayin kashi 3.4%.
Abin lura, mutuwar cutar a Hubei, China ya kai kashi 4.2%, yayin da mutuwar cutar a waje da yankin ya kai kashi 1.2%.
SARS-CoV-2 na haifar da cututtukan numfashi masu tsanani kamar SARS-CoV da MERS-CoV, suna bayyana a matsayin zazzabi, tari da kuma dyspnea.
Wasu marasa lafiya ma suna da ciwon hauka.
Ciwon huhu yana cikin munanan alamu kuma yana iya ƙaruwa da sauri zuwa ciwon numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda babban daidaiton nucleotide na 82%, kwayar cutar ta rarrabu zuwa rassa daban-daban a kan bishiyar phylogenetic.
SARS-CoV-2 ya bayyana ba shi da cutar amma yana da saurin yaduwa fiye da SARS-CoV da MERS-CoV.
An samu rahotanni na mutane da ke dauke da cutar SARS-CoV-2 kuma hakan na iya haifar da saurin yaduwar cutar a duniya.
Kwatanta SARS-CoV-2 da sauran HCoVs shida ya nuna kamance da bambance-bambance masu ban sha'awa.
Na farko, lokacin ragewa da tsawon lokacin cutar HCoV suna da kama sosai.
A wannan yanayin, SARS-CoV-2 ya bi halin da sauran HCoVs shida suka kasance.
Na biyu, cutar COVID-19 tana da alamun cutar tsakanin SARS-CoV da kuma HCoVs guda huɗu da aka samo daga al'umma (cf. HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna halaye da aka fi gani yayin kamuwa da HCoVs da aka samo daga al'umma, gami da kasancewar rashin takamaiman, rashin ƙarfi ko rashin alamun bayyanar cututtuka.
A wani bangare kuma, ana iya ganin karamin rukunin masu kamuwa da cutar COVID-19 kamar yadda ake ganin SARS-CoV, kodayake a ɗan ƙarami.
Na uku, yaduwar SARS-CoV-2 ta kuma nuna halaye masu ban sha'awa ga duka HCoVs da aka samo daga al'umma da SARS-CoV.
A wani bangare, cutar SARS-CoV-2 tana da cutarwa aƙalla kamar yadda HCoVs suke da su daga al'umma.
A gefe guda, yana da wuya a tabbatar ko cutar SARS-CoV-2 ta ragu bayan ta wuce ta hanyar mutane kamar yadda ya faru a cikin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfurin fitsari.
Ko watsawa ta hanyar hanci zuwa baki don SARS-CoV-2 yana taka muhimmiyar rawa kamar yadda yake a cikin yanayin SARS-CoV aƙalla a ƙarƙashin wasu yanayi yana jiran bayani ta hanyar nazarin gaba.
Yana da ban sha'awa kuma a ga ko SARS-CoV-2 na iya yaduwa ta yanayi kamar yadda yake a cikin yanayin HCoVs da ke kamuwa da cutar a cikin al'umma.
Duk da haka, halayen SARS-CoV-2 ciki har da kamuwa da cuta, cutar da ke haifar da cutar da kuma ci gaba da yaduwa bayan ta hanyar mutane zai shafi ƙarshen annobar COVID-19 da ke gudana.
Dukkanin HCoVs huɗu da suka kamu da cutar a cikin al'umma sun haifar da rashin alamun cutar kuma sun dace da mutane.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun daidaita da kyau ga waɗannan HCoVs huɗu.
A wasu kalmomi, dukansu sun tsira daga annobar HCoV na baya.
An kawar da kwayar cutar HCoV mai saurin kamuwa da cuta a cikin mutane da kuma mutane masu kamuwa da cutar HCoV mai tsanani.
Don a yi hakan, HCoVs dole ne su ninka a cikin mutane har zuwa isasshen matakin da zai ba da damar tattara canjin da ke adawa da abubuwan da ke hana mai masaukin baki.
Saboda haka, tsawon lokacin da annobar SARS-CoV-2 ta daɗe kuma mutane da yawa sun kamu da ita, mafi girman damar da kwayar cutar ta dace da mutane.
Idan kwayar cutar ta daidaita sosai, zai yi wuya a hana ta a cikin mutane ta hanyar keɓewa ko wasu matakan sarrafa kamuwa da cuta.
A cikin shekaru, CoVs huɗu da suka kamu da cutar a cikin al'umma sun yadu a cikin yawan mutane, suna haifar da mura a cikin batutuwa masu rauni.
Wannan cuta ba ta bukatar wani dabba.
A gefe guda, SARS-CoV da MERS-CoV ba su daidaita da kyau ga mutane ba kuma ba za a iya ci gaba da yaduwar kwayar cutar a cikin mutane ba.
Kwayar cutar tana bukatar ta zauna kuma ta yadu a cikin taskarta ta zoonotic kuma ta nemi damar yaduwa zuwa ga mutane masu saurin kamuwa, watakila ta hanyar daya ko fiye da masu watsa shirye-shirye da masu rarrabawa.
SARS-CoV-2 yana da halaye iri ɗaya da duka SARS-CoV/MERS-CoV da kuma duk HCoVs huɗu da ke kamuwa da cutar a cikin al'umma.
Yana da saurin yaduwa kamar HCoVs da ke kamuwa da cutar a cikin al'umma, aƙalla a yanzu.
Koyaya, kwayar cutar ta fi kwayar cutar HCoVs da ke kamuwa da ita a cikin al'umma kuma ba ta da cutar SARS-CoV ko MERS-CoV.
Lokaci zai nuna ko kwayar cutar ta daidaita da 'yan adam kuma ta yadu tsakanin mutane ba tare da wani tanadi ko kuma wani dabba ba.
Kafin mu tattauna asalin dabbobi da ke haifar da HCoV, ya fi kyau mu tattauna ma'anar da kuma halayen yanayin juyin halitta, yanayin, ma'aji, matsakaici da kuma haifuwar HCoV.
Dabba tana aiki a matsayin mai watsa shiri na juyin halitta don HCoVs idan tana da magada masu kusanci waɗanda ke da babban daidaituwa a matakin nucleotide.
Kwayar cutar kwayar cutar ta saba daidaitawa sosai kuma ba ta haifar da cuta a cikin wannan gidan.
Hakazalika, rundunar mai riƙewa tana adana HCoVs a kai a kai kuma na dogon lokaci.
A cikin duka biyun, mahaukaci yawanci yana kamuwa da cutar ta halitta kuma yana da al'ada ga HCoV ko virion.
A gefe guda, idan aka gabatar da sabon HCoV zuwa gawarwakin mai watsa shiri kafin ko kusa da gabatarwar sa ga ɗan adam, kwayar ba ta daidaita da kyau ga sabon mai watsa shiri kuma yawanci tana haifar da cuta.
Wadannan rundunonin na iya zama tushen zoonotic na kamuwa da cutar dan adam kuma suna taka rawa a matsayin masu watsa kwayar cutar ta hanyar barin kwayar cutar ta ninka na wani lokaci sannan ta yada kwayar cutar ga dan adam don kara girman kamuwa da cutar dan adam.
HCoV na iya kamuwa da cutar ta hanyar mutuwa idan ba zai iya ci gaba da yaduwar cutar a cikin rundunar ba.
A gefe guda, HCoVs na iya daidaitawa zuwa ga mai watsa shiri kuma ya haifar da ƙarancin lokaci.
A wannan yanayin, rundunar ta zama rundunar ruwa ta halitta.
Bayanan epidemiological sun bayyana a cikin retrospective cewa SARS index cases suna da tarihin hulɗa da dabbobi masu farauta.
Binciken da aka yi na ƙarin seroprevalence ya nuna cewa dillalan dabbobi suna da ƙimar anti-SARS-CoV IgG mafi girma fiye da na jama'a.
An fara gano cewa damisa (Paguma larvata) da karnukan rakuna a kasuwar dabbobi masu rai suna dauke da kwayar cutar SARS-CoV mai kama da SARS-CoV.
Wannan ya nuna cewa babu wani SARS da aka sake ba da rahoto bayan da ya kashe dukkan wasun da ke kasuwa.
Duk da haka, an ba da rahoton cewa lamur daga gandun daji ko gonaki ba tare da fallasa su ga kasuwar dabbobi masu rai ba sun kasance masu ƙarancin SARS-CoV, suna ba da shawarar cewa lamur na iya zama kawai mai ƙarfafa mai watsa shiri na matsakaici amma ba mai tanadin SARS-CoV ba.
Mafi mahimmanci, la'akari da cewa kashi 80% na dabbobi daban-daban a kasuwa a Guangzhou suna da rigakafin SARS-CoV, yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa na iya zama runduna masu ƙarfafa matsakaici don SARS-CoV ba za a iya yin watsi da su ba.
Dukkanin wadannan sun zama masu daukar bakuncin hanyar mutuwa ga SARS-CoV.
Binciken da aka yi na ciwon SARS-CoV a cikin dabbobi ya nuna cewa akwai wani nau'in CoV mai suna SARS-Rh-BatCoV HKU3 (SARSr-Rh-BatCoV HKU3) wanda ke da alaƙa da SARS, wanda ke cikin wani nau'in bat na kasar Sin.
Wannan bat yana da kyau ga anti-SARS-CoV antibodies da kuma SARSr-Rh-BatCoV HKU3 genomic sequence.
Wannan da sauran CoVs suna da kashi 88-92% na homology na nucleotide tare da SARS-CoV.
Wannan binciken ya samar da tushen sabon ra'ayi cewa garken bat yana haifar da cututtukan ɗan adam.
An kuma gano wasu CoVs kamar SARS (SL-CoVs) daga bat, amma babu wanda ya iya ware shi a matsayin kwayar cutar mai rai sai dai wanda ake kira WIV1.
An gano enzyme mai canza angiotensin 2 (ACE2) na ɗan adam a matsayin mai karɓar SARS-CoV.
WIV1 da aka samo daga samfurin ƙwayoyin bat an nuna ta amfani da bat, fox da ACE2 na mutum a matsayin masu karɓa don shigar da kwayar halitta.
Abin sha'awa, an gano cewa ƙwayoyin cutar SARS da ke warkewa sun iya kawar da cutar WIV1.
Ya zuwa yanzu, WIV1 yana wakiltar mafi kusanci ga SARS-CoV a cikin bat, yana raba kashi 95% na daidaiton nucleotide.
Duk da cewa akwai babban daidaituwa tsakanin waɗannan ƙwayoyin cuta guda biyu, ana gaskatawa cewa WIV1 ba kwayar cutar mahaifa ce ta kai tsaye ga SARS-CoV kuma bat ba rundunar mai riƙe da SARS-CoV kai tsaye ba ce.
Binciken phylogenetic ya sanya MERS-CoV a cikin rukuni ɗaya kamar yadda bat CoV-HKU4 da bat CoV-HKU5.
CoV-HKU4 da MERS-CoV na bat suna amfani da mai karɓar bakuncin guda ɗaya, peptidylpeptidase 4 (DPP4), don shigar da kwayar cutar.
RNA mai dogara da RNA polymerase na MERS-CoV yana da kusanci da kwayar cutar a cikin beta-CoVs da aka gano daga Turai da Afirka.
Ya zuwa yanzu, ba a gano wani kwayar cutar MERS mai rai a cikin namomin kaza ba.
MERS-CoV da kuma CoV-HKU25 na kusa da iyali na bat sun raba kashi 87% na daidaiton nucleotide.
Saboda haka, batsa ba za ta iya zama mai watsa labaran kai tsaye ga MERS-CoV ba.
A gefe guda, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman Arabian suna da tasiri mai kyau ga ƙwayoyin cuta na MERS-CoV, kamar yadda raƙuman Gabas ta Tsakiya suka fito daga ƙasashen Afirka daban-daban.
An gano kwayar cutar MERS-CoV mai kama da kwayar cutar da aka samu a cikin mutane ta hanyar swabs na hanci na raƙuman aladu, wanda ya nuna cewa raƙuman suna aiki ne a matsayin ainihin rukunin ajiyar MERS-CoV.
Ya kamata a lura cewa a gaba ɗaya ana lura da alamun rashin ƙarfi amma ana iya samun babban ɓarkewar kwayar cutar a cikin raƙuman da ke kamuwa da MERS-CoV.
Musamman, raƙuman da ke kamuwa da cutar suna fitar da ƙwayoyin cuta ba kawai ta hanyar numfashi ba amma kuma ta hanyar hanci da bakin, wanda kuma shine hanyar fitar da ƙwayoyin cuta daga bat.
Koyaya, tambaya ta kasance tun da yawancin waɗanda aka tabbatar da cutar MERS ba su da tarihin haɗuwa da raƙuma kafin bayyanar cututtuka, mai yiwuwa ana danganta su da hanyar yaduwar mutum zuwa mutum ko hanyar yaduwar da ba a sani ba wanda ya shafi nau'in dabbobi da ba a sani ba wanda ke ɗauke da MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na nucleotides masu alaƙa da CoV RaTG13 na bat wanda aka ware daga Rhinolophus affinis.
A cikin shari'ar SARS-CoV da MERS-CoV, karkacewar juzu'i tsakanin SARS-CoV-2 da RaTG13 ya yi yawa don tantance alaƙar mahaifa.
A cewarsa, batsa ba za ta iya zama mai masaukin SARS-CoV-2 ba sai dai an gano CoV mai kama da bat a nan gaba.
Wataƙila, mai watsa labaran dabbobi zuwa SARS-CoV-2 ya fito ne daga nau'in daji da aka sayar da kashe shi a Kasuwar Kasuwancin Kayan Kifin na Huanan, wanda aka danganta da yawancin shari'o'in COVID-19 na farko, yana nuna yiwuwar watsa dabbobi zuwa mutane.
Wasu binciken kwanan nan bisa ga jerin metagenomics sun ba da shawarar cewa wani ƙaramin rukuni na ƙananan dabbobi masu shayarwa da ake kira tengger (Manis javanica) na iya riƙe da beta-CoVs na zuriya da ke da alaƙa da SARS-CoV-2.
Wannan kwayar cutar ta CoV tana da kashi 85-92% na kwayar cutar ta SARS-CoV-2.
Duk da haka, suna da dangantaka ta kusa da RaTG13 tare da kusan kashi 90% na ainihi a matakin nucleotide.
An haɗa su cikin ƙananan ƙwayoyin cuta guda biyu na kwayar cutar SARS-CoV-2 a cikin bishiyar kwayar halitta, ɗayan yana da alaƙa da yankin mai ɗaure mai karɓa (RDB) wanda ya fi kama da SARS-CoV-2, tare da 97.4% na asalin amino acid.
A cikin bambancin da ya bayyana, RBDs na SARS-CoV-2 da RaTG13 sun fi karkata, duk da cewa suna da babban matakin daidaitawa na homology na genomic.
Binciken da aka yi a baya kan kamuwa da cutar na kuma bayar da rahoton gano kwayar cutar daga samfurin huhu, wanda daga baya aka gano cewa yana da alaƙa da SARS-CoV-2.
Wannan binciken ya yi amfani da tsarin tattarawa da kuma zaɓin tsari na hannu don samar da wani ɓangare na jerin genomes wanda ya ƙunshi kusan 86.3% na cikakken kwayar cutar.
Ba za mu iya yin watsi da yiwuwar cewa albasa na ɗaya daga cikin masu watsawa na SARS-CoV-2.
Duk da haka, a halin yanzu babu wata hujja da ke nuna cewa SARS-CoV-2 ya fito ne kai tsaye daga tururuwa saboda karkatar da hankali tsakanin SARS-CoV-2 da beta-CoV da ke da alaƙa da SARS-COV-2 na tururuwa.
Bugu da kari, tazarar tsakanin SARS-CoV-2 da RaTG13 ta fi tazarar tsakanin SARS-CoV-2 da beta-CoVs masu alaƙa da SARS-COV-2 na tururuwa.
Har yanzu ana bukatar tantance hanyar juyin halittar SARS-CoV-2 a cikin bat, tururuwa da sauran dabbobi masu shayarwa.
Yayin da aka sami mafi girman daidaiton daidaituwa a cikin RBD tsakanin SARS-COV-2 da tururuwa, beta-CoV yana da alaƙa da SARS-CoV-2, SARS-CoV-2 da RaTG12 waɗanda ke da mafi girman daidaiton daidaiton genomic.
An yi hasashen cewa babban daidaito tsakanin RBD na SARS-CoV-2 da SARS-CoV-2 na da nasaba da juyin halitta mai ma'ana.
An ba da shawarar sake haɗuwa tsakanin beta-CoVs masu alaƙa da SARS-CoV-2 na tururuwa da RaTG13 a cikin nau'in dabbobi na daji na uku.
A matsayin abin motsa juyin halitta, sake fasalin ya faru sosai a cikin beta-CoVs.
Ana ci gaba da bincike kan asalin SARS-CoV-2 na zoonotic kai tsaye.
Baya ga HCoVs masu cutarwa, asalin zoonotic HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1 suma an yi nazarin su.
Shaidar phylogenetic ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya fitowa daga CoVs na bat, yayin da aka gano virions na HCoV-OC43 da HCov-HKU1 a cikin beraye.
An bayar da rahoton cewa CoV na bat da aka yi wa lakabi da ARCoV.2 (Appalachian Ridge CoV) wanda aka gano a cikin bat mai launin uku na Arewacin Amurka ya nuna alaƙa da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa da kwayar cutar CoV ta wani bat, mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da kuma camellids ake zargin cewa sune mahaɗan.
Don ƙarin bayani, ilimin yanzu game da asalin dabbobi don HCoVs da aka sani an tsara su a cikin Hoto na 1 da Table 2.
Binciken phylogenetic ya ba da tabbaci ga abubuwan da suka faru na watsa HCoV tsakanin jinsuna a tarihi.
Lokacin da HCoV-OC43 ya tsallake nau'in don ya cutar da mutane daga dabbobin gida a kusa da 1890, an rubuta annobar cutar numfashi.
Tarihin watsa HCoV-229E tsakanin jinsuna ba shi da ma'ana.
Amma an gano alpha-CoVs na bat da ke da alaƙa da HCoV-229E.
Daga cikinsu akwai alpha-CoV na alpaca.
Akwai wasu shaidu da suka nuna cewa cutar ta iya kaiwa daga bat zuwa mutum kai tsaye.
Na farko, mutane amma ba alpacas ba na iya samun hulɗa da bat a cikin yanayin da aka raba.
Amma, mutane suna da dangantaka ta kud da kud da alpaca.
Na biyu, alpha-CoVs na bat da ke da alaƙa da HCoV-229E suna da yawa kuma ba su da cutar a cikin bat, yayin da alpha-CoVs na alpaca ke haifar da cututtukan numfashi a cikin dabbobi da ake tsammani.
A ƙarshe, ba a gano alpha-CoV na alpaca a cikin namun daji ba.
Saboda haka, ba za a iya ware yiwuwar alpacas sun sami HCoV-229E-da ke da alaƙa da alpha-CoV daga ɗan adam ba.
A gaskiya, namomin kaza su ne tushen cututtukan da ke haddasa cututtukan ɗan adam, har da cutar rabi, Ebola, Nipah da kuma Hendra.
Saboda haka ba abin mamaki ba ne cewa batutuwan na iya watsa HCoV-229E kai tsaye ga mutane.
A madadin haka, kodayake alpha-CoV na bat ne ke dauke da kwayar HCoV-229E, alpacas da Arabian camels na iya zama rundunar matsakaici da ke watsa kwayar cutar ga mutane, kamar yadda yake a cikin yanayin MERS-CoV.
MERS-CoV ya kasance misali mafi kyau na watsawa tsakanin jinsuna daga bat zuwa raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
An san asalin juyin halittar MERS-CoV daga bat ne a farkon gabatarwar kuma an tabbatar da shi tare da binciken da ya biyo baya.
A bayyane yake cewa bat ya samar da nau'in nau'in kwayar cutar don musayar ɓangarorin kwayoyin halitta tsakanin jinsuna da kuma watsawa tsakanin jinsuna.
Rayuwa mai tsawo, da zama a cikin ƙauyuka masu yawa, da yin hulɗa da mutane sosai da kuma iyawar tashi da kyau, duk yanayi ne da ke sa su zama masu yaɗa ƙwayoyin cuta.
Bugu da ƙari, an gabatar da MERS-CoV ga raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
Ya dace da waɗannan raƙuman da suka canza daga matsakaici zuwa tsayayyen, na halitta mai riƙewa.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙananan ƙimar canji a cikin waɗannan dabbobi.
Canzawar ta lokaci-lokaci zuwa ga mutane ba zato ba tsammani ce kuma mutane sun kasance a matsayin ƙarshen mai watsawa ga MERS-CoV saboda ba za a iya ci gaba da watsawa ba.
Ya bambanta da aikin raƙuman a cikin yaduwar MERS-CoV, aikin raƙuman ruwa, idan akwai, a cikin watsa SARS-CoV-2 ya bambanta.
Musamman, beta-CoV na tururuwa yana da matukar cutarwa a cikin tururuwa.
Suna iya zama ƙarshen runduna don beta-CoVs masu alaƙa da SARS-CoV-2, daidai da foxes a cikin yanayin SARS-CoV.
Wasu yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabbobi zuwa mutane ya kamata a karɓa ko a ƙi a cikin nazarin gaba.
Na farko, batutuwan na iya zama wuraren ajiyar kwayar cutar SARS-CoV-2 wanda ya yi kama da SARS-CoV-2.
Mutane na iya raba al'ada ta muhalli da batutuwan ta hanyar yanka ko hakar kwal.
Na biyu, tururuwa na iya zama ɗayan sabbin sanannun masu haɓaka runduna na SARS-CoV-2.
Mutane suna kamuwa da cutar ta hanyar yanka da cin dabbobi.
Wataƙila dabbobi masu shayarwa da dama sun kamu da cutar SARS-CoV-2.
Ana bukatar bincike a kan dabbobi da kuma namun daji don samun rigakafi.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'in nau'in na uku wanda ke da hulɗa da duka bat da tururuwa.
Ana ci gaba da binciken asalin dabbobi na SARS-CoV-2.
Baya ga bambancin nau'in mai watsa shiri, manyan abubuwa uku a cikin ɓangaren kwayar cutar suna da mahimmanci wajen sauƙaƙe CoVs don ƙetare shingen nau'in.
Na farko, suna da canji mai yawa a cikin kwayar RNA.
Idan aka kwatanta da kwayar RNA guda ɗaya, ƙididdigar ƙimar juyin halitta na CoV za a iya ɗauka a matsayin "mai sauƙi" zuwa "babba" tare da matsakaicin canjin canji na ~10-4 sauye-sauye a kowace shekara a kowane wurare 2, dangane da matakin daidaitawar CoV zuwa sabon mai watsa shiri.
CoV tana da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Abin sha'awa, an san analog na nucleotide na Remdesivir yana hana ninka CoV ta hanyar ƙaddamar da wannan exoribonuclease da RNA polymerase mai dogara da RNA.
Remdesivir yana ɗaya daga cikin mafi kyawun wakilai na anti-SARS-CoV-2 da aka gwada a gwaji na asibiti.
Duk da haka, yawan canjin CoV ya ninka na mai masaukin sau miliyan.
Bugu da ƙari, yawan canjin sau da yawa yana da girma idan CoVs ba su daidaita da kyau ga mai watsawa ba.
Idan aka kwatanta da SARS-CoVs masu yawan canji, SARS-CoV-2 yana da ƙananan canji, yana nuna cewa yana da babban matakin daidaitawa ga ɗan adam.
Wataƙila, ya yi amfani da wasu ƙwayoyin cuta da ke kusa da mu.
Baya ga SARS-CoV-2, wannan kuma ya shafi MERS-CoV, wanda ya dace da raƙuman raƙuman raƙuman.
A ka'ida, ba zai yiwu ba cewa sauyawar kwayoyin halitta zai sa allurar rigakafi da riga-kafi da ke yaki da SARS-CoV-2 su zama marasa tasiri a cikin ɗan gajeren lokaci.
Na biyu, babban kwayar RNA a cikin CoVs tana amfani da ƙarin filastik a cikin canjin kwayar halitta don canzawa da sake haɗuwa, yayin haɓaka yiwuwar juyin halitta tsakanin jinsuna, wanda ke da fa'ida ga fitowar sabbin CoVs lokacin da yanayi ya dace.
Wannan yana da goyon bayan da ke da yawa na musamman bude karanta frame da kuma aiki na sunadarai encoded zuwa 3 'karshen genome.
Na uku, CoVs suna canza samfuri ba zato ba tsammani kuma sau da yawa yayin kwafin RNA ta hanyar keɓaɓɓiyar hanyar "zabin kwafin".
A cikin kwayar da ke aiki a matsayin mai maye gurbin, musayar abubuwa na faruwa sau da yawa yayin fassarar RNA na CoV.
Za a iya sake haɗa cikakkun RNA da kuma ƙananan kwayoyin halittar da suka yi daidai da juna don samar da sabon CoV.
An sami tabbacin phylogenetic na haɗuwa ta halitta a cikin HCoV-HKU1 da HCoV-OC43, haka kuma a cikin CoV na dabbobi kamar su SL-CoV bat da CoV-HKU9 bat.
Haɗin gwiwar kwayar cutar yana da alaƙa da yaduwar cutar.
Baya ga abubuwan da aka ambata a sama, hulɗar kwayar cutar da mai karɓar mai watsa shiri wani babban abu ne wanda ke shafar yaduwar kwayar cutar tsakanin jinsuna.
A nan, ana ɗaukar sake haɗuwa da SARS-CoV a matsayin misali na musamman, wanda kuma ya nuna tabbataccen zaɓi yayin taron watsawa tsakanin jinsuna.
Dangane da nazarin kwatancen tsakanin tsinkayen ɗan adam da SARS-CoV na fox, ana tsammanin SARS-CoV yana fuskantar saurin daidaitawa a cikin wasu runduna daban-daban, musamman tare da sauye-sauye a cikin RBD akan S protein.
A yadda aka saba, RBD na furotin S a cikin CoV yana hulɗa da ƙwayoyin cuta kuma ana zaɓar shi sosai ta hanyar maganin rigakafin mai masaukin baki.
A cikin SARS-CoV, RBD yana cikin amino acid na 318 zuwa 510 a kan S1 shard, wanda ke ɗaure ga ACE2 na ɗan adam da kuma masu karɓar haɗin gwiwa don shigar da kwayar cutar.
RBD na SARS-CoV yana iya gano masu karɓar ACE2 daga dabbobi da yawa, gami da bat, fox, mice da raccoon, yana ba da damar yaduwar kwayar cutar tsakanin jinsuna.
A zahiri, kawai sauran amino acid guda 6 aka lura dasu daban-daban daga kwayar cutar mutum da fox a cikin RBD kuma 4 daga cikinsu suna cikin hanyar haɗuwa da mai karɓar don hulɗa tare da mai karɓar ACE2.
SARS-CoV fox yana da K479N da S487T juyin halitta a cikin RBD, wanda zai iya haɓaka haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin
A wasu kalmomi, ana iya cewa musayar amino acid biyu na da muhimmanci wajen daidaita kwayar cutar ga mutane.
Ya kamata a lura cewa SARS-CoV-2 yana da kwayar mai karɓa iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 naúrar fiye da S sunadaran sun nuna cewa alaƙar wannan S sunadaran tare da ACE2 na ɗan adam na iya canzawa.
A zahiri, binciken cryo-EM ya nuna cewa wannan alaƙar ta ninka ta sau 10 zuwa 20 fiye da tsakanin ACE2 na ɗan adam da kuma furotin SARS-CoV S.
Hakanan yana da ban sha'awa don tantance ko ana buƙatar wasu masu karɓar karɓa don yaduwar SARS-CoV-2.
Abin sha'awa, HCoV-NL63 kuma yana da alaƙa da ACE2 amma tare da wani ɓangare na S daban.
Akwai sauran masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E, da sialic acid na 9-O na acetylteracetyl don HCoV-OC43.
Wataƙila shi ne ya sa mutane suka yi nasarar daidaita wannan cuta bayan kamuwa da ita tsakanin jinsuna daga dabbobi.
Baya ga masu karɓar salula, sakamakon watsawa tsakanin nau'in HCoVs kuma ya dogara da dogaro da mai watsawa da sauran abubuwan hanawa.
Bambancin wannan furotin na mai watsa shiri tsakanin mutane da masu watsa kwayar cutar HCoV kamar su bat, camel maraba da rodents na iya haifar da shinge ga watsawa tsakanin jinsuna.
HCoVs suna buƙatar kama abubuwan dogaro da mai watsa shiri da kuma lalata abubuwan hanawa na mai watsa shiri don yaduwar nau'ikan nau'ikan nau'ikan.
A wannan yanayin, ba a gano kuma a bayyana ma'anar kwayoyin da ke cikin muhimman yankunan hulɗar kwayar cutar ba.
Yin bincike a kusa da kwayar halitta wanda ba shi da son zuciya don dogaro da mai watsa shiri da kuma abubuwan da ke hana SARS-CoV-2 amfani da fasahar CRISPR mai ci gaba na iya haifar da sakamako.
Bayyanar sabon HCoV: koma baya
Bambancin CoV na bat yana ba da babbar dama ga fitowar sabon HCoV.
A wannan ma'anar, CoVs na bat suna aiki a matsayin ɗakunan kwayoyin HCoV.
Bugu da ƙari, saurin maye gurbi da sake haɗuwa na kwayoyin halitta sun kuma haifar da juyin HCoVs kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Alal misali, samun ko rasa wani sabon kwayar halitta yana da damar canza fasalin kwayar cutar sosai.
Daga cikin sunadarai masu amfani da SARS-CoV, ORF8 an yi la'akari da shi da mahimmanci wajen daidaitawa ga ɗan adam, saboda cutar SARS-CoV mai alaƙa da bat an keɓe amma an sami lambar ORF8 mai haɗawa.
An gano fasalin kashe nucleotide-29 na SARS-CoV a cikin wani nau'in da aka ware a farkon barkewar cutar a cikin mutane.
Wannan katsewar ta raba ORF8 zuwa ORF8a da ORF8b kuma ana ɗaukarsa a matsayin maye gurbin daidaitawa wanda ke inganta musayar baƙo.
Bugu da ƙari, SARS-CoV yana da yiwuwar tarihin sake haɗuwa tare da zuriyar CoVs na alpha da gamma, wanda yawancin ƙananan yankunan sake haɗuwa an gano su a cikin RNA mai dogara da RNA polymerase.
An kuma gano wuraren sake haɗuwa a cikin nsp9, yawancin nsp10 da kuma wani ɓangare na nsp14.
Hakazalika, an nuna cewa annobar MERS-CoV ta sami sake haɗuwa tsakanin jinsuna daban-daban, wanda ya faru a cikin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da sake haɗuwa a cikin wasu HCoVs, wanda ke ganin HCoVs sun sake haɗuwa da wasu CoVs na dabbobi a cikin ƙwayoyin halittar su.
Ya kamata a kuma yi gargadin cewa yin amfani da zaɓin ɓoye na iya haifar da canje-canje da ba a so a cikin kwayar cutar, wanda wataƙila ya samo asali ne daga 'yantar da kwayar cutar daga matsin zaɓin da aka sanya, kamar yadda tsarin rigakafin mai watsa shiri yake.
Misali na wannan tasirin shine asarar ORF4 na tsawon lokaci a cikin kwayar HCoV-229E, sakamakon kashe nucleotides biyu.
Yayin da ake iya ganin ORF4 mai ƙarfi a cikin bat da kwayar cutar raƙumi da ke da alaƙa da HCoV-229E, alpha-CoV alpaca yana nuna shigarwar nucleotide guda ɗaya, wanda ke haifar da motsi na tsarin.
A ƙarshe, juyin halittar sabbin kwayar cutar HCoVs kuma ya haifar da matsin lamba na zaɓi a cikin rukunin mai watsa su.
An gano rashin bayyanar cututtuka ko kuma rashin bayyanar cututtuka lokacin da batutuwan suka kamu da CoV, wanda ke nuna daidaituwa tsakanin CoV da batutuwan.
Kamar dai yadda aka gani, batutuwan sun dace da kwayar cutar sosai a fannin jiki da kuma tunani.
Alal misali, lalacewa a kunna martani na kumburi a cikin batutuwan yana rage tasirin cutar da CoV ke haifar.
Bugu da ƙari, aikin kwayar halitta a cikin bat an hana shi saboda ƙaruwa a cikin kwayar halitta mai haɗari mai haɗari mai haɗari NKG2/CD94 da ƙananan matakan magana don kwayar halitta ta 1 na babban tsarin histokeresin.
Bugu da ƙari, babban matakin nau'in oxygen mai saurin motsa jiki (ROS) wanda aka samar daga ayyukan metabolism mai yawa na bat zai iya hana ninka CoV da shafar karatun prof da exoribonuclease, yayin da kuma samar da matsin lamba don kula da kwayar cutar kwayar cuta mai saurin kamuwa da cuta lokacin da aka gabatar da ita ga sabon mai watsa shiri.
Ƙarin nau'ikan CoV na cututtukan cuta na iya haɓaka ta hanyar sake haɗuwa, wanda ke haifar da samun sabbin sunadarai ko kuma halayen sunadarai don daidaitawar gida.
Saboda haka, ba daidaituwa ba ce da aka samu sababbin kwayar cutar HCoV guda uku a cikin shekaru ashirin da suka gabata.
CoVs ba su da cutar ko kuma suna haifar da ƙananan alamomi a cikin rundunarsu kamar su bat da raƙumi.
Yana ninkawa sosai ba tare da ya jawo amsawar garkuwar jiki mai ƙarfi ba.
A nan ne asirin asymptomatic carrier ke zaune kuma dalilin da ya sa ake samun munanan cututtuka a cikin mutane.
Ainihin alamun cutar yawanci suna faruwa ne ta hanyar kunna hawan jikin mutum da kuma tashin sitokin da ke sa jikin mutum ya yi tsananin rashin lafiya.
A gefe guda, a cikin masu dauke da cutar, an daidaita amsawar garkuwar jiki daga ninka CoV.
Irin wannan dabarar da ke warware matsalar rigakafin cutar na iya samun fa'ida a maganin SARS-CoV-2.
Amsar interferon tana da ƙarfi sosai a cikin bat.
Saboda haka, bayar da nau'in interferon 1 aƙalla a farkon farkon kamuwa da cutar SARS-CoV-2 a cikin mutane ya zama da amfani.
Bugu da ƙari, kunnawar ƙwayar cuta a cikin bat ba shi da tasiri.
Saboda wannan dalili, haɓakar NLRP3 na kumburi tare da MCC950 na iya zama da amfani wajen magance COVID-19.
Bayyanar SARS-CoV-2 ya bi jigon bayyanar SARS-CoV da MERS-CoV.
Duk da yake an gano beta-CoVs na bat da ke da kashi 95% na kwayar cutar nucleotide tare da SARS-CoV, akwai kuma CoVs na bat da ke da kashi 96% na kwayar cutar nucleotide tare da SARS-CoV-2.
Duk da yake an gano foxes da sauran dabbobin da ke kasuwa suna da kwayar cutar da ta yi kama da SARS-CoV, ba a gano wani mai watsa shiri na kai tsaye na SARS-CoV-2 ba.
An gano beta-CoV na tururuwa wanda yake da alaƙa da SARS-CoV-2, yana nuna cewa tururuwa na iya zama ɗaya daga cikin rundunonin matsakaici ko kuma beta-CoV na tururuwa na iya ba da gudummawar ɓarnar gene ga ƙarshen SARS-CoV-2.
Duk da tambayoyin, babu wata hujja da ke nuna cewa SARS-CoV-2 na haifar da mutum da gangan ko kuma ba da gangan ba.
CoVs sun sake zama abin birgewa sakamakon annobar SARS-CoV-2 kwanan nan.
Nazarin CoVs a cikin bat da sauran dabbobi ya canza ra'ayinmu game da mahimmancin asalin zoonotic da kuma ma'adinan dabbobi don HCoVs a cikin yaduwar ɗan adam.
Tabbacin ya nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga bat kuma an watsa su ga mutane ta hanyar rundunar.
Tun da cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da wasun kasuwa, rufe kasuwar da ke da ruwa da kashe wasun ya kamata ya kawo ƙarshen cutar ta SARS.
A kan irin wannan dalili, ya kamata a cire tururuwa daga kasuwannin da aka shayar don hana yaduwar kwayar cutar, saboda gano kwayar beta-CoV mai yawa da ke da alaƙa da SARS-CoV-2.
Duk da haka, yanayin da kuma yadda SARS-CoV-2 ke yaduwa ga mutane ta hanyar tururuwa da sauran dabbobi masu shayarwa ya kamata a bayyana a cikin bincike na gaba.
A gefe guda, MERS-CoV ya wanzu a cikin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
Ta zama muhimmiyar hanyar sufuri da kuma babbar hanyar samar da nama, madara, fata da kayayyakin fur ga al'ummar yankin.
Ana samun wannan raƙumi a dukan Gabas ta Tsakiya da kuma Afirka.
Saboda haka ba zai yiwu a sadaukar da dukkan raƙuma don sarrafa MERS ba, kamar yadda aka yi a kasuwar namun daji a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana sake yaduwar annobar MERS, dole ne a dauki cikakkiyar hanyar samar da maganin rigakafin cutar MERS-CoV ga raƙuma, wanda aka haɗa shi da sauran matakan sarrafa kamuwa da cuta.
Tun da ba za mu iya kawar da wannan cutar ba, za a iya samun sabon nau'in da zai iya haifar da annoba.
An samu bambancin kwayar cutar zoonotic a cikin daji.
Musamman, CoVs na bat da ke da yuwuwar cutar dabbobi sun bambanta sosai.
Akwai damar da yawa ga wannan CoV na zoonotic ya sake juyawa kuma ya sake haɗuwa, yana haifar da fitowar sabbin CoVs waɗanda ke da saurin yaduwa da / ko kuma na iya kashewa a cikin mutane a nan gaba.
Dole ne a dakatar da cin naman daji a wasu wurare a kasar Sin domin rage hulda da dabbobi.
Tare da mummunan kwarewar SARS, MERS da COVID-19, ya kamata a yi shirye-shirye da kuma tsara shirye-shiryen amsawa.
A gaskiya, ƙwayoyin cuta da yawa sun wanzu a duniyar nan tun da daɗewa.
Kwayar cutar tana ci gaba da zama a cikin ɗakunan ajiya har sai an sami damar yaduwa.
Duk da cewa batutuwan suna da halaye da yawa da ke sauƙaƙa yaduwar kwayar cutar, damar ɗan adam na samun hulɗa da batutuwan da sauran nau'ikan namun daji za a iya rage su idan an ilimantar da jama'a don nisantar da su.
Ana bukatar ci gaba da lura da dabbobi masu shayarwa don fahimtar yanayin CoV da kuma yanayin da suke ciki, wanda zai iya taimakawa wajen hana yaduwar dabbobi zuwa mutane da kuma annoba a nan gaba.
A ƙarshe, hanya mafi inganci don hana kamuwa da cutar ta ƙwayoyin cuta ita ce ta hanyar mutane su guje wa yanayin halitta na ƙwayoyin cuta.
Wasu batutuwa da suka haifar da tambaya game da asalin SARS-CoV-2 na zoonotic har yanzu ba a amsa ba.
Na farko, idan batutuwan sun yada kwayar cutar SARS-CoV-2 ga tsuntsaye, zai zama abin sha'awa ganin yadda batutuwan da tsuntsaye za su iya raba yanayin muhalli iri ɗaya.
Na biyu, idan da gaske ne cewa batutuwan suna taka rawa wajen yaduwa ga mutane, dole ne mu yi la'akari da yadda mutane ke hulɗa da su.
Na uku, idan dabbobi masu shayarwa na uku suna aiki a matsayin ainihin runduna, ya kamata a bayyana yadda suke hulɗa da nau'o'in daban-daban ciki har da mutane, bat da kuma tururuwa.
A ƙarshe, saboda yawancin dabbobi masu shayarwa ciki har da dabbobi masu ban mamaki na iya fuskantar cutar SARS-CoV-2, dole ne a gudanar da sa ido da kuma kamuwa da cuta ta hanyar gwaji.
Ko dai bat, da jinjirin ko wasu dabbobi masu shayarwa, ana tsammanin cewa SARS-CoV-2 ko kuma irin wannan kwayar cutar za a gano a cikin mahaifarsu a nan gaba.
Bincike mai gudana a cikin wannan yanki zai bayyana hanyar juyin halittar SARS-CoV-2 a cikin dabbobi, tare da mahimman abubuwan da ke tattare da rigakafin COVID-19 da sarrafawa a cikin mutane.
Ana bukatar sabunta ka'idojin ganewar asali na "matsalolin da ake zargi" da "matsalolin da aka tabbatar" na COVID-19
A ranar 6 ga Fabrairu, 2020, tawagarmu ta wallafa jagororin shawarwari masu sauri don ganewa da kuma kula da cutar coronavirus na 2019 (2019-nCoV), kuma wannan jagorar ta samar da kwarewarmu a matsayin kyakkyawan tunani don yaƙi da wannan annoba a duniya.
Duk da haka, cutar coronavirus 2019 (COVID-19) sabuwar cuta ce, kuma iliminmu da wayewarmu suna ƙaruwa a hankali bisa ga binciken bincike da ake gudanarwa da kuma kwarewar aikin asibiti; saboda haka, dabarun ganewar asali da magani suna ci gaba da sabuntawa.
A cikin wannan wasika, mun amsa wani bita kan ka'idodinmu kuma mun samar da sabbin ka'idojin bincike don "abin da ake zargi" da "abin da aka tabbatar" bisa ga sabon ka'idojin Ganowa da Kula da COVID-19 (na bakwai) da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin ya fitar.
A watan Disamba na 2019, sabon kwayar cutar coronavirus ta 2019 (2019-nCoV) ta haifar da barkewar cutar, wanda yanzu aka sanya masa suna cutar coronavirus ta 2019 (COVID-19) kuma an sanya wa kwayar cutar sunan coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-10 a matsayin annoba.
Don yaƙi da cutar SARS-CoV-2, ƙungiyarmu ta samar da jagororin gaggawa da aka buga a cikin Kasuwancin Kiwon Lafiya na Soja na 06 ga Fabrairu 2020.
An yi wa wannan littafin ja-gora sosai tun da aka wallafa shi.
Duk da haka, a lura cewa COVID-19 sabuwar cuta ce, iliminmu da wayewarmu suna ƙaruwa a hankali bisa ga binciken bincike da ake yi da kuma kwarewar aikin asibiti; saboda haka, dabarun ganewar asali da magani dole ne a ci gaba da sabunta su.
Misali, Jagoran Gwaji da Kulawa don COVID-19 wanda Kwamitin Lafiya na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya fitar, tsakanin 16 ga Janairu 2020 zuwa 3 ga Maris 2020, ya fitar da bugu bakwai tare da wasu mahallin da aka canza.
Yanzu, ka'idodinmu sun sami bita daga Zhou et al., waɗanda suka gabatar da shawarwari masu sauƙi na alama bisa ga kwarewarsu ta asibiti.
Ƙoƙarinsu ya ba da ƙarin tabbaci ga ƙa'idodinmu kuma ya zama muhimmin bayani game da wannan annobar a duniya.
Muna godiya da irin wannan gagarumar aiki da suka yi.
Koyaya, ƙoƙarin su kuma yana buƙatar sabuntawa bisa ga sabon Jagorar Ganowa da Kulawa don COVID-19 (Gwaji na bakwai) da sabon binciken.
A cewar fitowar ta bakwai (3 Maris 2020), tabbatar da yanayin da ake zargi yana buƙatar haɗuwa da kowane ɗayan abubuwan tarihin cutar tare da abubuwa biyu na bayyanar asibiti don samar da cikakken bincike, ko kuma ya kamata ya cika abubuwa uku na bayyanar asibiti idan ba tare da bayyanar tarihin cutar ba:
Tarihin cutar: (1) Tarihin tafiya ko zama a cikin birnin Wuhan da kewaye, ko kuma wasu al'ummomin da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (2) Tarihin hulɗa da cutar SARS-CoV-2 (tare da gwajin tabbatacce na nucleic acid); (3) Tarihin hulɗa da marasa lafiya da zazzabi ko alamun numfashi daga birnin Wuhan da kewaye, ko kuma wasu al'ummomin da aka ba da rahoton COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (4) Tarihin hulɗa da cluster na tabbatar da shari'o'i.
Bayyanar asibiti: (1) zazzabi da/ko alamun numfashi; (2) tare da fasalin hoto na kamuwa da COVID-19; (3) ƙididdigar ƙwayoyin jini na nuna al'ada, raguwa, ko ƙarancin ƙididdigar lymphocyte a farkon farawa.
Ganowar tabbatar da cutar ya kamata ya dogara da yanayin da ake zargi da kowane irin abu mai cutarwa ko hujja ta serological kamar haka: (1) gwajin PCR na ainihi wanda ya tabbata ga SARS-CoV-2; (2) jerin kwayoyin cutar gabaɗaya suna nuna ɗabi'a mai yawa ga sabon coronavirus da aka sani; (3) tabbatacce ga IgM da IgG antibodies na musamman ga SARS-CoV-2 a cikin gwajin magani; ko musayar IgG na musamman ga SaRS-CoV-2 daga mara kyau zuwa tabbatacce, ko ƙaruwa na titer > sau 4 a cikin farfadowa akan yanayin gaggawa.
Za mu iya ganin cewa an kara gwajin PCR na lokaci-lokaci don kwayar nucleic acid a cikin hanyoyin numfashi ko samfurin jini zuwa na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
Binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Wannan gyare-gyare ya dogara ne akan ci gaba da aikin masu bincike waɗanda ke neman mafi kyawun kayan aikin gano nucleic acid don ganowa da sauri, da kuma samfura daga hanyoyin numfashi gami da samfuran jini, wanda ke haɓaka wadatar samfuran daban-daban, kuma yana tallafawa kawo ƙimar tabbatacciyar kwayar cutar ta musamman cikin ƙa'idodin da aka tabbatar.
Bugu da ƙari, akwai ƙarin tabbaci da ke tunatar da mu mu mai da hankali ga marasa lafiya da ke da alamun cutar ko kuma marasa alamun cutar.
Saboda haka, ya kamata a sabunta taswirar da Zhou et al. suka yi, domin sun ce mutane da ba su da alamun asibiti suna da "ƙarancin haɗari".
Dole ne a tabbatar da tsarin ƙididdigar a cikin aikin da kuma nazarin asibiti.
A ƙarshe, muna fatan ƙarin tabbaci na kai tsaye zai zo kuma ya kira masu karatu su yi tsokaci.
Don ganewar asali na "matsalolin da ake zargi" da "matsalolin da aka tabbatar", muna ba da shawarar ganowa da kuma bin sababbin ka'idojin ƙasarsu.
Ƙungiyarmu za ta kuma sabunta ƙa'idodinmu a kai a kai don bayar da taimako.
Bangladesh ta bayar da rahoton sabbin mutuwar COVID-19 guda biyar, wanda shine mafi girma a kowace rana
A jiya, Bangladesh ta tabbatar da sabbin mutuwar COVID-19 guda biyar a wannan rana.
Wannan shi ne adadin mutuwar da cutar ta yi a rana guda.
Har zuwa jiya, Cibiyar Kula da Cututtuka ta Bangladesh (IEDCR) ta ba da rahoton adadin kamuwa da cuta da aka samu ciki har da masu aiki 114 da masu murmurewa 33 da ke zaune a gida.
An samu mutuwar mutane 17.
A cikin wani rahoto na labarai na kan layi, daraktan IEDCR, Dr Meerjady Sabrina Flora, ta ce mutuwar ta hada da maza hudu da mace daya.
A cewar Dr Meerjady, mutum biyu sun haura shekara 60, biyu daga cikinsu 51 da 60, kuma 41 zuwa 50.
Ya kuma ce biyu daga cikin wadanda aka kashe daga birnin Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID 19 a matsayin annoba a ranar 11 ga Maris.
Jami'an asibitin sun shaida wa wani majiyar labarai na gida, Anadolu Agency cewa daya daga cikin wadanda suka kamu da cutar shi ne Jalal Saifur Rahman, daraktan hukumar yaki da cin hanci da rashawa ta Bengali, wanda ke kwance a asibitin Maitree na Kuwait.
A ranar Asabar, a cikin sanarwar bidiyo ta yanar gizo, Ministan Sufuri da Tituna na Bangladesh Obaidul Quader ya ce za a rufe sufuri na jama'a fiye da yadda aka tsara, har zuwa Asabar mai zuwa.
An fara rufe hanyoyin sufuri ne a ranar 26 ga watan Maris kuma an shirya za a kammala ranar Asabar, 4 ga watan Afrilu.
Ana ci gaba da ba da izinin jigilar kayayyaki masu muhimmanci kamar magani, mai da abinci.
An fara samun cutar COVID-19 a Bangladesh a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da kuma matar daya daga cikinsu.
A ranar 19 ga watan Maris, dukan su uku sun warke.
SARS-CoV-2 ya zarce kamuwa da cutar miliyan daya a duniya.
A ranar Alhamis, jimillar adadin masu kamuwa da cutar SARS-CoV-2 ya zarce miliyan daya a duniya, a cewar bayanai daga Jami'ar Johns Hopkins.
Akalla 52 dubu ne suka mutu sakamakon cutar COVID-19, wanda cutar coronavirus ce ta haddasa.
Wannan ci gaban ya zo ne a ranar da Malawi ta tabbatar da kamuwa da cutar ta farko da kuma Zambia ta samu mutuwar farko da ke da nasaba da cutar.
Koriya ta Arewa ta ce, har zuwa ranar Alhamis, tana cikin kasashe kalilan da ba su kamu da cutar ba.
Har zuwa jiya, Hukumar Lafiya ta Duniya ta ba da rahoton 1,051,635 da aka tabbatar da su, ciki har da 79,332 a cikin awanni ashirin da huɗu zuwa 10 na safe Central European Time (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu fiye da mutane 244,000 da suka kamu da cutar, wanda ya kai ga mutuwar mutane 5,900.
Jaridar CBS ta ruwaito, tana mai ambaton bayanan Jami'ar Johns Hopkins, sama da mutane 1,000 ne suka mutu a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duk duniya, kasashe sun sanar da tsauraran matakai don hana yaduwar annobar.
A ranar Alhamis, magajin garin Moscow, Sergie Sobyanin, ya tsawaita dokar kulle birnin har zuwa ranar 1 ga watan Mayu.
A fadin kasar, Shugaba Vladimir Putin ya ce 'yan kasar Rasha na iya ci gaba da samun albashi ba tare da zuwa aiki ba har zuwa 30 ga watan Afrilu.
Majalisar Portugal ta yi zabe don tsawaita dokar ta baci zuwa kwanaki 15; an amince da kuri'u 215 a kan wannan, goma a kan wannan, kuma daya a kan wannan.
Saudiyya ta tsawaita dokar hana fita a biranen Makka da Madina zuwa duk tsawon rana; a baya, dokar hana fita ta kasance tsakanin karfe 3 na yamma zuwa karfe 6 na safe.
Thailand na shirin aiwatar da dokar hana fita tsakanin karfe 10 na dare da karfe 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar zama a gida har zuwa ranar 1 ga watan Mayu.
Shaguna a Australia sun rage yawan kayan wanka da suke amfani da su a cikin kasuwanci.
A ranar Lahadi da Asabar, manyan kantunan Australiya Woolworths da Coles sun rage takunkumin sayen kayan wanka zuwa biyu da kuma kunshin daya a duk wuraren sayar da kayayyaki a kasar.
ALDI ta kuma gabatar da iyakar kunshin daya, a ranar Litinin.
An buga wannan sakon ne a matsayin sako a kan jerin sunayen masu fita daga aiki, da kuma shafin Facebook na kamfanin.
An bayar da rahoton cewa masu siye sun sayi hannun jari saboda tsoron COVID-19 idan mutum ya keɓe kansa.
A ranar Laraba, Woolworths ta kuma rage sayen kayan wanka don sayen kaya zuwa gida zuwa kunshin daya a kowane oda.
Wannan canjin ya biyo bayan takunkumin kunshin hudu ga kowane ma'amala da Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris, bi da bi.
Coles, a cikin sanarwar kafofin watsa labarai a ranar 8 ga Maris, ta ruwaito cewa tare da aiwatar da takunkumin kunshin guda huɗu, "yawancin shagunan har yanzu suna cikin ajiyar kaya a cikin sa'a ɗaya bayan jigilar kaya", kuma ya sanya bukatar a matsayin "maras misaltuwa", yayin da ALDI, a cikin saƙon Facebook a ranar Talata, ya kira shi "ba zato ba tsammani".
Sayarwa ta yi "hawan sama" a makon da ya gabata, in ji mai magana da yawun Woolworths.
Costco's a Canberra ma ya ƙuntata adadin da za a iya shigowa da shi zuwa fakiti biyu a makon da ya gabata.
Don ci gaba da sauƙaƙe ƙarancin, Coles ya ba da umarnin ƙarin kaya daga masu samarwa da haɓaka yawan jigilar kayayyaki, Woolworths ya ba da umarnin ƙarin kaya, yayin da ALDI ke sanya kayan aiki don shirin na musamman na ranar Laraba da za a iya samu da wuri.
Russell Zimmerman, shugaban zartarwa na kungiyar 'yan kasuwa ta Australiya, ya ce 'yan kasuwa suna kokarin kara kaya amma takunkumin majalisar dokokin yankin kan lokacin da za a kai kaya ta hanyar truck ya sa hakan ya zama da wuya.
Ya yi tsammanin farashin kayayyakin zai karu, yayin da masu samarwa ke kokarin biyan bukatar, da kuma wasu abubuwan musamman.
A ranar Talata, ALDI ta sanar da cewa sakamakon fitowar farko na jari, wasu shagunan ba za su iya gudanar da na musamman na ranar Laraba ba.
A wani rahoto da News.com.au ta fitar, Dr. Gary Mortimer, wani masanin sayar da kayayyaki daga jami'ar fasaha ta Queensland, ya ce shaguna suna cike da kayayyaki a kowane dare.
Ya gaya musu cewa kayan wanka suna da yawa, yana haifar da ƙarancin adadin kaya, kuma, idan aka sayar, ya bar sararin sararin samaniya, yana ƙara ƙara jin ƙarancin.
Coles da Woolworths suna da ra'ayin cewa idan akwai abubuwa da yawa a kan shelf, idan kayayyaki kamar su wankin wanka da kayan wanki za a iya saya kuma suna da yawa, za ku iya rage fargaba, in ji Russell Zimmerman a ABC News.
Kamfanin da ke yin kayan wanka da ake sake amfani da su ya sake buga littafin nan "Wanene Yake Ba da Crap?" a ranar Laraba da ta gabata.
Kimberly-Clark, wanda ke yin Kleenex Toilet, da kuma Solaris Paper wanda ke yin Sorbent, sun tabbatar da cewa suna aiki 24/7 don kiyaye wadata, kamar yadda rahoton New.com.au ya nuna.
Shafin yanar gizo na dukiya, Domain.com, ya ruwaito wasu dillalai na gida suna ba da kayan wanka kyauta ga masu fara siyarwa a lokacin da ake siyar da kayayyaki a Melbourne, lokacin da aka yi wasu 'yan gwanjo saboda masu siye da siyarwa sun yi hutu a lokacin hutun ranar ma'aikata.
Mujallar ranar Alhamis ta NT News, jaridar jarida a Darwin, ta saka wasu shafuffuka takwas na takarda da aka yi niyyar yankewa da kuma amfani da su a matsayin kayan wanka.
Shaguna sun fara yin watsi da sanya takunkumi, a cewar wani rahoto daga ABC Australia a ranar 3 ga Maris wanda ya ga cewa ba su da shirin gabatar da iyakance kan sayayya.
Russell Zimmerman ya kara da cewa wasu kayayyaki ma suna da matukar bukatar, ciki har da masks, kayan shafawa, kayan bushewa, kayan wanki da bene.
Hakazalika a waje da Australia, a ranar Lahadi da yamma, an ga Ocado ta hanyar intanet tana iyakance sayen kayan wanka na Andres zuwa fakiti biyu na 12 na wanka.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana annobar COVID-19 mai gudana  cutar da ke haifar da kwayar cutar SARS-CoV-2  a matsayin annoba.
Ko da yake kalmar "annoba" tana nufin yadda cutar ta yadu, ba yadda cutar take da hatsari ba, WHO ta fahimci bukatar karfafawa gwamnatoci gwiwa su dauki mataki:
Dukkanin kasashe na iya sauya yanayin annobar.
Idan kasashen suka gano, gwada, kula, ware, bi da kuma motsa mutanensu su dauki mataki, in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
Muna matukar damuwa game da matakin yaduwar cutar da kuma tsananin rashin aiki.
Wani tsohon darektan Hukumar Kula da Cututtuka a Amirka, Dr. Tom Frieden ya ce, annobar "ba ta taɓa faruwa ba".
Ya ce, a cikin wani labarin da CNN ta wallafa a watan Fabrairu, "ban da mura, babu wata kwayar cutar numfashi da aka gano daga fitowar zuwa yaduwar yaduwar duniya".
Ghebreyesus ya bayyana irin wannan ra'ayi, yana cewa "ba mu taɓa ganin annobar da coronavirus ta haifar ba".
Ya ci gaba, "kuma ba mu taɓa ganin wata annoba da za a iya sarrafawa a lokaci ɗaya ba".
Sabon matsayin da aka ba da cutar ya biyo bayan shawarar da WHO ta yanke a watan Janairu na ayyana annobar a matsayin gaggawa ta lafiyar jama'a a duniya.
Daraktan Cibiyar Kula da Cututtuka da Ciwo na Ƙasa ta Amirka, Dokta Anthony Fauci, ya ce game da annobar, "a taƙaice, za ta ƙara muni".
Kamar yadda na jiya Alhamis, Kamfanin dillancin labarai na Associated Press ya ruwaito akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, inda suka yi mutuwar mutane fiye da 4,600.
Cutar cutar coronavirus ta 201920 ita ce cutar cutar coronavirus ta 2019 (COVID-19), wadda ke gudana, wadda ta haifar da cutar coronavirus 2 (SARS-CoV-2).
An gano annobar a Wuhan, China, a watan Disamba na 2019, an ayyana ta a matsayin Matsalar Lafiya ta Duniya a ranar 30 ga Janairu, 2020, kuma an ayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
Ya zuwa 10 ga Afrilu 2020, an samu rahoton kimanin mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe 210 da yankuna, wanda ya yi sanadiyar mutuwar mutane 97,000.
An warkar da mutane 364,000.
An kiyasta yawan mutuwar mutane a kasar Sin ya kai kashi 4%, yayin da a duniya ya kai 13.04% a Aljeriya zuwa .08% a New Zealand.
Alamun cutar sun hada da zazzabi, tari da kuma numfashi.
Ƙari ga haka, za a iya samun ciwon huhu da kuma ciwon baƙin ciki na numfashi.
Lokaci daga bayyanar zuwa farkon bayyanar cututtuka yawanci kusan kwanaki biyar ne, amma yana iya kasancewa tsakanin kwana biyu zuwa goma sha huɗu.
Babu maganin rigakafi ko magani na musamman da aka sani.
Babban maganin shine maganin cututtuka da tallafi. Matakan rigakafi da aka ba da shawarar sun hada da wanke hannu, rufe baki yayin tari, nisantar mutane, da kuma sanya ido da keɓe kai ga waɗanda suka yi zargin cewa suna da cutar.
Hukumomi a duniya sun amsa da aiwatar da takunkumin tafiye-tafiye, keɓewa, dokar hana fita, kula da haɗarin aiki da rufe wuraren aiki.
Cutar ta haifar da rikice-rikicen zamantakewar tattalin arziki na duniya, jinkiri ko soke wasanni, addini, siyasa da al'adu, da kuma karancin wadataccen kayan masarufi wanda sayayya ta haifar.
Makarantu da jami'o'i sun rufe ko dai a kasa ko a gida a kasashe 193, wanda ya shafi kimanin kashi 99.4 cikin 100 na yawan daliban duniya.
Rashin gaskiya game da cutar ya bazu a yanar gizo, kuma akwai wasu abubuwan da ke nuna kyamar 'yan kasashen waje da kuma nuna wariya ga Sinawa, wasu mutanen da ke da asalin Gabas ta Tsakiya da kuma Asiya ta Kudu maso gabashin Asiya, da kuma wadanda ke daga yankunan da ke da yawan kamuwa da cutar.
Sakamakon rage tafiye-tafiye da rufe manyan masana'antu, akwai raguwar gurbataccen iska da fitar da carbon.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton tarin cututtukan cutar huhu daga asalin da ba a sani ba a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu, 2020.
Yawancin waɗannan lamuran sun danganci kasuwar sayar da abincin teku ta Huanan kuma sun haifar da cutar da ake zargin tana da asalin dabbobi.
Kwayar cutar da ta haifar da annobar ta zama SARS-CoV-2, sabuwar kwayar cutar da aka gano wacce ke da alaƙa da kwayar cutar bat coronavirus, kwayar cutar tenggerger, da SARS-CoV. An gano farkon mutumin da aka sani da alamun cutar a ranar 1 ga Disamba, 2019, kuma mutumin ba shi da alaƙa da alamun kasuwannin da suka biyo baya.
A cikin rukunin farko na masu cutar da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku sun kasance masu alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba daga South China Morning Post ya ba da shawarar cewa wani shari'ar da aka gano a ranar 17 ga Nuwamba, 2019, a cikin wani mai shekaru 55 daga lardin Hubei, na iya zama na farko. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, yayin da aka samu sabbin shari'o'in da aka ruwaito a kasar Sin amma suka yi tashin gwauron zabi a Italiya, Iran da Koriya ta Kudu, adadin sabbin shari'o'in da suka auku a wajen kasar Sin ya zarce na sabon shari'o'in da aka samu a kasar Sin a karon farko.
Wataƙila akwai adadin marasa rahoton da suka yi daidai, musamman a cikin waɗanda ke da ƙananan alamun.
Har zuwa 26 ga Fabrairu, an samu rahotanni kaɗan a cikin matasa, tare da waɗanda shekarunsu 19 da ƙasa da kashi 2.4% na masu cutar a duniya. Babban mai ba da shawara kan kimiyyar Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya dole ne a yi musu allurar rigakafi kafin a sami tasirin garkuwar garkuwar.
Lamarin ya shafi adadin mutanen da aka gwada wa COVID-19, kuma waɗanda aka tabbatar da cewa sun kamu da cutar bisa ga ka'idojin hukuma.
Ya zuwa ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawan jama'arta, kuma ƙasashe da yawa da suka riga sun kafa ƙa'ida ta rashin gwada waɗanda ke da ƙananan alamun cutar, kamar Italiya, Netherlands, Spain, da Switzerland.
Wani bincike da aka buga a ranar 16 ga watan Maris ya gano cewa a kasar Sin, har zuwa ranar 23 ga watan Janairu, an kiyasta cewa kashi 86% na kamuwa da cutar COVID-19 ba a gano su ba, kuma cewa wannan kamuwa da cutar da ba a rubuta ba ce ta samar da kashi 79% na wadanda aka rubuta.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa adadin masu kamuwa da cutar a Italiya ya fi adadin da aka ruwaito.
Hasashen farko na ƙaruwar lamba (R0) don COVID-19 shine 1.4 zuwa 2.4.
Wani bincike da aka wallafa daga Cibiyar Kula da Cututtuka ta Amurka ya ce wannan adadi zai iya zama 5.7.
Yawancin mutanen da suka kamu da COVID-19 sun warke.
Ga waɗanda ba su da shi, lokaci na bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, wanda ya fi kwana 14 na kowa.
Ya zuwa 10 ga Afrilu 2020, kusan mutuwar 97,000 an danganta su da COVID-19.
A China, kamar yadda aka yi a ranar 5 ga Fabrairu, kusan kashi 80% na mutuwar sun kasance a cikin waɗanda suka haura shekaru 60, kuma kashi 75% suna da matsalolin kiwon lafiya da suka hada da cututtukan zuciya da ciwon sukari.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma, saboda ba zai haɗa da waɗanda suka mutu ba tare da an gwada su ba - misali a gida, a cibiyar kulawa, da sauransu.
Bayanai na sashi daga Italiya sun gano cewa yawan mutuwar da aka yi a lokacin annobar ya wuce adadin mutuwar COVID na hukuma da kashi 4-5x.
Wata mai magana da yawun cibiyar kula da cututtuka ta Amurka (CDC) ta bayyana cewa "Mun san cewa [adadin mutuwar da aka bayar] ba a kasafin kudi ba ne", wata sanarwa da ke da goyan bayan rahotanni na rashin yawan mutane a Amurka. Irin wannan rashin kasafin kudi yana faruwa sau da yawa a cikin annoba, kamar yadda ya faru a lokacin annobar cutar sankarar naman alade ta H1N1 na 2009 H1N1.
Mutuwa ta farko a waje da kasar Sin ta faru ne a ranar 1 ga watan Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ita ce a Faransa a ranar 14 ga watan Fabrairu.
Har zuwa 28 ga watan Fabrairu, a wajen kasar Sin, an samu mutuwar mutane fiye da goma sha biyu a kowace kasa a Iran, Koriya ta Kudu, da Italiya.
A ranar 13 ga watan Maris, sama da kasashe 40 da yankuna sun bayar da rahoton mutuwar mutane, a duk nahiyoyi sai Antarctica.
Wannan adadi ya bambanta ta yanki da lokaci, kuma ana rinjayarsa ta yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓin magani, lokaci tun farkon annobar, da kuma halaye na yawan jama'a kamar shekaru, jinsi, da kuma lafiyar gaba ɗaya.
Bisa ga ƙididdigar Jami'ar Johns Hopkins, yawan mutuwar da cutar a duniya ya kai 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu 2020.
Wannan adadi ya bambanta da yankin.
A China, kimantawa don yawan mutuwar da cutar ta yi ya ragu daga 17.3% (ga waɗanda ke da alamun farawa 110 Janairu 2020) zuwa 0.7% (ga waɗanda ke da alamun farawa bayan 1 Fabrairu 2020). Sauran matakan sun haɗa da yawan mutuwar cutar (CFR), wanda ke nuna kashi na waɗanda aka gano waɗanda suka mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna kashi na waɗanda suka kamu (wanda aka gano da wanda ba a gano ba) wanda ya mutu daga cutar.
Waɗannan ƙididdigar ba su da alaƙa da lokaci kuma suna bin takamaiman yawan jama'a daga kamuwa da cuta ta hanyar warwarewar shari'a.
Wasu masana kimiyya sun yi ƙoƙari su ƙididdige wannan adadi don ƙididdigar yawan jama'a.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar kamuwa da cutar a cikin cutar gaba ɗaya ya kasance tsakanin 0.1% da 0.39%.
Ƙididdigar sama don wannan zangon ya kasance daidai da sakamakon gwajin farko na COVID-19 a Jamus, da kuma nazarin ƙididdiga da ke nazarin tasirin gwajin akan ƙididdigar CFR.
Hukumar Lafiya ta Duniya ta tabbatar da cewa za a iya shawo kan annobar.
Lokacin da annobar ta kai ƙarshenta ba shi da tabbas kuma yana iya bambanta da wuri.
Maciej Boni na Jami'ar Jihar Penn ya ce, "Idan ba a bincika ba, annobar cutar tana yawan zama a kwance sannan ta fara raguwa idan cutar ta ƙare gidajen da ake da su.
Amma ba shi yiwuwa a yi wani annabci mai kyau a yanzu game da lokacin da hakan zai faru".
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin kasar Sin Zhong Nanshan ya yi jayayya cewa "za a iya kawo karshen annobar a watan Yuni" idan za a iya tura dukkan kasashe su bi shawarar WHO kan matakan da za a dauka don dakatar da yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Kiwon Lafiya da Magunguna ta London ya ce SARS-CoV-2 "zai ci gaba da yaduwa, mai yiwuwa na shekara ɗaya ko biyu".
A cewar wani binciken da kwalejin Imperial ta yi wanda Neil Ferguson ya jagoranta, za a bukaci yin atisaye da sauran matakan "har sai an samu allurar rigakafi (watakila na tsawon watanni 18 ko fiye da haka)".
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu ba cewa wannan kwayar cutar korona ta ɓace gaba ɗaya saboda tana da saurin yaduwa" kuma "mai yiwuwa ta zama cutar yanayi, tana sake bayyana kowace shekara".
Yadda cutar za ta sake dawowa zai dangana ne a kan garkuwar garkuwar da kuma irin canjin da aka yi.
Alamun COVID-19 na iya zama marasa takamaiman kuma wanda ya kamu da cutar na iya zama mai rashin alamun cutar.
Alamun biyu da suka fi kowa su ne zazzabi (88%) da kuma tari mai bushe (68%).
Alamun da ba sa yawan faruwa sun hada da gajiya, samar da kumburi na numfashi (na numfashi), rashin jin ƙanshi, numfashi mai wuya, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, sanyi, amai, haemopthitis, diarrhea ko cyanosis. WHO ta ce kusan mutum daya cikin shida ya zama mai matukar ciwo kuma yana da wahalar numfashi.
Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta Amurka ta lissafa alamun gaggawa kamar wahalar numfashi, ciwo ko matsin lamba a cikin kirji, rikicewar kwatsam, wahalar farkawa daga bacci, da idanu ko lebe suna zama blue; ana ba da magani nan da nan idan akwai waɗannan alamun.
Wasu mutane da suka kamu da cutar na iya zama marasa alamun cutar, ba tare da wata alama ta asibiti ba amma tare da sakamakon gwajin da ke tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawarar cewa waɗanda ke da kusanci da mutanen da aka tabbatar suna da cutar su kula sosai kuma a duba su don tabbatar da cewa ba su da kamuwa da cutar.
China ta kiyasta yawan mutanen da ba su da alamun cutar daga kadan zuwa kashi 44 cikin dari.
Lokacin jinkiri na yau da kullun (lokacin tsakanin kamuwa da cuta da bayyanar cututtuka) ya kasance daga rana ɗaya zuwa 14; mafi yawan kwanaki biyar.A matsayin misali na rashin tabbas, ƙididdigar kashi na mutanen da ke da COVID-19 waɗanda suka rasa ƙanshin su da farko ya kai 30% sannan ya ragu zuwa 15%.
Ana ci gaba da tantance wasu abubuwa game da yadda cutar take yaduwa.
An yi imanin cewa cutar tana yaduwa ne musamman yayin hulɗa da juna da kuma ta hanyar ƙananan ɗigon da aka samu yayin tari, tari, ko magana; tare da hulɗa ta kusa da nesa na mita 1 zuwa 2 (3 zuwa 6 feet).
Nazarin ya gano cewa tari mara kariya zai haifar da saukad da ai yana motsawa har zuwa mita 4.5 (15 feet) zuwa mita 8.2 (27 feet).
Wasu mutane sun ba da shawarar cewa cutar na iya yaduwa ta hanyar ƙananan saukad da da ke kasancewa na dogon lokaci a cikin iska, wanda wataƙila ana samarwa yayin magana. Saukad da numfashi na iya haifar da numfashi, gami da yayin magana, kodayake kwayar cutar ba ta da iska.
Za a iya sauko da shi a bakin mutum ko kuma a hancinsa ko kuma a sha shi a cikin huhu.
Wasu hanyoyin kiwon lafiya kamar su intubation da cardiopulmonary resuscitation (CPR) na iya haifar da ɓarkewar shayarwa kuma saboda haka haifar da yaduwar iska.
Haka kuma za a iya yada cutar idan mutum ya taba gurbataccen abu, ciki har da fata, sannan ya taba idanunsa, hanci ko bakinsa.
Duk da cewa akwai damuwa cewa kwayar cutar za ta iya yaduwa ta hanyar fitsari, an yi imanin cewa wannan hadarin yana da ƙarancin gaske.
Gwamnatin China ta musanta yiwuwar yaduwar SARS-CoV-2 ta bakin muƙamuƙi. Kwayar cutar tana da saukin kamuwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, amma ana iya kamuwa da cutar kafin bayyanar cututtuka da kuma a matakin cutar.
Mutane sun gwada tabbatacce ga cutar har zuwa kwanaki uku kafin bayyanar cututtuka yana nuna cewa ana iya samun kamuwa da cutar kafin bayyanar cututtuka.
Rahotanni kalilan ne kawai na asymptomatic lab-confirmed cases, amma an gano asymptomatic transmission ta wasu kasashe yayin binciken ganowa.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta bayyana cewa ko da yake ba a san yadda sauƙin cutar take yaɗuwa ba, mutum ɗaya yakan kamu da mutane biyu ko uku.
Musamman, an gano cewa kwayar cutar ta iya yin kwanaki uku a kan filastik (polypropylene) da bakin karfe 304, rana a kan kwali, da kuma tsawon sa'o'i huɗu a kan tagulla.
Wannan, duk da haka, ya bambanta dangane da zafi da zafin jiki. Dabbobi da sauran dabbobi sun gwada tabbatacce ga COVID-19.
Babu tabbacin cewa dabbobi na iya yada cutar zuwa ga mutane, amma hukumomin Birtaniya sun ba da shawarar wanke hannu bayan sun taba dabbobi, kamar su bayan sun taba wasu wurare da waɗanda ke dauke da cutar suka taɓa.
Kwayar cuta mai saurin numfashi mai saurin kamuwa da cuta 2 (SARS-CoV-2) kwayar cutar ce ta zamani, da farko an ware ta daga mutane uku da ke fama da cutar huhu da ke da nasaba da wani rukunin cututtukan numfashi mai saurin kamuwa da cuta a Wuhan.
Dukkanin sabbin halayen kwayar cutar SARS-CoV-2 sun faru ne dangane da kwayar cutar coronaviruses a cikin yanayi. A wajen jikin mutum, kwayar cutar tana kashe ta ta hanyar sabulu na gida, wanda ke lalata garkuwar kariya. SARS-CoV-2 yana da alaƙa da ainihin SARS-CoV.
An yi zaton cewa cutar ta zoonotic ne.
Binciken kwayoyin halitta ya bayyana cewa kwayar cutar ta kwayar halitta ta haɗu da kwayar Betacoronavirus, a cikin Sarbecovirus (tsarin B) tare da abubuwa biyu da aka samo daga bat.
Kwayar cutar ta yi kama da kashi 96 cikin dari a matakin cikakken kwayoyin halitta da wasu kwayoyin cutar bat coronavirus (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci guda daya na amino acid a wani bangare na tsarin kwayoyin halitta tsakanin kwayar cutar daga tururuwa da kwayar cutar daga mutum.
Bambancin da aka samu a cikin dukkanin kwayoyin halitta ya nuna cewa kashi 92% na kwayoyin halitta sun kasance tsakanin kwayar cutar tengleberry da SARS-CoV-2, wanda bai isa ya tabbatar da tengleberry a matsayin matsakaiciyar gida ba.
Ana iya gano kamuwa da kwayar cutar a ɗan lokaci bisa ga bayyanar cututtuka, kodayake an tabbatar da hakan ta hanyar fassarar jujjuyawar polymerase chain reaction (rRT-PCR) na ɓarkewar kamuwa da cutar ko CT.
Wani bincike da ya kwatanta PCR da CT a Wuhan ya nuna cewa CT ya fi PCR saukin ganewa, ko da yake ba shi da takamaiman bayani, saboda yawancin abubuwan da ke nunawa sun shafi ciwon huhu da sauran cututtuka.
Tun daga Maris 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "Bai kamata a yi amfani da CT don yin bincike ko kuma a matsayin gwajin farko na gano COVID-19 ba".
WHO ta wallafa wasu ka'idojin gwajin RNA don SARS-CoV-1, tare da na farko da aka fitar a ranar 17 ga Janairu.
Gwajin yana amfani da fassarar jujjuyawar polymerase chain reaction (rRT-PCR) na ainihi.
Ana iya yin gwajin ne a jikin mutum ko kuma a jikin jini.
Sakamakon gwajin yakan kasance cikin sa'o'i da yawa zuwa kwanaki da yawa.
Ana yin wannan gwajin ne da kwayar nasopharyngeal amma ana iya amfani da kwayar hanci. Yawancin dakunan gwaje-gwaje da kamfanoni suna haɓaka gwajin serology, wanda ke gano ƙwayoyin cuta.
Ya zuwa ranar 6 ga Afrilu, 2020, babu ɗayan waɗannan gwaje-gwajen da aka tabbatar da su da suka isa a amince da su don amfani da su a ko'ina.
A Amurka an amince da gwajin serology da Cellex ta samar don amfani na gaggawa ta hanyar ingantattun dakunan gwaje-gwaje kawai.
Abubuwan da ke nunawa a kan radiographs da kuma CT scan na hawaye masu alamun sun hada da asymmetrical glazing na ƙasa da kuma rashin pleural effusion.
Ƙungiyar Radiology ta Italiya tana tattara bayanai a kan layi na kasa da kasa don neman hotuna don tabbatar da yanayin.
Saboda rikici da wasu cututtuka kamar adenovirus, ƙirar tabbaci ta PCR tana da iyakantaccen ƙwarewa wajen gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa kodayake hoton ba shi da takamaiman kamuwa da cuta, hanyar ta fi sauri kuma ta fi saukin kamuwa da cuta, yana ba da shawarar yin la'akari da hanyar a matsayin kayan aikin tacewa a yankunan da ke fama da annoba.
An gina cibiyar sadarwa ta hanyar kwakwalwa don gano kwayar cutar ta hanyar daukar hoto ta hanyar radiographs da CT.
Dabaru don hana yaduwar cuta sun hada da kiyaye tsabtar jiki gaba daya, wanke hannu, guje wa taɓa idanu, hanci, ko baki da hannaye marasa wanke, da kuma yin tari ko sneezing a kan takarda sannan a jefa shi kai tsaye cikin kwandon shara.
An shawarci wadanda suka kamu da cutar da su sanya abin rufe fuska a wuraren da jama'a suke.
An kuma ba da shawarar matakan keɓewa ta jiki don hana yaduwar cutar. Yawancin gwamnatoci sun hana ko ba da shawarar kauce wa duk tafiye-tafiye marasa mahimmanci zuwa da kuma daga ƙasashe da yankunan da cutar ta shafa.
Duk da haka, cutar ta kai matakin yaduwar al'umma a yawancin sassan duniya.
Wannan yana nufin cewa kwayar cutar ta yadu a cikin al'umma, kuma wasu membobin al'umma ba su san inda ko yadda aka kamu da ita ba. Ana ba da shawarar masu ba da kiwon lafiya da ke kula da wanda zai iya kamuwa da cutar su yi amfani da matakan tsaro na yau da kullun, matakan tuntuɓar tuntuɓar, da kariya ta ido. Binciken tuntuɓar hanya ce mai mahimmanci don gano tushen kamuwa da cuta da kuma hana ci gaba da yaduwa.
Amfani da bayanan wurin da ake samu daga wayoyin salula ta gwamnati don wannan dalili ya haifar da damuwa game da sirrin, tare da Amnesty International da fiye da kungiyoyi 100 da suka fito da sanarwa da ke neman a takaita irin wannan sa ido.
An aiwatar da aikace-aikacen hannu da yawa ko kuma an ba da shawarar su don amfani na son rai, kuma har zuwa 7 ga Afrilu 2020, sama da gungun masana dozin suna aiki kan mafita mai sada zumunta, kamar amfani da Bluetooth don yin rajistar kusanci da mai amfani tare da wata wayar salula.
Masu amfani daga baya suna karɓar saƙo idan sun kasance cikin kusanci da wani wanda ya gwada tabbatacce ga COVID-19. Rashin fahimta yana yawo game da yadda za a hana kamuwa da cuta; misali, wanke hanci da yin taushi da maganin hanci ba shi da tasiri.
Babu allurar rigakafin COVID-19, duk da cewa kungiyoyi da dama na kokarin samar da rigakafin.
Ana ba da shawarar wanke hannu don hana yaduwar annobar.
CDC ta ba da shawarar cewa jama'a su wanke hannayensu akai-akai da sabulu da ruwa na akalla sakan ashirin, musamman bayan sun je gidan wanka ko idan hannayensu sun kasance masu datti; kafin cin abinci; da kuma bayan shan hanci, tari, ko tari.
Wannan saboda a waje da jikin mutum, sabulu na gida yana kashe shi, yana lalata kumburin kariya.
CDC ta kara ba da shawarar yin amfani da maganin tsabtace hannu na barasa wanda ya ƙunshi aƙalla kashi 60% na barasa lokacin da sabulu da ruwa ba su da isasshen amfani.
Hukumar ta WHO ta shawarci jama'a da su guji taɓa idanunsu, hanci, ko bakinsu da hannuwansu da ba a wanke ba.
Surfaces na iya zama gurbatacce da wasu magunguna (a cikin minti daya na fallasa ga disinfectant don saman bakin karfe), gami da 6271% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidon-iodin.
Sauran hanyoyin, kamar su benzalkonium chloride da crohexidine gluconate, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan an yi zargin ko an tabbatar da cutar COVID a wuraren kamar ofisoshi ko cibiyoyin kula da yara, ya kamata a rufe dukkan wuraren kamar ofisoshi, wuraren wanka, wuraren taruwa, kayan aikin lantarki da ake rabawa kamar su kwamfutar hannu, allon taɓawa, keyboard, na'urorin sarrafawa na nesa da na'urorin ATM da masu cutar ke amfani da su.
Ƙungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hancinsu da hannayensu masu lankwasa ko kuma kayan da suka shafa yayin da suke tari ko kuma hancin su, kuma su zubar da duk wani kayan da suka shafa nan da nan.
Ana ba da shawarar abin rufe fuska na tiyata ga waɗanda za su iya kamuwa da cutar, saboda sanya abin rufe fuska na iya iyakance adadin da kuma nisan tafiyar da ɗigon numfashi da ke yaduwa yayin magana, hancin, da tari.
Hukumar Lafiya ta Duniya ta fitar da umarni kan lokacin da kuma yadda ake amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin cututtuka a Jami'ar Leeds, "Sanya abin rufe fuska na iya rage yawan mutanen da ke taɓawa fuskokinsu, wanda shine babban tushen kamuwa da cuta ba tare da kulawar tsabtace hannu ba". An kuma bada shawarar cewa masu kula da wanda ke da cutar su yi amfani da abin rufe fuska.
Hukumar ta WHO ta ba da shawarar sanya abin rufe fuska ga masu lafiya kawai idan suna da babban haɗari, kamar waɗanda ke kula da mutanen da ke da COVID-19, kodayake ta kuma yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskokinsu.
Wasu kasashe sun fara inganta amfani da abin rufe fuska ta hanyar al'umma.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska wanda ba na likita ba wanda aka yi da masana'anta. China ta ba da shawarar musamman amfani da abin rufe fuska na likita da za a iya zubar da shi ta hanyar mutanen da ke da lafiya, musamman lokacin da suke hulɗa da juna (1 mita (3 feet) ko ƙasa da haka) da wasu.
Hong Kong ta ba da shawarar sanya abin rufe fuska yayin amfani da sufuri na jama'a ko kuma kasancewa a cikin cunkoson jama'a.
Jami'an kiwon lafiya na Thailand sun karfafa wa jama'a gwiwa su yi takunkumin fuska a gida kuma su wanke shi kullum.
Jamhuriyar Czech da Slovakia sun hana fita waje ba tare da sanya abin rufe fuska ba ko rufe hanci da baki.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa da kowa ya sanya abin rufe fuska yayin fita a fili don kare kansa da sauran mutane.
Gwamnatin Austria ta kafa dokar cewa duk wanda ya shiga kantin sayar da kayayyaki dole ne ya sanya abin rufe fuska.
Isra'ila ta bukaci dukkan mazauna yankin su sanya abin rufe fuska a wuraren jama'a.
Taiwan, wadda ta samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da na bas da ke tsakanin birane su sanya abin rufe fuska a ranar 1 ga Afrilu.
Panama ta tilasta sanya abin rufe fuska yayin fita, yayin da kuma ta ba da shawarar yin abin rufe fuska a gida ga waɗanda ba za su iya sayan abin rufe fuska ba.
An kuma yi amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa nesa (wanda kuma ake kira da nesa ta jiki) yana tare da matakan sarrafa kamuwa da cuta da nufin rage yaduwar cuta ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun hada da keɓewa; takunkumin tafiye-tafiye; da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo ko cibiyoyin kasuwanci.
Mutane na iya aiwatar da hanyoyin nisantar jama'a ta hanyar zama a gida, rage tafiye-tafiye, guje wa wuraren da mutane ke yawan zama, amfani da kayan wanka ba tare da tuntuɓar mutum ba, da kuma ware kansu daga wasu.
Gwamnatoci da dama yanzu suna tilasta ko bada shawarar nisantar da jama'a a yankunan da cutar ta shafa.
Matsakaicin girman taron da hukumomin gwamnati na Amurka da kungiyoyin kiwon lafiya suka ba da shawarar an rage shi da sauri daga mutane 250 (idan babu sanadin cutar COVID-19 a yankin) zuwa mutane 50, sannan zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a sama da mutane biyu. Manyan tsofaffi da waɗanda ke da matsalolin rashin lafiya kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, da tsarin rigakafi na fuskantar haɗarin kamuwa da cuta da rikitarwa kuma CDC ta shawarce su da su zauna a gida kamar yadda zai yiwu a yankunan da ke fama da cutar. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar "ajiyar zamantakewa" da "ajiyar jiki", don bayyana cewa makasudin shine rage taɓawa ta jiki yayin kiyaye alaƙar zamantakewa, ko dai ta hanyar nesa ko ta hanyar nesa.
Amfani da kalmar "ciwon zamantakewa" ya haifar da ma'anar cewa mutane suyi cikakken keɓewa na zamantakewa, maimakon ƙarfafa su su yi hulɗa da wasu ta wasu hanyoyi. Wasu sun ba da jagororin kiwon lafiya na jima'i don amfani a lokacin annobar.
Wannan ya haɗa da shawarar yin jima'i da wanda kuke zama tare da shi, wanda ba shi da kwayar cutar ko kuma alamun cutar.
An ba da shawarar keɓe kai a gida ga waɗanda aka gano suna da COVID-19 da waɗanda ake zargin sun kamu da cutar.
Hukumomin kiwon lafiya sun fitar da umarni dalla-dalla na yadda za a kebe kai. Gwamnatoci da dama sun ba da umarni ko kuma sun ba da shawarar kebe kai ga dukkan mutanen da ke zaune a yankunan da cutar ta shafa.
An ba da umarnin keɓe kai mafi tsauri ga waɗanda ke cikin rukunin haɗari.
Wadanda suka iya fuskantar mutum da COVID-19 da waɗanda suka taɓa tafiya zuwa ƙasashe ko yankuna tare da yaduwar yaduwar cutar an shawarce su da su keɓe kansu na tsawon kwanaki 14 daga lokacin da aka iya gano su.
Dabaru na sarrafa annobar su ne hana ko kuma hana, da ragewa.
An gudanar da rigakafin ne a farkon barkewar cutar kuma an yi niyyar bin diddigin wadanda suka kamu da cutar da kuma gabatar da wasu matakan kula da kamuwa da cuta da kuma allurar rigakafi don dakatar da cutar daga yaduwa ga sauran jama'a.
Lokacin da ba zai yiwu a hana yaduwar cutar ba, sai a koma ga ragewa: ana daukar matakai don rage yaduwar cutar da rage tasirinta ga tsarin kiwon lafiya da al'umma.
Za a iya yin hada-hadar hanawa da ragewa a lokaci guda.
Matsi yana buƙatar ƙarin matakai don dakatar da annobar ta hanyar rage ƙididdigar asali zuwa ƙasa da 1. Wani ɓangare na yadda ake sarrafa yaduwar cututtukan cututtuka shine ƙoƙarin rage ƙaruwar annobar, wanda aka sani da daidaita yanayin annobar.
Wannan yana rage haɗarin ayyukan kiwon lafiya su zama masu nauyi kuma yana ba da ƙarin lokaci don samar da allurar rigakafi da magani.
Hanyoyin da ba na magani ba da za su iya sarrafa yaduwar sun hada da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da keɓe kai; matakan al'umma da aka yi niyya kan nisantar jiki kamar rufe makarantu da soke taron taro; shigar da jama'a don inganta karɓa da shiga cikin irin waɗannan matakan; haka kuma matakan muhalli kamar tsabtace farfajiyar. An ɗauki matakai masu mahimmanci da aka yi niyya don hana yaduwar cutar a China bayan bayyanar cutar, misali tare da keɓewar gari da tsaurara takunkumin tafiye-tafiye.
Sauran ƙasashe ma sun ɗauki matakai da dama da suka shafi hana yaduwar cutar.
Koriya ta Kudu ta gabatar da tsauraran matakai na tantancewa da kuma keɓewar gida, tare da bayar da gargadi game da motsin mutane masu kamuwa da cutar.
Singapore tana ba da tallafi na kuɗi ga waɗanda suka kamu da cutar waɗanda suka keɓe kansu kuma suna ba da babbar tarar ga waɗanda suka kasa yin hakan.
Taiwan ta kara samar da takunkumin rufe fuska kuma ta ci tarar samar da kayayyakin kiwon lafiya. Simulations ga Great Britain da Amurka sun nuna cewa ragewa (ragewa amma ba dakatar da yaduwar annoba) da kuma hana (dakatar da ci gaban annoba) suna da manyan kalubale.
Tsarin rage yawan cutar zai iya rage yawan bukatar kiwon lafiya da ya kai kashi biyu cikin uku da mutuwar mutane da rabi, amma har yanzu yana haifar da dubban dubban mutuwar mutane da kuma wahalar da tsarin kiwon lafiya ke fuskanta.
Matakai na iya zama zaɓi amma ya kamata a ci gaba da shi muddin kwayar cutar tana yaduwa a cikin yawan mutane (ko kuma har sai an sami rigakafi, idan hakan ta fara), saboda yaduwar za ta sake dawowa nan da nan idan an sassauta matakan kariya.
Saurin hana annobar ya jawo tsadar tattalin arziki da zamantakewa.
Babu wani maganin rigakafi da aka amince da shi musamman don COVID-19, amma ana ci gaba da kokarin samar da shi, gami da gwajin maganin da ake da shi.
Shan maganin mura da aka ba da shi a kantin sayar da magani, shan ruwa, da kuma hutawa zai taimaka wajen rage alamun cutar.
Dangane da tsananin cutar, za a iya bukatar maganin oxygen, ruwan da ke cikin jijiya da kuma taimakon numfashi.
Yin amfani da kwayoyin steroid zai iya sa sakamakon ya yi muni.
Wasu abubuwa da aka amince da su a baya don magance wasu cututtukan kwayar cuta ana binciken su don amfani da su wajen magance COVID-19.
WHO ta kuma bayyana cewa wasu "magungunan gargajiya da na gida" na iya taimakawa wajen rage alamun cutar SARS-CoV-19.
WHO ta bayyana haɓaka iya aiki da daidaita kiwon lafiya don bukatun marasa lafiya na COVID-19 a matsayin matakin amsawa na asali.
ECDC da ofishin WHO na Yammacin Turai sun fitar da jagororin ga manyan asibitoci da sabis na kiwon lafiya don motsa albarkatu a matakai daban-daban, gami da mai da hankali kan sabis na dakin gwaje-gwaje zuwa gwajin COVID-19, soke hanyoyin zaɓe lokacin da ya cancanta, warewa da keɓe marasa lafiya masu cutar COVID-19, da haɓaka ƙarfin kulawa ta hanyar horar da ma'aikata da haɓaka adadin masu amfani da iska da gadaje.
Akwai ra'ayoyi da dama game da inda lamarin farko (wanda ake kira marasa lafiya marasa lamba) ya fito.
An gano farkon sanannen sabon kwayar cutar coronavirus a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
An danganta wannan lamarin ne ga kasuwar sayar da abincin teku ta Huanan, wacce kuma ke sayar da dabbobi masu rai, kuma daya daga cikin ka'idodin shine cewa kwayar cutar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi; ko, a wasu kalmomin, tana da asalin zoonotic. An lura da tarin cutar huhu wanda ba a san dalilinsa ba a ranar 26 ga Disamba kuma likita Zhang Jixian ya kula da shi a Asibitin lardin Hubei, wanda ya sanar da CDC Wuhan Jianghan a ranar 27 ga Disamba.
A ranar 30 ga watan Disamba, wata ƙungiyar likitoci a asibitin Wuhan ta sanar da abokan aikinsu game da "kwayar cutar korona mai kama da SARS".
Wadannan likitoci takwas, ciki har da Li Wenliang, 'yan sanda sun gargadi su saboda yada jita-jita, kuma wani, Ai Fen, ya sha azaba daga shugabanninsa saboda tayar da lamarin.
Hukumar Lafiya ta Wuhan ta ba da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An samu isassun mutane da suka kamu da cutar a Wuhan da suka fara bincike a farkon watan Janairu.
A farkon da tsakiyar watan Janairun 2020, cutar ta bazu zuwa sauran lardunan kasar Sin, tare da taimakon ƙaurawar Sabuwar Shekarar China da Wuhan ta zama cibiyar sufuri da kuma babbar hanyar jirgin ƙasa.
A ranar 20 ga watan Janairu, kasar Sin ta bayar da rahoton kusan sabbin mutane 140 a rana, ciki har da mutane biyu a Beijing da daya a Shenzhen.
Bayanai na hukuma daga baya sun nuna cewa mutane 6,174 sun nuna alamun cutar a ranar 20 ga Janairu, 2020.Zuwa 26 ga Maris, Amurka ta shawo kan China da Italiya tare da mafi yawan adadin waɗanda aka tabbatar da su a duniya.Zuwa 9 ga Afrilu, 2020, an ba da rahoton sama da mutane miliyan 1.61 a duniya; sama da mutane 97,000 sun mutu kuma sama da mutane 364,000 sun warke.
Kimanin kasashe 200 da yankuna sun samu akalla mutum daya da ya kamu da cutar.
Sakamakon annobar a Turai, ƙasashe da yawa a yankin Schengen sun takaita motsi da keɓaɓɓu da kuma sanya iko a kan iyakoki.
Amsar kasa ta hada da matakan kariya kamar su keɓewa (wanda aka fi sani da umarnin zama a gida, umarnin mafaka, ko gaggawa) da umarnin keɓewa. Kamar yadda na 2 ga Afrilu, kusan mutane miliyan 300, ko kuma kusan kashi 90% na yawan jama'a, suna ƙarƙashin wani nau'in gaggawa a Amurka, sama da mutane miliyan 50 suna cikin gaggawa a Philippines, kusan mutane miliyan 59 suna cikin gaggawa a Afirka ta Kudu da mutane biliyan 1.3 suna cikin gaggawa a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna cikin yanayin gaggawa, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu - kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An gano farkon tabbataccen shari'ar COVID 19 a ranar 1 ga Disamba, 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa an fara gano shi ne a ranar 17 ga Nuwamba.
Likita Zhang Jixiang ya lura da wani tarin mutane da suka kamu da cutar huhu da ba a san dalilin da ya sa ba a ranar 26 ga watan Disamba, sai asibitinsa ya sanar da CDC Wuhan Jianghan a ranar 27 ga watan Disamba.
Gwajin farko na kwayoyin halitta don samfurin marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna kasancewar coronavirus kamar SARS.
An fitar da sanarwar jama'a ne daga hukumar kiwon lafiya ta birnin Wuhan a ranar 31 ga watan Disamba.
An sanar da WHO a ranar.
A lokacin da aka sanar da hakan, 'yan sanda sun gargadi likitoci a Wuhan saboda "yaɗa jita-jita" game da annobar.
Hukumar Lafiya ta kasa ta kasar Sin da farko ta yi ikirarin cewa babu "tabbaci" na kamuwa da mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na kawo karshen cutar da babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya bayyana a matsayin "yaƙin jama'a" domin dakile yaduwar cutar.
A cikin abin da aka kira "mafi girman keɓewa a tarihin ɗan adam", an sanar da keɓewar a ranar 23 ga Janairu wanda ya dakatar da tafiya zuwa da fita daga Wuhan, wanda aka faɗaɗa zuwa birane 15 a Hubei, wanda ya shafi mutane miliyan 57.
An hana amfani da motoci masu zaman kansu a cikin birnin.
An soke bikin Sabuwar Shekarar Sin (Janairu 25) a wurare da yawa.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, asibitin Huoshenshan, wanda aka kammala cikin kwanaki 10.
An gina wani asibiti bayan haka, asibitin Leishenshan, don kula da ƙarin marasa lafiya.
Baya ga sabon asibitin da aka gina, kasar Sin ta kuma sauya wasu wurare 14 a Wuhan kamar cibiyoyin taro da filayen wasa, zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta fara wasu matakai don shawo kan annobar COVID-19, gami da bayar da sanarwar lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
Jami'o'i da makarantu a duk fadin kasar sun rufe.
Yankin Hong Kong da Macau sun fara wasu matakai, musamman game da makarantu da jami'o'i.
An fara aikin na nesa a wasu lardunan kasar Sin.
An kafa takunkumin hana zirga-zirga a ciki da wajen Hubei.
An gyara hanyoyin sufuri na jama'a, kuma an rufe gidajen tarihi a duk fadin kasar Sin na wani lokaci.
An aiwatar da sarrafa motsin jama'a a cikin birane da yawa, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) suna fuskantar wasu nau'ikan takunkumin fita waje. Bayan yaduwar cutar ta shiga matakin duniya a watan Maris, gwamnatin China ta ɗauki tsauraran matakai don hana cutar daga "shigowa" daga wasu ƙasashe.
Misali, Beijing ta sanya wa dukkan matafiya na kasa da kasa da ke shiga birnin takunkumi na kwanaki 14. A ranar 23 ga watan Maris, kasar Sin ta samu mutum daya da ya kamu da cutar a cikin kwanaki biyar, a wannan yanayin matafiyin ya koma Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan China Li Keqiang ya ba da rahoton cewa an toshe ainihin yaduwar cutar ta cikin gida kuma China ta sarrafa ta.
An sassauta takunkumin tafiye-tafiye na rana ɗaya a Hubei, ban da Wuhan, watanni biyu bayan da aka aiwatar da dokar ta baci. Ministan Harkokin Wajen China ya sanar a ranar 26 ga Maris, 2020 cewa shigar da visa ko masu riƙe da izinin zama za a dakatar da su daga ranar 28 ga Maris zuwa gaba, ba tare da takamaiman bayani kan lokacin da wannan manufar za ta ƙare ba.
Waɗanda suke son shiga ƙasar Sin suna bukatar su nemi biza a ofishin jakadancin ƙasar Sin ko kuma ofishin jakadancin ƙasar.
Gwamnatin kasar Sin ta karfafa kasuwancin da masana'antun da za su sake budewa a ranar 30 ga Maris, kuma ta samar da kudaden karfafa gwiwa ga kamfanoni. Majalisar Jiha ta ayyana ranar makoki da fara minti uku na shiru a karfe 10:00 na ranar 4 ga Afrilu, wanda ya yi daidai da bikin Qingming, duk da cewa gwamnatin tarayya ta nemi iyalai su nuna girmamawa ta yanar gizo kamar yadda suka bi tsarin nisantar jiki don gujewa sake barkewar cutar COVID-19.
An tabbatar da cewa COVID-19 ya yadu zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020 daga China.
Hukumar kiwon lafiya ta kasa ta bayar da rahoton karuwar wadanda suka kamu da cutar a ranar 20 ga watan Fabrairu, yawancinsu ana danganta su ne da taron da aka yi a Daegu na wani sabon addini da ake kira Shincheonji Jesus Church.
An yi zargin cewa Shincheonji da ke ziyartar Daegu daga Wuhan ne ya haddasa cutar.
A ranar 22 ga watan Fabrairu, a cikin masu bin cocin 9,336, mutane 1,261 ko kuma kimanin kashi 13 cikin 100 sun nuna alamun cutar.
A ranar 28 ga Fabrairu, an samu sama da mutane 2,000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan gwajin da aka yi ya tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma shafi jadawalin jiragen sama, saboda haka an canza jadawalin. Koriya ta Kudu ta gabatar da abin da ake ganin shi ne mafi yawan shirye-shirye a duniya don tace yawan jama'a don gano kwayar cutar, da kuma keɓe duk wani mutum da ke da cutar da kuma ganowa da kuma keɓe mutanen da suka yi hulɗa da su.
Hanyoyin tantancewa sun hada da tilastawa kai tsaye kan alamun bayyanar da sabbin masu shigowa daga kasashen waje ta hanyar manhajar wayar salula, gwajin kwayar cutar da aka riga aka yi tare da samun sakamako washegari, da kuma kara karfin gwajin wanda ya ba da damar gwajin mutane 20,000 a kowace rana.
An yi la'akari da shirin Koriya ta Kudu na samun nasara wajen shawo kan annobar duk da cewa ba a killace dukkan biranen ba.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman a kori Moon saboda abin da suka ce shi ne rashin kulawar gwamnati kan annobar, ko kuma yabon yadda ya amsa.
A ranar 23 ga Maris, an ruwaito cewa Koriya ta Kudu tana da mafi ƙarancin adadin masu kamuwa da cutar a cikin mako huɗu.
A ranar 29 ga Maris aka ruwaito cewa daga ranar 1 ga Afrilu duk sabbin masu shigowa daga kasashen waje za a killace su na tsawon makonni biyu.
Kamar yadda kafofin watsa labarai suka ruwaito a ranar 1 ga Afrilu, Koriya ta Kudu ta karbi buƙatun taimako don gwajin kwayar cutar daga kasashe daban-daban 121.
Iran ta bayar da rahoton farkon tabbatar da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, wanda ya ga, a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu sun mutu a wannan rana.
Matakan farko na rigakafin da gwamnati ta sanar sun hada da soke kide kide da wake-wake da sauran al'adu, wasannin motsa jiki, da sallar Juma'a, da rufe jami'o'i, cibiyoyin ilimi, da makarantu.
Iran ta ware tiriliyan biyar na riyal don yaki da cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairu 2020 cewa babu wani shiri na killace yankunan da cutar ta shafa, kuma za a killace mutane ne kawai.
An sanar da shirin rage zirga-zirgar tsakanin biranen a watan Maris, duk da cewa cunkoson zirga-zirgar tsakanin biranen kafin bikin Sabuwar Shekarar Farisa ya ci gaba.
Cin abinci na Shi'a a Qom ya kasance a bude ga masu ziyara har zuwa 16 ga Maris, 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
Duk da zargin cewa cutar ta yadu a Iran, sama da kasashe goma sun gano ko sun dawo da cutar zuwa Iran a ranar 28 ga watan Fabrairu, wanda ke nuna cewa cutar ta fi ta 388 da gwamnatin Iran ta ruwaito a ranar.
An rufe majalisar dokokin Iran, inda aka ce 23 daga cikin mambobinta 290 sun kamu da cutar a ranar 3 ga watan Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin gidan yarin Iran da su saki 'yan gwagwarmayar kare hakkin dan adam da aka tsare saboda zanga-zangar lumana ba tare da wani sharadi ba, da kuma sakin dukkan fursunonin da suka cancanci su zauna na dan lokaci.
Ya ce akwai babban hadarin kamuwa da kwayar cutar a cikin gidajen da aka rufe kamar cibiyoyin tsare mutane, wanda kuma ke da karancin kulawar lafiya.
A ranar 15 ga watan Maris, gwamnatin Iran ta bayar da rahoton mutuwar mutane 100 a rana, wanda shi ne mafi yawan wadanda suka mutu a kasar tun bayan barkewar cutar.
Akalla 'yan siyasa 12 da jami'an gwamnati ko kuma tsoffin jami'ai sun mutu sakamakon cutar har zuwa ranar 17 ga watan Maris.
Har zuwa 23 ga watan Maris, Iran na samun sabbin mutane 50 a kowace awa kuma tana samun sabon mutum daya da ke mutuwa a kowane minti goma saboda cutar coronavirus.
Ma'aikatan WHO sun ce akwai yiwuwar kamuwa da cutar sau biyar a Iran fiye da yadda aka ruwaito.
Ya kuma nuna cewa takunkumin Amurka kan Iran na iya shafar ikon kasar wajen magance cutar.
Babban Kwamishinan 'Yancin Dan Adam na Majalisar Dinkin Duniya ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da wasu matafiya biyu 'yan kasar Sin suka gwada tabbatacciyar cutar SARS-CoV-2 a Rome.
Lamarin ya fara ƙaruwa sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa da kuma daga China kuma ta ayyana dokar ta baci.
An gano wasu clusters na marasa alaƙa da COVID-19 daga baya, farawa da 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministocin ta ba da sanarwar sabon dokar dokar da za ta hana barkewar cutar, gami da keɓe mutane sama da 50,000 daga gundumomi 11 daban-daban a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "A yankunan da cutar ta addabi, ba za a yarda da shiga ko fita ba.
An kuma umarci dakatar da ayyukan aiki da wasanni a yankin. "A ranar 4 ga watan Maris, gwamnatin Italiya ta umarci rufe dukkan makarantu da jami'o'i a duk fadin kasar yayin da Italiya ta kai adadin mutuwar mutum 100.
Duk manyan wasannin wasanni, ciki har da wasannin kwallon kafa na Serie A, ya kamata a gudanar da su a rufe har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasannin gaba daya na akalla wata daya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci ban da manyan kantuna da kantin magani. A ranar 6 ga Maris, Kwalejin Anaesthesia, Analgesia, Resuscitation da Rape na Italiya (SIAARTI) ta buga takardar shaidar ɗabi'a game da hanyoyin da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta zarce China a matsayin kasa da ke da yawan mutuwar coronavirus a duniya bayan da ta bayar da rahoton mutuwar mutane 3,405 daga cutar.
A ranar 22 ga watan Maris, an ruwaito cewa Rasha ta aika da jiragen sama tara na soja dauke da kayan aikin likita zuwa Italiya.
Ya zuwa ranar 5 ga Afrilu, an sami mutane 128,948 da suka kamu da cutar, 15,887 sun mutu, kuma 21,815 sun warke a Italiya, tare da yawancinsu a lardin Lombardy.
Wani rahoto na CNN ya nuna cewa haɗuwa da yawan tsofaffi a Italiya da rashin iya gwajin duk wanda ya kamu da cutar har zuwa yau na iya zama mai ba da gudummawa ga yawan mutuwar.
Amsar da Burtaniya ta bayar ga cutar da farko ta bayyana a matsayin ɗaya daga cikin ƙasashe masu saurin kamuwa da cutar, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya kowane nau'i na nisantar jama'a ko matakan keɓewa ga jama'arta ba.
A sakamakon haka, gwamnati ta fuskanci suka saboda rashin saurin da kuma sahihancin martani ga damuwar da al'umma ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya yi sanarwa da ke ba da shawarar kauce wa duk tafiye-tafiye marasa mahimmanci da hulɗa da jama'a, yana ba da shawarar mutane suyi aiki daga gida idan za su iya kuma su guji wurare kamar mashaya, gidajen cin abinci, da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren shakatawa kamar mashaya da dakin motsa jiki ya kamata a rufe su da wuri-wuri, kuma ta yi alƙawarin biyan kashi 80% na albashin ma'aikata har zuwa iyakar £2,500 a wata don kauce wa rashin aikin yi a cikin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan nisantar zamantakewar jama'a, ya hana taron mutane sama da biyu da kuma iyakance tafiye-tafiye da ayyukan waje ga waɗanda aka ƙayyade da gaske.
Ba kamar matakan da suka gabata ba, 'yan sanda ne ke tilasta wannan takunkumin ta hanyar fitar da karar da kuma dakatar da taron.
An umarci yawancin kasuwancin da za a rufe, tare da keɓewa ga kasuwancin da aka ɗauka "mahimmanci", gami da manyan kantuna, kantin magani, bankuna, shagunan kayan aiki, tashoshin mai, da kuma wuraren aiki.
A ranar 20 ga watan Janairu, an tabbatar da farkon sanannen cutar COVID-19 a jihar Pacific ta Arewa maso Yammacin Washington a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga watan Janairu.
An kafa rukunin jami'an kula da cutar korona a ranar 29 ga watan Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta lafiyar jama'a, kuma ta sanya takunkumin hana shiga balaguro daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka - babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka - ta sanar da cewa sun kirkiro nasu saitin gwajin.
Duk da haka, Amurka ta fara jinkirin gwadawa, wanda ke kare ainihin yanayin annobar a halin yanzu.
Gwajin ya shafi lalacewar kayan gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin samun amincewar gwamnati ga kayan gwajin da ba na gwamnati ba (na jami'o'i, kamfanoni da asibitoci) har zuwa karshen watan Fabrairu, da kuma tsauraran ka'idoji ga mutanen da suka cancanci yin gwajin har zuwa farkon watan Maris (ana bukatar shawarar likita bayan haka).
Har zuwa ranar 27 ga watan Fabrairu, jaridar Washington Post ta ruwaito cewa an yi gwaje-gwaje kasa da 4,000 a Amurka.
Har zuwa 13 ga Maris, The Atlantic ta ruwaito cewa an yi gwaje-gwaje kasa da 14,000.
A ranar 22 ga Maris, kamfanin dillancin labarai na Associated Press ya ruwaito cewa: "Mutane da dama da ke fama da alamun cutar da umarnin likita sun jira sa'o'i ko kwanaki don a gwada su". Bayan an samu mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, ba da daɗewa ba sauran jihohi suka bi sahun.
Makarantu a yankin Seattle sun soke karatu a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar sun rufe. A ranar 6 ga Maris, 2020, an ba da hasashen tasirin sabon coronavirus a Amurka ta hanyar ƙungiyar masu ilimin cututtukan cuta a Imperial College London.
A wannan ranar ne Shugaba Trump ya sanya hannu kan Dokar Karin Kuɗi don Shirye-shirye da Amsa Coronavirus, wanda ya samar da dala biliyan 8.3 a cikin kudaden gaggawa ga hukumomin gwamnati don amsa cutar.
Kamfanoni sun kafa takunkumin hana ma'aikata tafiya, sun soke taro, kuma sun karfafa ma'aikata su yi aiki daga gida.
An soke wasanni da kuma lokutan wasanni. A ranar 11 ga watan Maris, Trump ya sanar da dakatar da tafiye-tafiye zuwa ga yawancin yankuna na Turai ban da United Kingdom, na tsawon kwanaki 30, daga ranar 13 ga watan Maris.
Washegari, ya faɗaɗa takunkumin ya haɗa da Ƙasar Ingila da Ireland.
A ranar 13 ga Maris, ya ayyana dokar ta baci, wanda ya sanya kudaden tarayya a bayyane don mayar da martani ga rikicin.
Tun daga ranar 15 ga watan Maris, yawancin kasuwancin da ke fadin Amurka sun rufe ko kuma rage lokacin gudanar da ayyukansu domin rage yaduwar cutar.
Ya zuwa ranar 17 ga watan Maris, an tabbatar da annobar a jihohi 50 da kuma a Gundumar Columbia. A ranar 23 ga watan Maris, an bayar da rahoton cewa Birnin New York yana da mutane 10,700 da suka kamu da cutar, fiye da adadin mutanen da suka kamu da cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce nesa da jama'a na da tasiri, yayin da kimar adadin masu kamuwa da cutar ta fara raguwa daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga Maris, an tabbatar da mutane 32,308 a Birnin New York, kuma mutane 672 sun mutu daga cutar. A ranar 26 ga Maris, Amurka ta ba da rahoton cewa tana da ƙarin masu kamuwa da cutar coronavirus fiye da kowace ƙasa a duniya, gami da China da Italiya.
Kamar yadda kafofin watsa labarai suka ruwaito a ranar 30 ga watan Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita ka'idojin nisantar jama'a har zuwa ranar 30 ga watan Afrilu.
A wannan rana, jirgin asibiti mai ɗauke da gado guda 1,000, wato, USNS Comfort, ya sauka a New York.
A ranar 3 ga Afrilu, Amurka ta samu mutuwar mutane 884 sakamakon cutar coronavirus a cikin sa'o'i 24.
A jihar New York, an samu fiye da mutum 100,000 da suka kamu da cutar a ranar 3 ga Afrilu. An soki fadar White House da rage barazanar da kuma sarrafa sakonni ta hanyar umurtar jami'an kiwon lafiya da masana kimiyya da su hada baki da ofishin mataimakin shugaban kasa Mike Pence wajen sanar da jama'a game da cutar.
Taron amincewa da gwamnatin Trump kan rikicin ya kasance ne a kan bangarori daban-daban.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyakin masarufi, ciki har da kayayyakin kiwon lafiya, daga China.
An yi amfani da nazarin yanayin tafiye-tafiye na iska don tsarawa da kuma hango hasashen yanayin yaduwar cutar kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
Dangane da bayanan 2018 daga Transportungiyar Jirgin Sama ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei sun sami mafi yawan masu yawon buɗe ido daga Wuhan.
Dubai, Sydney, da Melbourne kuma an bayar da rahoton cewa su ne wuraren da mutane ke zuwa daga Wuhan.
Bali an bayar da rahoton cewa ita ce mafi ƙarancin kuɗi a cikin manyan biranen tafiye-tafiye 20 na duniya dangane da wadatar su, yayin da biranen Australiya suka fi samun kuɗi. Australia ta fitar da Tsarin Amincewa da Gaggawa don Sabon Kwayar cuta ta Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya bayyana cewa akwai sauran abubuwa da ba a sani ba game da COVID-19, kuma cewa Ostiraliya za ta ba da hankali kan kula da kan iyakoki da sadarwa a cikin martani ga annobar.
A ranar 21 ga watan Maris, an ayyana dokar ta-baci ta kare lafiyar dan adam a Australia.
Bisa ga aiwatar da keɓewar sufuri na jama'a a Wuhan da Hubei, wasu ƙasashe sun shirya su kwashe 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, galibi ta jirgin da ƙasarsu ta haya, tare da izinin hukumomin China.
Kanada, Amirka, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand suna cikin ƙasashe na farko da suka fara shirin ƙaurar da mutanensu.
Pakistan ta ce ba za ta fitar da 'yan kasarta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu ban da 'yan Poland hudu, da wani dan kasar Sin, da kuma wani dan Indiya.
An saukar da mutanen Poland, China, da Indiya a Poland, inda jirgin ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan Brazil da ke zuwa Wuhan a wani sansanin soji da ke kusa da Brasilia.
A wannan ranar, an kai 'yan Kanada 215 (mutane 176 daga jirgin farko, da kuma 39 daga jirgin na biyu da gwamnatin Amurka ta yi haya) daga Wuhan zuwa CFB Trenton don keɓewa na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgi mai dauke da 'yan kasar Canada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Australia sun mayar da mutane 277 a ranar 3 da 4 ga watan Fabrairu zuwa Cibiyar Kula da Yanayin Tsibirin Kirsimeti, wanda aka canza aikinsa zuwa wurin keɓewa, inda suka zauna na tsawon kwanaki 14.
Jirgin saukar jiragen sama na New Zealand ya isa Aukland a ranar 5 ga Fabrairu; fasinjojinsa (ciki har da wasu daga Australia da Pacific) an killace su a sansanin sojin ruwa na Whangaparoa, arewacin Aukland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa zuwa jirgin ruwa mai suna Diamond Princess.
A ranar 21 ga watan Fabrairu, wani jirgin sama dauke da 'yan kasar Canada 129 da aka kwashe daga Diamond Princess ya sauka a Trento, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, wani jirgin saman kamfanin South African Airways da gwamnatin Afirka ta Kudu ta yi haya ya dawo da 'yan Afirka ta Kudu 112.
An gudanar da binciken lafiyar kafin a saki, kuma an bar 'yan Afirka ta Kudu huɗu da ke nuna alamun cutar coronavirus don rage haɗarin.
Sai dai 'yan Afirka ta Kudu da suka yi gwajin ba su da cutar ne kawai za a mayar da su gida.
Sakamakon gwajin ya tabbatar da cewa duk 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal,' yan sanda da sojoji da ke cikin aikin agaji, wanda, a matsayin matakin tsaro, an sanya su a karkashin kulawa da keɓewa na kwanaki 14 a The Ranch Resort.
A watan Maris, Amurka ta fara janye wasu dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ministan Harkokin Wajen China ya bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da agaji zuwa China.
Dalibai 'yan kasar Sin a jami'o'in Amurka sun hada kai don taimakawa wajen kai agaji zuwa yankunan da cutar ta addabi kasar Sin, tare da wasu kungiyoyi a yankin Chicago da aka ruwaito sun samu nasarar kai takunkumin N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga watan Janairu. Kungiyar agaji ta Direct Relief, tare da hadin gwiwa da FedEx, ta kai takunkumin rufe fuska 200,000 tare da sauran kayan kariya na mutum, ciki har da safofin hannu da riguna, ta hanyar jigilar kayayyaki na gaggawa ta iska zuwa asibitin Wuhan Union a ranar 30 ga watan Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa binciken allurar rigakafi da kuma kokarin magance cutar tare don kare "mutane masu hadarin gaske a Afirka da Kudancin Asiya".
Interaction ta ruwaito cewa gwamnatin China ta ba da gudummawar masks 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan da Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan ɗaya zuwa Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da tan 13 na kayan aikin likita zuwa Wuhan, Malaysia ta sanar da bayar da gudummawar safofin hannu na likita miliyan 18 zuwa China, Jamus ta aika da kayan aikin likita da yawa ciki har da kayan Hazmat 10,000, kuma Amurka ta ba da gudummawar tan 17.8 na kayan aikin likita zuwa China kuma ta yi alkawarin ƙarin dala miliyan 100 a cikin taimakon kuɗi ga ƙasashen da abin ya shafa. Bayan shari'o'in da ke China sun daidaita, ƙasar ta aika da taimako zuwa ƙasashe da yawa da cutar ta shafa.
A watan Maris, China, Cuba da Rasha sun aika da taimakon likita da kwararru don taimakawa Italiya wajen shawo kan annobar coronavirus.
Dan kasuwa Jack Ma ya tura kayan gwaji miliyan 1.1, da abin rufe fuska miliyan 6, da kuma kayan kariya 60,000 zuwa Addis Ababa, Habasha domin kungiyar tarayyar Afirka ta rarraba su.
Daga baya ya aika da kayan gwaji 5,000, da abin rufe fuska 100,000 da na'urorin numfashi biyar zuwa Panama.
Ma ya kuma ba da gudummawar kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia, da Czech Republic sun nuna damuwarsu game da abin rufe fuska da kayan gwajin da aka yi a kasar Sin.
Misali, Spain ta dawo da kayan gwajin cutar coronavirus 58,000 da aka yi da kasar Sin tare da daidaito na kashi 30 cikin dari, yayin da Netherlands ta dawo da abin rufe fuska 600,000 da suka lalace daga kasar Sin.
Belgium ta dawo da abin rufe fuska 100,000 da ba za a iya amfani da su ba, wanda ake zargin daga China ne, amma a zahiri daga Colombia.
A wani bangare kuma, tallafin da kasar Sin ta bayar ya samu karbuwa a wasu sassan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da wani aikin gaggawa na tallafa wa kasashe masu tasowa.
Hukumar Lafiya ta Duniya ta yaba wa gwamnatin kasar Sin kan kokarin da take yi na sarrafa cutar.
WHO ta lura da bambanci tsakanin barkewar cutar SARS ta 2002-2004, lokacin da aka zargi gwamnatin China da yin ɓoye-ɓoye har ta shafi rigakafin da ƙoƙarin sarrafawa, da kuma rikicin na yanzu wanda ya ga gwamnatin tsakiya "ta ba da sabuntawa na yau da kullun don kauce wa tashin hankali kafin hutun Sabuwar Shekarar Sin".
A ranar 23 ga watan Janairu, a martanin da ya mayar wa matakin da gwamnatin tsakiya ta dauka na sanya takunkumin hana zirga-zirga a Wuhan, wakilin WHO Gauden Galea ya bayyana cewa duk da cewa "ba shawarar da WHO ta bayar ba ce", amma kuma "wani muhimmin alama ne ga kudurin da aka dauka na shawo kan annobar a inda ta fi yawa" kuma ya kira ta "marasa misali a tarihin lafiyar jama'a".A ranar 30 ga watan Janairu, biyo bayan tabbatar da kamuwa da cutar daga mutum zuwa mutum a wajen kasar Sin da kuma karuwar adadin wadanda suka kamu da ita a wasu kasashe, WHO ta ayyana annobar a matsayin Matsalar Lafiya ta Duniya (PHEIC), PHEIC ta shida da aka fara yin irin wannan matakin tun lokacin annobar cutar ta alade a shekarar 2009.
Darakta-janar na WHO Tedros Adhanom ya ce PHEIC sakamakon "hadarin yaduwar cutar a duniya musamman ga ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi ba tare da ingantaccen tsarin kiwon lafiya ba.
A cikin martani game da aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa "babu wani dalili na matakan da ke hana tafiye-tafiye da cinikayya ta duniya" kuma "WHO ba ta ba da shawarar hana kasuwanci da motsi ba".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da gudummawar dala miliyan 675 domin tallafawa shirye-shiryen da aka yi a kasashe masu karancin kudin shiga, tana mai ambaton muhimmancin tallafawa kasashen da "ba su da tsarin da zai iya gano mutanen da suka kamu da cutar, idan ta taso".
Tedros ya kara da cewa "mu ne mafi karfi a sarkar da muke da rauni" kuma ya bukaci al'ummar duniya da su "saka hannun jari a yanzu ko kuma su biya daga baya".A ranar 11 ga watan Fabrairu, WHO a wani taron manema labarai ta sanya sunan cutar COVID-19 a matsayin sunan cutar.
A wannan ranar, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince ya ba da "ikon da dukan tsarin Majalisar Dinkin Duniya ke da shi a matsayin martani".
Sakamakon haka an kunna tawagar gudanar da rikicin Majalisar Dinkin Duniya, wanda ya ba da damar daidaita aikin Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar "mai da hankali kan aikin kiwon lafiya yayin da sauran hukumomi za su iya kawo ƙwarewarsu don magance mummunan tasirin zamantakewar al'umma, tattalin arziki da ci gaba daga annobar".
A ranar 14 ga Fabrairu, an kunna wani Kungiyar Haɗin gwiwa ta China da WHO ke jagoranta don samar da ƙwarewar duniya da WHO a cikin filin a China don taimakawa cikin gudanar da cikin gida da kuma kimanta "yanayin cutar da yaduwar cutar" ta hanyar gudanar da bita da tarurruka tare da manyan cibiyoyin matakin ƙasa da kuma gudanar da ziyarar bita don kimanta "tasirin ayyukan mayar da martani a yankuna da ƙauyuka, gami da birane da ƙauyuka".A ranar 25 ga Fabrairu, WHO ta bayyana cewa "duniya dole ne ta yi ƙarin shirye-shirye don yiwuwar cutar ta coronavirus" ta bayyana cewa duk da cewa har yanzu da wuri don a kira ta annoba, ƙasashe ya kamata su kasance "a cikin shiri".
A cikin martani ga annobar da ke tasowa a Iran, WHO ta tura wani Taron Haɗin gwiwa zuwa can don kimanta yanayin. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a ɗaga ƙimar barazanar coronavirus a duniya daga "babba" zuwa "mafi girma", matakin mafi girma na gargadi da kimanta hadari.
Mike Ryan, babban daraktan shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin a cikin sanarwar cewa "Wannan shi ne abin da ya kamata a yi wa kowace gwamnati a duniya: Tashi.
Wannan cuta na iya kasancewa a kan hanya kuma ya kamata ku kasance a shirye", yana mai ba da shawara cewa matakan da suka dace na amsawa na iya taimakawa duniya ta guje wa "mafi munin yanayi".
Ryan ya ci gaba da cewa bayanan na yanzu ba su ba da damar jami'an kiwon lafiya su ayyana annobar a duniya ba, kamar yadda sanarwar ke nufin "mun amince da cewa dukkan mutane a duniya za su iya kamuwa da cutar".
A ranar 11 ga watan Maris, WHO ta ayyana barkewar cutar coronavirus a matsayin annoba.
Darakta-Janar ya ce WHO "ta damu matuka game da matakan yaduwar cutar da tsananin cutar, da kuma matakin rashin aiki". WHO ta fuskanci zargi mai yawa game da abin da ake ganin rashin kula da cutar, gami da jinkirin sanar da gaggawa na kiwon lafiya da kuma rarraba cutar a matsayin annoba.
Tashin hankalin ya hada da takardar neman daraktan WHO Tedros Adhanom ya yi murabus, wanda mutane 733,000 suka sanya hannu har zuwa ranar 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, ƙwararrun masanan haƙƙin ɗan adam na Majalisar Dinkin Duniya sun ba da shawarar haƙƙin kowane mutum yayin annobar COVID-19.
Kungiyar ta ce kowa na da hakkin samun taimakon da zai ceci rayuka kuma gwamnati ce ke da wannan hakkin.
Kungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya ba dalili bane na nuna bambanci ga wasu kungiyoyi.
Masana sun jaddada cewa kowa yana da hakkin kiwon lafiya, ciki har da nakasassu, 'yan tsiraru, tsofaffi, marasa gida, marasa gida, waɗanda ke zaune a cikin mawuyacin yanayi, fursunoni, da 'yan gudun hijira da sauran kungiyoyin da ke bukatar taimakon gwamnati.
Kungiyoyin gwamnati na duniya suna magance tasirin COVID-19 a kan tattalin arziki da zamantakewa.
Kungiyar hadin gwiwar tattalin arziki da ci gaba ta kaddamar da wani dandamali don samar da cikakken bayani kan lokacin da kuma cikakkun bayanai kan ra'ayoyin manufofi a kasashe a duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofi don ƙarfafa tsarin kiwon lafiya da tattalin arziƙin duniya zuwa tattauna tasirin gaggawa da ƙuntatawa kan tafiye-tafiye, cibiyoyin dijital sun haɗa da Binciken Manufofin Kasashe, kuma suna da niyyar taimaka wa ƙasashe su koya daga juna da kuma sauƙaƙe haɗin kai na duniya game da ƙalubalen coronavirus.
Gwamnatin China ta fuskanci suka daga Amurka, Ministan Harkokin Kasuwancin Burtaniya Michael Gove da kuma dan Shugaban Brazil Jair Bolsonaro Eduardo Bolsonaro sakamakon yadda suka shawo kan annobar, wacce ta fara a lardin Hubei na kasar Sin.
An kori wasu jami'an matakin lardin daga jam'iyyar kwaminis ta kasar Sin (CPC) saboda yadda ake gudanar da aikin killace mutane a tsakiyar kasar Sin, a matsayin alamar rashin gamsuwa da yadda kungiyoyin siyasa suka mayar da martani ga yaduwar cutar a lardin.
Wasu manazarta sun yi imanin cewa an yi wannan yunkurin ne don kare Babban Sakataren Jam'iyyar Kwaminis ta Sin Xi Jinping daga fushin jama'a daga kamuwa da cutar coronavirus.
Wasu jami'an kasar Sin, ct. Zhao Lijian sun yi watsi da sanarwar farko cewa annobar coronavirus ta samo asali ne daga Wuhan, suna amincewa da ka'idar maƙarƙashiya game da COVID-19 da ta samo asali ne daga Amurka ko Italiya.
Gwamnatin Amurka a karkashin Donald Trump ta yi magana game da coronavirus a matsayin "kwayar kasar Sin" ko kuma "kwayar Wuhan" tana mai cewa "Shayana ta samar da kwayar cutar da ta zama annoba ta duniya", wanda daga baya wasu masu sukar ta suka soki a matsayin na wariyar launin fata da kuma "ƙoƙarin karkatar da hankali daga gazawar gwamnatinta wajen shawo kan cutar".
Jaridar Daily Beast ta samu wani tashar gwamnatin Amurka da ke nuna cewa akwai wata cuta ta sadarwa da ke da tushe a cikin hukumar tsaron kasa, inda ta ce "dukkanin abubuwa game da kasar Sin ne.
An sanar da mu cewa mu yi kokarin tabbatar da cewa an bayyana wannan sakon ta kowace hanya, ciki har da taron manema labarai da kuma fitowar talabijin".Kasuwanci irin su Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da China ke yi na tura agaji ga kasashen da cutar ta addabi wani bangare ne na farfagandar da take yi na yin tasiri a duniya.
Shugaban manufofin kasashen waje na EU Josep Borrell ya yi gargadin cewa akwai "wani bangare na siyasa na kasa da kasa da ya hada da gwagwarmayar samun tasiri ta hanyar juyawa da kuma 'siyasa mai alheri'.
Borrell ya kuma ce "China tana ta kokarin tura sakon cewa, ba kamar Amurka ba, tana da alhakin da za a iya dogara da ita".
China ta kuma bukaci Amurka da ta janye takunkumin hana hana ayyukan ta na Syria da Venezuela da kuma Iran, yayin da ta kai tallafi ga kasashen biyu na karshe.
An dakatar da gudummawar kayan rufe fuska 100,000 daga Jack Ma zuwa Cuba ta takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da tura taimakon da ake bayarwa ga wasu kasashe zuwa kasarsu.
Kuma an samu rigingimu game da abin rufe fuska a tsakanin wasu kasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Ƙari ga haka, Turkiyya ta kwace ɗarurruwan na'urorin numfashi da ke zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kan Tarayyar Turai da Italiya da cutar coronavirus ta shafa.
Maurizio Massari, jakadan Italiya a EU, ya ce "Shayana ce kawai ke bayar da amsa ta bangarorin biyu.
Hakika, wannan ba kyakkyawan alama ba ne na hadin kan Turai".
A ranar 22 ga watan Maris, bayan kiran waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya umarci sojojin Rasha da su tura rundunar likitocin soja, motocin kwantar da hankali na musamman da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta yi ƙaulin wani "babban jami'in siyasa" da ba a ambata sunansa ba, ya ce kashi 80 cikin ɗari na taimakon da Rasha take bayarwa "ba shi da amfani ko kuma bai taimaka wa Italiya ba".
Majiyar ta zargi Rasha da yin kuskuren "geopolitical da diplomasiyya".
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahoton kuma sun nuna godiyarsu.
Rasha ta kuma aika da jirgin ruwa mai dauke da kayan kiwon lafiya zuwa Amurka.
Kakakin Kremlin Dmitry Peskov ya ce "a lokacin da yake ba da taimako ga abokansa a Amurka, [Putin] ya yi tunanin cewa idan masana'antun kayan aikin likitanci na Amurka suka samu ci gaba, za su iya mayar da martani idan ya cancanta".
An shirya atisayen sojin NATO na "Defender 2020" a Jamus, Poland da ƙasashen Balkans, mafi girma a cikin atisayen yaƙi na NATO tun ƙarshen Cold War, za a gudanar da su a kan karami.
Sakatare Janar na Kamfen na Rashin Yakin Nukiliya Kate Hudson ta soki aikin Defender 2020: "A cikin rikicin kiwon lafiyar jama'a na yanzu, yana sanya rayukan ba kawai sojoji daga Amurka da sauran ƙasashen Turai da ke cikin saukin kai ba amma har da mutanen ƙasashen da suke aiki".
Shugaban Iran Hassan Rouhani ya rubuta wasika a bude ga shugabannin duniya don neman taimako a ranar 14 ga Maris, 2020, yana mai cewa kasarsa na fama da cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka kan Iran. Cutar ta bukaci Amurka da ta aiwatar da manufofin zamantakewar da aka saba da su a wasu kasashe masu arziki, gami da kiwon lafiya na duniya baki daya, kula da yara na duniya, hutun dangi mai biya, da kuma karin kudade ga lafiyar jama'a.
Masu sharhi na siyasa sun yi tsammanin yanayin zai yi tasiri mara kyau ga damar Donald Trump na sake zaɓe a zaben shugaban kasa na 2020. Dangantakar diflomasiyya tsakanin Japan da Koriya ta Kudu ta yi muni saboda cutar.
Koriya ta Kudu ta soki "talakawar da ba ta da ma'ana da kuma rashin kulawa" bayan da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a sanya shi a cikin keɓewa na tsawon makonni biyu a wuraren da gwamnati ta tsara.
Da farko jama'ar Koriya ta Kudu ba su da tabbas game da yadda Shugaba Moon Jae-in ya amsa rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takarda neman a kori Moon saboda abin da ake ganin rashin kulawar gwamnati game da annobar, ko kuma yabon martanin da ta bayar.
Wasu masu sharhi sun nuna damuwa cewa matakin zai baiwa gwamnati damar karfafa ikon da take da shi.
A Hungary, majalisar dokoki ta kada kuri'ar amincewa da firaminista, Viktor Orbán, ya yi mulki bisa umarni na dindindin, ya dakatar da majalisa da zaben da kuma hukunta wadanda ake ganin sun yada labaran karya game da cutar da kuma yadda gwamnati ke tafiyar da rikicin.
An zargi annobar coronavirus da wasu cututtukan samar da kayayyaki, sakamakon amfani da kayan aiki don yaƙar annobar da ke ƙaruwa a duniya, sayayya ta firgita, da kuma katsewar masana'antu da ayyukan dabaru.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin likita sakamakon karuwar bukatar masu amfani da su da kuma katsewar masu samar da kayayyaki.
Wasu yankuna kuma sun ga sayayya ta firgita wanda ya haifar da shimfidar ɗakunan ajiya na kayan masarufi kamar abinci, kayan wanka, da ruwan kwalba, wanda ya haifar da karancin kayayyaki.
Masana fasahar zamani musamman sun yi gargadin jinkirin isar da kayayyakin lantarki.
A cewar babban daraktan WHO Tedros Adhanom, bukatar kayan kariya ta mutum ya ninka sau 100.
Wannan bukatar ta haifar da hauhawar farashin har sau ashirin na farashin al'ada kuma ya haifar da jinkirin samar da kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
Hakan kuma ya haifar da karancin kayan kariya na mutum a duniya, tare da WHO ta yi gargadin cewa hakan zai yi illa ga lafiyar ma'aikata.
A Ostiraliya, annobar ta samar da sabbin dama ga masu sayen daigou don sayar da kayayyakin Australiya zuwa China.
Wannan aikin ya haifar da karancin kayan abinci na jarirai a wasu manyan kasuwanni kuma an dakatar da shi a baya ta gwamnatin Australia. Duk da yawan adadin COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma ci gaba da neman abinci, yankunan biyu sun tsira daga matsanancin karancin abinci.
Matakan da China da Italiya suka dauka na yaki da tarin kayayyaki da sayar da kayayyakin da ake bukata sun yi nasara, inda suka kauce wa tsananin karancin abinci da aka yi hasashen zai auku a Turai da kuma Arewacin Amurka.
Arewacin Italiya tare da samar da kayan gona mai mahimmanci ba su ga raguwa mai yawa ba, amma farashin na iya ƙaruwa bisa ga wakilan masana'antu.
Rashin abinci na ɗan lokaci ne, har ma a birnin Wuhan, yayin da jami'an gwamnatin kasar Sin ke sakin kayan abinci don tabbatar da wadatar abinci ga jama'a.
Haka kuma a ƙasar Italiya, ana bukatar masu sayar da abinci su ajiye abinci don irin wannan gaggawa.
An ji rauni ga tattalin arzikin duniya a China: a cewar rahoton kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya yi rauni sosai a cikin watanni biyu na farko na shekarar 2020 sakamakon matakan da gwamnati ta dauka na shawo kan yaduwar kwayar cutar, kuma tallace-tallace na kantin sayar da kayayyaki sun ragu da kashi 20.5%.
Tunda babban yankin kasar Sin babban cibiyar tattalin arziki ne da samar da kayayyaki, an ga annobar cutar tana kawo babbar barazana ga zaman lafiyar tattalin arzikin duniya.
Agathe Demarais na sashen bincike na tattalin arziki ya yi hasashen cewa, kasuwa za ta ci gaba da tashi sama da ƙasa har sai an sami cikakken bayani game da sakamakon da za a samu.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa annobar annobar cutar za ta iya shafar ci gaban tattalin arziki a duniya fiye da yadda cutar SARS ta yi a 2002-2004.
Wani ƙididdiga daga masana a Jami'ar Washington a St. Louis ya ba da tasirin dala biliyan 300+ a kan sarkar samar da kayayyaki ta duniya wanda zai iya wucewa har zuwa shekaru biyu.
Kungiyar Kasashen Da Ke Fitar Da Man Fetur (OPEC) ta ruwaito "ta yi takaici" bayan faduwar farashin mai sakamakon karamin bukatar da kasar Sin ke yi.
Kasuwannin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu sakamakon karuwar adadin masu kamuwa da cutar COVID-19 a kasashen waje.
A ranar 27 ga Fabrairu, sakamakon karuwar damuwa game da yaduwar cutar coronavirus, wasu alamun hannun jari na Amurka ciki har da NASDAQ-100, S&P 500, da Dow Jones Industrial Average sun ba da rahoton mafi munin faduwa tun 2008, tare da faduwar Dow da maki 1,191, mafi girman faduwar rana tun bayan rikicin kuɗi na 2007-08.
Dukkanin alamomin uku sun ƙare mako da raguwa fiye da 10%.
A ranar 28 ga watan Fabrairu, Binciken Skop GmbH ya tabbatar da damar da ake da ita na darajar darajar bashi na kasar Sin, amma ya riƙe da Ra'ayi mara kyau.
Hannun jari sun yi kasa saboda tsoron cutar korona, wanda ya fi kowanne kasawa a ranar 16 ga watan Maris.
Mutane da yawa sun yi zaton cewa za a yi koma bayan tattalin arziki.
Masanin tattalin arziki Mohamed El-Erian ya yaba da matakin gaggawa na babban bankin kasar da kuma na jihar.
Babban bankin ya amsa da sauri fiye da yadda suka yi a lokacin matsalar kuɗi ta 2008.
Yawon shakatawa shi ne bangaren da ya fi fuskantar matsalar ta hanyar takunkumin tafiye-tafiye, rufe wuraren taruwa da wuraren shakatawa, da kuma shawarwarin gwamnati na hana tafiye-tafiye a duniya.
Sakamakon haka, kamfanonin jiragen sama da yawa sun soke zirga-zirga saboda karancin bukatar, ciki har da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanonin jiragen sama na yankin British Flybe suka yi kasa.
Tasirin da masana'antar jiragen ruwa ke yi a wannan lokacin ba a taɓa ganin irinsa ba.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa.
Cutar ta faru ne a lokacin Chunyun, lokacin tafiye-tafiye da ake yi a lokacin bikin Sabuwar Shekarar kasar Sin.
Wasu al'amuran da suka shafi jama'a sun soke su ta hanyar jihohi da gwamnatocin larduna, ciki har da bikin Sabuwar Shekara na shekara-shekara, tare da kamfanoni masu zaman kansu da ke rufe shagunan su da wuraren shakatawa kamar su Disneyland Hong Kong da Disneyland Shanghai.
An rufe bukukuwan Sabuwar Shekara da wuraren yawon bude ido da dama don kauce wa manyan tarurruka, ciki har da birnin Beijing da kuma bukukuwa a gidajen ibada na gargajiya.
A larduna 24 daga cikin 31 na kasar Sin, gundumomi da larduna, hukumomi sun tsawaita hutun Sabuwar Shekara har zuwa 10 ga watan Fabrairu, suna ba da umarnin cewa ba za a sake bude wuraren aiki ba har sai wannan ranar.
Wannan yanki yana wakiltar kashi 80% na GDP na ƙasar da 90% na fitarwa.
Hong Kong ta kara yawan kamuwa da cutar zuwa mafi girman matakin kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris kuma ta soke bikin Sabuwar Shekara.
Ziyarar kantin sayar da kayayyaki a Turai da Latin Amurka sun ragu da kashi 40 cikin dari.
Kasashen Arewacin Amurka da Gabas ta Tsakiya sun ga raguwar kashi 50-60 cikin dari.
Wannan kuma ya haifar da raguwar kashi 33-43% a cikin zirga-zirgar ƙafa zuwa cibiyoyin cin kasuwa a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da cibiyoyin cin kasuwa a duk duniya suna aiwatar da ƙarin matakan, misali haɓaka tsabta, sanya masu auna zafin jiki don bincika yanayin zafin jiki na baƙi, da soke abubuwan da suka faru.A cewar Hukumar Tattalin Arzikin Majalisar Dinkin Duniya don Latin Amurka, koma bayan da cutar ta haifar na iya haifar da ƙarin tsakanin mutane miliyan 14 zuwa 22 cikin matsanancin talauci a Latin Amurka fiye da waɗanda ke cikin yanayin ba tare da cutar ba.
A watan Janairu da Fabrairu na shekarar 2020, lokacin da annobar ta yi tsanani a birnin Wuhan, mutane miliyan biyar ne suka rasa ayyukansu a kasar Sin.
Yawancin ma'aikatan balaguro kusan miliyan 300 daga yankunan karkara na kasar Sin sun makale a gidajensu a cikin karkara ko kuma sun makale a lardin Hubei.
Cutar coronavirus na iya kawar da ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi na iya kaiwa kashi 32%, a cewar wani kimantawa da Bankin Tarayyar St. Louis ya yi.
A tsakiyar watan Maris, ma'aikata miliyan 4 na Faransa sun nemi fa'idodin rashin aikin yi na wucin gadi kuma ma'aikata miliyan 1 na Burtaniya sun nemi tsarin bashi na duniya. Kusan kamfanoni miliyan biyu a Jamus sun tura ma'aikatansu zuwa tsarin ma'aikata na ɗan gajeren lokaci da gwamnati ke tallafawa da ake kira Kurzarbeit.
Faransa da kuma Biritaniya sun kafa tsarin biyan diyya na ɗan lokaci.
Yankin wasan kwaikwayon fasaha da al'adun gargajiya sun sami mummunan rauni sakamakon annobar, wanda ya shafi ayyukan ƙungiyoyi da kuma mutane - duka masu aiki da masu zaman kansu - a duk duniya.
Kungiyoyin bangaren fasaha da al'adu suna ƙoƙari su haɓaka ayyukansu (yawanci ana ba da kuɗin jama'a) don samar da damar zuwa al'adun al'adu ga al'umma, kiyaye lafiyar ma'aikatansu da al'umma, da kuma tallafawa masu fasaha a duk lokacin da zai yiwu.
Har zuwa Maris 202 a duk duniya da kuma a matakai daban-daban, gidajen tarihi, dakunan karatu, wuraren baje kolin, da sauran cibiyoyin al'adu sun rufe nune-nunen, an soke gudanar da ayyuka da kuma gabatar da su har abada.
A cikin martani, an yi amfani da matakai masu ƙarfi don samar da madadin sabis ta hanyar dandamali na dijital. Wani sabon faɗuwa kuma mai saurin raguwa saboda annobar shine soke ayyukan addini, manyan abubuwan wasanni, da sauran abubuwan zamantakewa, kamar bukukuwan kiɗa da kide-kide, taron karawa juna sani na fasaha, da nunin kayan kwalliya.
An kuma yi wa masana'antar fim barazana. Vatican ta sanar da cewa an soke bikin Lahadi mai tsarki a Roma, wanda ke faruwa a makon ƙarshe na Lent na lokacin tuba na Kirista.
Yawancin bishops sun ba da shawarar tsofaffin masu bin Kiristanci su zauna a gida maimakon halartar Ayyukan Coci a ranar Lahadi; wasu majami'u sun gudanar da ayyukan coci ta hanyar rediyo, live streaming ko talabijin yayin da wasu ke ba da bautar da aka yi a baya.
Tare da Bishop na Roman Katolika na Roma ya rufe majami'u da ƙananan majami'u da kuma filin St. Peter an kori shi daga ikilisiyoyin Kirista, sauran hukumomin addini sun soke ayyuka kuma sun iyakance tarurrukan jama'a a majami'u, masallatai, majami'u, temples da majami'u.
Ministan Lafiya na Iran ya sanar da soke sallar Juma'a a yankunan da cutar ta shafa kuma an rufe kaburbura, yayin da Saudiyya ta hana baƙi da mazauna yankin shiga wuraren ibada a Makka da Madina.
Cutar ta haifar da babbar matsala ga kalandar wasanni a duk duniya tun lokacin yakin duniya na biyu.
Yawancin manyan wasannin wasanni an soke su ko kuma an dage su, ciki har da 2019 UEFA Champions League 20, 2019 Premier League 20, UEFA Euro 2020, kakar NBA 20 da kuma kakar NHL ta 2019 20.
Cutar ta shafi shirye-shirye don 2020 Summer Olympics, wanda aka fara shirin farawa a ƙarshen Yuli; Kwamitin Olympic na International Olympic ya sanar a ranar 24 ga Maris cewa za a sake shirya taron zuwa kwanan wata bayan 2020 amma ba bayan bazara 2021 ba. An rufe gidajen caca da wuraren caca a duk duniya kuma an dakatar da wasannin karta kai tsaye ko kuma an soke su.
Wannan ya haifar da yawancin caca caca zuwa kan layi, tare da yawancin rukunin caca na kan layi suna ba da rahoton ƙaruwa mai yawa a cikin sabon rajistar su.
Wasu manyan gidajen wasan kwaikwayo kamar su Broadway sun dakatar da duk wani wasan kwaikwayon da aka yi.
Wasu masu fasaha sun bincika hanyoyin da za su ci gaba da samarwa da kuma raba ayyuka ta hanyar intanet a matsayin madadin al'adun gargajiya na rayuwa, kamar su wasan kwaikwayon raye-raye ko ƙirƙirar "bikin" na yanar gizo don masu fasaha su gabatar, rarraba da gabatar da ayyukansu.
A kan layi, yawancin abubuwan da ke cikin Intanet game da coronavirus sun bazu yayin da mutane da yawa suka juya zuwa ban dariya da nishaɗi a cikin rashin tabbas.
Tun bayan barkewar COVID-19, an lura da karuwar nuna bambanci, kyamar baki da wariyar launin fata ga mutanen da ke da asalin Sinawa da na Gabashin Asiya, da kuma ga mutanen da ke da asalin wurare masu zafi a Turai, Amurka da sauran ƙasashe.
An lura da abubuwan tsoro, shakku, da tashin hankali a kasashe da dama, musamman a Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya-Pacific.
Rahoton daga watan Fabrairu (lokacin da mafi yawan masu kamuwa da cutar ke kasar Sin) ya nuna cewa akwai ra'ayin wariyar launin fata a kungiyoyi daban-daban a duniya da ke cewa 'yan kasar Sin sun cancanci kamuwa da cutar ko kuma su karbi abin da ake zargi da cewa fansa ce mai kyau.
Wasu ƙasashe a Afirka ma sun ga karuwar nuna kyamar Sin.
Yawancin mazauna Wuhan da Hubei sun bayar da rahoton nuna wariya bisa ga yankinsu na asali.
Akwai tallafi ga China, a ciki da wajen layi, da kuma wadanda ke cikin yankunan da cutar ta fi yawa.
Bayan yaduwar annobar zuwa sabuwar kasar mai zafi, mutane daga Italiya, kasar Turai ta farko da ta fara fuskantar mummunan annobar COVID-19, na iya zama abin zargi da kuma kishin kasashen waje. Mutane a kasashe da suka hada da Malaysia, New Zealand, Singapore da Koriya ta Kudu sun fara sanya hannu kan takardun neman hana Sinawa shiga kasar a kokarin dakatar da cutar.
A Japan, alamar #ChineseDontComeToJapan ta yi ta yawo a shafin Twitter.
Mutanen kasar Sin da sauran mutanen Asiya a Birtaniya da Amurka sun bayar da rahoton cewa ana samun tashin hankali na wariyar launin fata, da kuma karuwar hare-hare.
Shugaban Amurka Donald Trump ya fuskanci suka saboda yin magana game da coronavirus a matsayin "Cin virus", wani lokaci da masu sukar ke ganin wariyar launin fata da kuma adawa da China.
Masu zanga-zanga a Ukraine sun kai hari kan bas da ke dauke da 'yan kasar Ukraine da kuma 'yan kasashen waje daga Wuhan zuwa Novi Sanzhary.
Dalibai daga Arewa maso Gabashin Indiya, wanda ke da iyaka da China, kuma suna karatu a manyan biranen Indiya sun ba da rahoton samun rikice-rikice da ke da alaƙa da annobar coronavirus.
Shugaban jam'iyyar Bharatiya Janata a jihar Bengal Dilip Ghosh ya ce mutanen China suna lalata muhalli kuma "Allah ne ke hukunta su".
Bayanin daga bisani ya yi tir da shi daga ofishin jakadancin China a Kolkata, yana mai cewa "ba daidai ba ne". A China, ƙiyayya da wariyar launin fata ga mutanen da ba Sinawa ba sun zama sananne ta hanyar cutar, tare da bayyana baƙi a matsayin "ƙazamar ƙasa" da kuma niyya don "kashewa".
Jaridu da yawa da ke da tallace-tallace da aka biya sun fitar da su don wasu ko duk labaran su na coronavirus.
Yawancin masu wallafa kimiyya suna yin takardun kimiyya game da annoba waɗanda ke samuwa a buɗe.
Wasu masana kimiyya sun fi son su raba sakamakon su kai tsaye a kan sabobin buga takardu kamar bioRxiv.
Cutar da ke tasowa  Cutar da ke tasowa tare da kwayar cuta, yawanci sabon abu ne a cikin annobar ko yanayin watsawa
Duniya da cuta  Bayani mai zurfi game da duniya da cuta
Jerin annoba da annobar - Jerin yawan mutuwar cututtukan da ke haddasa cututtuka
Cinikin namun daji da cutar zoonosis - Rashin lafiyar da ke tattare da cinikin namun daji na waje
Gwajin dakin gwaje-gwaje don cutar coronavirus na numfashi na 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ke da alaƙa sun haɗa da hanyoyin gano kasancewar kwayar cutar da kuma hanyoyin da ke gano ƙwayoyin cuta da aka samar a cikin martani ga kamuwa da cuta.
An tabbatar da kasancewar kwayar a cikin samfurin ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano kwayar cutar SARS-CoV-2 RNA kawai.
Ana amfani da gwajin ne wajen tabbatar da cewa akwai sabon kamuwa da cuta ko kuma yana aiki.
Ana iya amfani da ganowar antibody (serology) don duka ganewar asali da kuma kula da al'umma.
Gwajin kwayar cutar ya nuna adadin marasa lafiya da suka kamu da cutar, ciki har da wadanda alamun su ba su da yawa don a ba da rahoto ko kuma wadanda ba su da alamun cutar.
Za a iya sanin ainihin mutuwar cutar da kuma matakin garkuwar garkuwar a cikin al'umma daga sakamakon wannan gwajin.
Sakamakon iyakancewar gwaji, har zuwa Maris 2020 babu wata ƙasa da ke da bayanan da za a iya tsammani game da yaduwar kwayar cutar a cikin al'ummarsu.
Har zuwa 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawan jama'arta, kuma akwai bambancin da ke tsakanin adadin gwajin da aka yi a ƙasashe daban-daban.
Wannan bambancin zai iya shafar yawan mutuwar da ake bayar da rahoto, wanda za a iya yin hasashen cewa ya yi yawa a wasu ƙasashe.
Amfani da fassarar jujjuyawar polymerase chain reaction (rRT-PCR) na ainihi ana iya yin gwajin akan samfuran numfashi da aka samo ta hanyoyi daban-daban, gami da swabs na nasopharyngeal da samfuran sputum.
Ana samun sakamako a cikin sa'o'i da yawa zuwa kwanaki biyu.
Gwajin RT-PCR da aka yi da swabs na hanci ya kasance mai inganci ne kawai a makon farko na cutar.
Kuma cutar za ta iya ɓace a cikin makogwaro yayin da take ci gaba da ninka a cikin huhu.
Ga waɗanda suka kamu da cutar da aka gwada a cikin na biyu, a madadin haka za a iya ɗaukar samfurin daga cikin iska ta cikin iska ta hanyar amfani da catheter na numfashi ko kuma za a iya amfani da kayan da ke haifar da tari (sputum).
An haɓaka ɗayan farkon gwajin PCR a Charité a Berlin a cikin Janairu 2020 ta amfani da fassarar maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin.
Ƙasar Ingila ta kuma samar da gwajin zuwa 23 ga Janairu 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya samar da PCR, na asibiti (PowerChek Coronavirus) na SARS-CoV-2 na yau da kullun a ranar 28 ga Janairu, 2020.
Yana neman "E" gene wanda duk beta coronavirus ke raba shi, da kuma RdRp gene wanda ke da alaƙa da SARS-CoV-2. A cikin China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka karɓi amincewar amfani da gaggawa daga Hukumar Kula da Samfuran Magunguna ta China don kayan aikin gano SARS-CoV-2 na PCR. A Amurka, Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) suna rarraba Rukunin Gano RT-PCR 2019-Novel Coronavirus (2019-nCoV) na Lokaci na Gaskiya ga dakunan gwaje-gwajen kiwon lafiyar jama'a ta hanyar International Reagent Resource.
Daya daga cikin gwaje-gwaje uku na kwayoyin halitta a cikin tsohuwar sigar kayan gwajin ya haifar da sakamakon da ba shi da tabbas saboda lalacewar reagent, da gwajin kwalba a CDC a Atlanta; wannan ya haifar da matsakaita na ƙasa da samfuran 100 a rana waɗanda aka sarrafa su cikin watan Fabrairu na 2020;
Gwajin amfani da abubuwa biyu ba zai iya tabbatar da amincinsa ba har zuwa 28 ga Fabrairu, 2020, kuma kafin wannan lokacin ba a ba da izinin fara gwajin ga dakunan gwaje-gwaje na jihohi da na gida ba.
An amince da gwajin ne ta Hukumar Abinci da Magunguna a karkashin dokar Amfani da Gaggawa.
Ya zuwa ranar 5 ga Maris, 2020, LabCorp ta sanar da cewa za a iya yin gwajin COVID-19 bisa RT-PCR a duk faɗin ƙasar.
Quest Diagnostics kuma ta sanya gwajin COVID-19 a duk faɗin ƙasar daga 9 ga Maris, 2020.
Babu iyakar adadin da aka sanar; dole ne a yi tarin samfuran da sarrafa su bisa ga bukatun CDC.
A Rasha, an haɓaka gwajin COVID-19 kuma an samar da shi ta Cibiyar Bincike ta Kiwon Lafiyar cuta da Fasaha ta VECTOR.
A ranar 12 ga Maris, 2020, Clinic Mayo ta ba da rahoton cewa ta haɓaka gwajin don gano cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin awanni 3.5 a cikin adadi mai yawa, yayin da yake ba da damar injin guda ɗaya don yin kusan gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don gwaji a kan tsarin m2000 na Abbott; FDA ta ba da izini irin wannan ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta kuma sami EUA daga FDA don gwajin da ya ɗauki kimanin minti 45.
Hukumar FDA ta amince da gwajin da ke amfani da fasahar isothermal nucleic acid amplification maimakon PCR.
Tun da wannan gwajin ba ya bukatar jerin zafin jiki mai sauyawa wannan hanyar na iya ba da sakamako mai kyau a cikin minti biyar da sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin 18,000 na waɗannan na'urori a Amurka kuma Abbott yana sa ran hanzarta samarwa don isar da gwaje-gwaje 50,000 a rana. Ana haɓaka gwajin da ke amfani da ƙwayoyin cuta na monoclonal waɗanda ke da alaƙa da ƙwayoyin nucleocapsid (N protein) na sabon coronavirus a Taiwan, tare da fatan gwajin zai iya ba da sakamako a cikin mintuna 15 zuwa 20 kamar yadda gwajin hanzari na mura yake.
A cikin Maris 2020 wani bita na rubutu ya kammala da cewa "radiograph na kirji yana da ƙarancin ƙimar bincike a farkon matakin, yayin da binciken CT [kwamfuta na kwamfuta] na iya kasancewa har ma kafin bayyanar cututtuka ta fara".
Wani fasalin CT shi ne duhu mai yawa na dutsen dutse tare da rarrabawar da aka yi, da kuma baya.
Ƙarfin subpleural, buɗewa da haɗuwa suna faruwa yayin da cutar ta samo asali.
Wani bincike da ya kwatanta PCR da CT a Wuhan a farkon annobar cutar ya nuna cewa CT na da matukar damuwa fiye da PCR, kodayake ba ta da takamaiman bayani, saboda yawan abubuwan da ke nunawa na nuna cewa tana da alaka da ciwon huhu da sauran cututtuka.
Ya zuwa Maris 2020, Kwalejin Kula da Radiology ta Amurka ta ba da shawarar cewa "Bai kamata a yi amfani da CT don yin bincike ko a matsayin gwajin farko don gano COVID-19 ba". Ya zuwa Maris 2020, CDC ta ba da shawarar PCR don yin bincike na farko.
Wani ɓangare na amsawar garkuwar jiki ga kamuwa da cuta shine samar da ƙwayoyin cuta ciki har da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cuta a cikin mutum daga kwanaki 7 ko makamancin haka bayan bayyanar cututtuka, don tantance rigakafi, da kuma a cikin kulawar al'umma. Ana iya yin kimantawa a cikin cibiyar bincike (CLT) ko ta hanyar gwajin-wuri-na-kula (PoCT).
Tsarin atomatik mai zurfi a yawancin dakunan gwaje-gwaje na asibiti zai iya yin wannan kimantawa amma wadatarsa zai dogara da yawan samarwa ga kowane tsarin.
Don CLT ana amfani da samfurin jini guda ɗaya na jini, kodayake ana iya amfani da samfurin jerin don bin diddigin amsawar rigakafi.
Don PoCT ana samun jini guda ɗaya ta hanyar allura a cikin fata.
Ba kamar hanyar PCR ba, ba a buƙatar matakan ƙira kafin kimantawa. A ranar 26 ga Maris, 2020, FDA ta sanya sunayen ƙungiyoyi 29 waɗanda suka ba da rahoton ga hukumar kamar yadda ake buƙata kuma saboda haka yanzu suna iya rarraba gwajin antibody ɗin su.
Ya zuwa ranar 7 ga Afrilu, 2020, kawai gwajin guda ɗaya ne FDA ta amince da shi a ƙarƙashin izinin amfani na gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su, wanda zai iya gano IgG da IgA antibodies ga kwayar cutar a cikin samfurin jini.
Ana iya yin gwajin da ɗaruruwan samfurori a cikin sa'o'i kaɗan kuma saboda haka ya fi saurin yin PCR na yau da kullun don nazarin RNA na kwayar cuta.
Antibodies yawanci ana iya gano su kwanaki 14 bayan kamuwa da cutar. A farkon watan Afrilu, Birtaniya ta gano cewa babu wani kayan gwajin antibody da aka saya da ya isa amfani.
Hong Kong ta kafa wata dabara da ke ganin marasa lafiya da ake zargi za su iya zama a gida, "sashen gaggawa zai ba wa marasa lafiya bututun samfurin", za su yi ta tsotsa a cikin bututun, su aika da shi kuma su sami sakamakon gwajin ba da daɗewa ba. NHS British ta sanar da cewa tana kan gaba wajen tsara wata dabara don gwada masu zargin a gida, wanda ke kawar da hadarin marasa lafiya na kamuwa da wasu idan suka je asibiti ko kuma su cire motar asibiti idan an yi amfani da ita. A cikin gwajin da aka yi na COVID-19 na masu zargin, ma'aikatan kiwon lafiya sun dauki samfurin ta hanyar yin amfani da matakan da suka dace.
A Jamus, Ƙungiyar Ƙwararrun Likitocin Kiwan Lafiya ta ce a ranar 2 ga Maris, suna da damar yin gwaji 12,000 a rana a cikin yanayin asibiti kuma an gwada 10,700 a makon da ya gabata.
Inshorar lafiya ce take biyan kuɗin idan likita ya bukaci a yi gwajin.
A cewar shugaban cibiyar Robert Koch, Jerrman tana da damar yin gwajin 160,000 a mako.
Tun daga ranar 19 ga watan Maris ana gudanar da gwajin tuki a wasu manyan birane.
Ya zuwa 26 ga Maris 2020 ba a san yawan gwajin da aka yi a Jamus ba, saboda sakamakon da aka bayar na tabbatacce ne kawai.
Binciken farko na dakin gwaje-gwaje ya nuna cewa har zuwa makon kalanda na 12/2020 an gwada samfurori 483,295 ciki har da na 12/2020 kuma 33,491 samfurori (6.9%) sun gwada tabbatacce ga SARS-CoV-2. A Isra'ila, masu bincike a asibitocin Technion da Rambam sun haɓaka da gwada hanyar yin gwajin samfurori daga marasa lafiya 64 a lokaci guda, ta hanyar tattara samfurori kuma kawai su ci gaba da gwaji idan an sami samfurin da aka haɗa. A Wuhan wani dakin gwaje-gwaje na gaggawa na wucin gadi mai girman murabba'in mita 2000 da aka sanya wa suna "Hou-Yan" (Sinanci: ko "Fire" a Turanci) an buɗe shi a ranar 5 ga Fabrairu 2020 ta BGI, wanda zai iya aiwatar da sama da samfurori 10,000 a rana.
Tare da gina wanda BGI co-kafa Wan Jian ya lura da shi kuma ya ɗauki kwanaki 5, samfurin ya nuna cewa shari'o'in a Hubei za su kasance 47% mafi girma kuma farashin da ya dace don gudanar da keɓewa zai ninka idan ƙarfin gwajin bai kai ga burin ba.
An bi Wuhan nan da nan sai Hou Yan a Shenzhen, Tianjin, Beijing, da Shanghai, a birane 12 a duk fadin kasar Sin.
Har zuwa 4 ga Maris, 2020, jimlar gwajin yau da kullun ya kai 50,000. An fitar da buɗe tushen, ƙirar multiplex da aka samar ta Origami Assays wanda zai iya gwada samfuran marasa lafiya 1122 don COVID19 ta amfani da ƙididdiga 93 kawai.
Har zuwa watan Maris, karancin isassun kayan aikin sun sa aka yi gaggawa a EU da Birtaniya da kuma Amurka.
Wannan ya sa wasu marubuta suka binciki tsarin shirya samfurin wanda ya shafi dumama samfurin a 98 C (208 F) na mintuna 5 don fitar da kwayar RNA don ƙarin gwaji. A ranar 31 ga Maris an sanar da cewa Hadaddiyar Daular Larabawa tana gwada yawancin jama'arta don Coronavirus a kan mutum fiye da kowace ƙasa, kuma tana kan hanya mai kyau don haɓaka sikelin matakin gwaji don isa ga yawancin jama'a.
Wannan ta hanyar hada hadin kan iyawar tuki, da kuma sayen manyan-scale-matsanancin sarrafawa na lab daga Group 42 da BGI (bisa ga "Hou-Yan" lab na gaggawa na bincike a China)
An gina shi cikin kwanaki 14, zai iya gudanar da dubban gwaje-gwajen RT-PCR a rana kuma shi ne na farko a duniya a wannan sikelin da za a gudanar a wajen kasar Sin.
An fara yin wasu gwaje-gwaje da suka shafi sassan kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta amince da hanyar Jamus ta samar da kayan aikin da aka tura wa ƙasashe masu karancin kuɗi waɗanda ba su da albarkatun da za su samar da kayan aikin kansu.
An buga hanyoyin Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyoyin Kula da Cututtuka na Amurka suka tsara ba ta kasance ba har zuwa 28 ga Janairu, tana jinkirta gwajin da ke akwai a cikin Amurka. China da Amurka suna da matsala game da amincin kayan gwajin a farkon ci gaban su, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isassun kayan aikin don biyan buƙatu da shawarwari don gwaji ta masana kiwon lafiya.
A maimakon haka, masana sun ce, shirye-shiryen Koriya ta Kudu na yin gwaji na taimakawa wajen rage yaduwar sabon coronavirus.
Ginin gwajin, galibi yana cikin dakin gwaje-gwaje na kamfanoni, wanda gwamnatin Koriya ta Kudu ta gina a cikin 'yan shekaru.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a kara shirin gwajin a matsayin hanya mafi kyau ta rage saurin cutar COVID-19. Babban bukatar gwajin saboda yaduwar kwayar cutar ya haifar da jinkiri na dubban daruruwan gwaje-gwaje a dakunan gwaje-gwaje na masu zaman kansu na Amurka, kuma samar da kayan shafawa da na sinadarai sun zama iyakance.
A watan Maris na shekarar 2020 kasar Sin ta bayar da rahoton matsalar daidaito a kayan gwajin su.
A Amurka, kayan gwajin da CDC ta haɓaka suna da "raunin"; Gwamnati daga baya ta gabatar da takunkumin hukuma wanda ya hana gwajin masu zaman kansu. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Biotechnology Co ltd na China, amma ta sami shawarar ba daidai ba.
Kamfanin ya bayyana cewa sakamakon da bai dace ba na iya zama sakamakon rashin samun samfurin ko amfani da kayan aikin da ya dace.
Ma'aikatar Spain ta ce za ta janye kayan aikin da suka dawo da sakamakon da bai dace ba, kuma za ta maye gurbin su da wasu kayan aikin gwajin da Shenzhen Bioeasy ta samar. 80% na kayan aikin gwajin da Czech Republic ta saya daga China sun ba da sakamako mara kyau. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga China waɗanda aka gano ba daidai ba.
Firayim Minista Matovic ya ba da shawarar a jefa kayan gwajin a cikin Danube. Ates Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da "babban kuskuren kuskure" kuma ba su "yi amfani da su ba".
Gwajin, wanda ya biyo bayan keɓe waɗanda suka gwada tabbatacce da kuma gano waɗanda suka kasance tare da masu cutar SARS-CoV-2 a cikin, ya ba da sakamako mai kyau.
Masu binciken da ke aiki a garin Vo na Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu a kan yawan mutane kusan 3,400, a tsakanin kwanaki goma.
Kusan rabin mutanen da suka gwada ba su da alamun cutar, kuma an killace dukkan wadanda aka gano.
Tare da takunkumin tafiye-tafiye, ya kawar da sabon kamuwa da cuta gaba daya.
Tare da saurin ganowa, takunkumin shiga, gwaji, da keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta yi jinkiri fiye da sauran ƙasashe masu tasowa, amma ba tare da takunkumi masu ƙarfi ba kamar rufe gidajen abinci da kantin sayar da kaya.
An soke ayyuka da yawa, kuma Singapore ta fara ba wa 'yan kasar shawarar su zauna a gida a ranar 28 ga Maris, amma za a sake bude makarantu a kan lokaci bayan hutun ranar 23 ga Maris.
Wasu ƙasashe ma sun shawo kan cutar ta hanyar sa ido kan tuntuɓar mutane, ƙuntatawa kan shiga, gwaji da keɓewa, amma tare da umarnin gaggawa, kamar Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya gano cewa ƙasashe da suka yi gwaje-gwaje da yawa, dangane da yawan mutuwar, suna da ƙananan mutuwar, mai yiwuwa saboda waɗannan ƙasashe suna iya gano waɗanda ke da ƙananan alamun ko kuma ba su da alamun bayyanar.
WHO ta ba da shawarar cewa ƙasashe da ba su da ƙarfin gwaji da kuma dakunan gwaje-gwaje na ƙasa tare da ƙarancin ƙwarewar COVID-19 su aika da samfuran farko masu inganci biyar da samfuran COVID-19 marasa inganci goma zuwa ɗayan dakunan gwaje-gwaje na WHO 16 don tabbatarwa.
Daga cikin dakunan gwaje-gwaje 16 da aka yi wa kwatancen, 7 suna Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka da 1 a Australia.
A cikin ginshiƙi na gaba, shafi na "Gaskiya a matsayin kashi na gwaji" ya shafi manufar gwajin ƙasa.
Kasashen da suka gwada kawai mutanen da suka shiga asibiti za su sami mafi girman sakamako mai kyau a matsayin kashi na gwaji fiye da ƙasashen da suka gwada duk jama'a, ko suna nuna alamun ko a'a, sauran sun yi daidai.
Wanke hannu (ko wanke hannu), wanda kuma ake kira tsabtace hannu, shine aikin wanke hannuwan mutum wanda nufin kawar da datti, mai, microorganisms, ko wasu abubuwa marasa so.
Wanke hannuwanka da sabulu a kai a kai a "lokaci mai muhimmanci" na rana yana hana kamuwa da cututtuka da yawa, kamar su diarrhea da tari, waɗanda suke yaɗuwa ta hanyar hanci zuwa baki.
Mutum na iya kuma kamuwa da cututtukan numfashi kamar su mura ko kuma mura, misali, idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci, ko bakinsu (misali, mucous membranes).
Wajibi ne a wanke hannaye da sabulu a lokatai biyar masu muhimmanci na rana: kafin da bayan wankewa, bayan wankewa da baya ko canza kayan wanka, kafin ciyar da yara, kafin cin abinci da kafin da bayan shirya abinci ko sarrafa naman alade, kifi ko tsuntsaye.
Idan babu sabulu da ruwa, za a iya wanke hannaye da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu:
Kafin, lokacin da ake dafa abinci da kuma bayan an gama.
Kafin da kuma bayan kula da marasa lafiya.
Bayan an canja wanki ko kuma bayan an wanke yaran da suka shiga bayan gida.
Bayan ka hura hanci, ka yi tari ko kuma ka yi tari.
Bayan ka taɓa dabba, abincin dabba, ko kuma sharar dabba.
Tsabtace hannu na likita yana nufin ayyukan tsabtace da suka shafi hanyoyin kiwon lafiya.
Wanke hannu kafin shan magani ko yin jinya zai iya hana ko rage yaduwar cuta.
Babban manufar likita na wanke hannu shine tsabtace hannu daga pathogens (kwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta waɗanda zasu iya haifar da cuta) da sunadarai waɗanda zasu iya haifar da haɗari ko cuta.
Wannan yana da mahimmanci ga mutanen da ke sarrafa abinci ko aiki a fannin kiwon lafiya, amma kuma yana da mahimmanci ga al'umma.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, gami da rage yaduwar mura, coronavirus da sauran cututtukan da ke yaduwa; hana tushen cutar diarrhea; rage kamuwa da cututtukan numfashi;
kuma rage yawan mutuwar jarirai a gida.
Wani bincike a shekarar 2013 ya nuna cewa ingantaccen wanke hannu zai haifar da karamin ci gaba a cikin tsayin yara a ƙarƙashin shekaru biyar.
A ƙasashe masu tasowa, ana iya rage mutuwar yara da ke da nasaba da cututtukan numfashi da kuma zawo ta hanyar gabatar da sauye-sauye na dabi'u masu sauƙi, kamar wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage yawan mutuwar mutane da ke fama da wannan cuta da kusan kashi hamsin.
Maganin da ke ba da shawarar wanke hannu zai iya rage yawan hawan hanci da kashi ɗaya bisa uku, kuma wannan zai iya kwatanta da samar da ruwa mai tsabta a yankunan masu karamin arziki.
Kashi 48% na raguwar faruwar fitsari na hanci za a iya danganta shi da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya guda mai inganci da araha don guje wa fitsari da cututtukan numfashi na gaggawa (ARI), a matsayin aikin da aka saba yi a gidaje, makarantu da al'ummomi a duk duniya.
Ciwon huhu, ARI da ke da iko, ita ce sanadin mutuwa mafi girma a cikin yara 'yan ƙasa da shekara biyar, tana kashe kusan yara miliyan 1.8 a shekara.
Cutar kumburi da ciwon huhu suna kashe yara kusan miliyan 3.5 a kowace shekara.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da kuma bayan wanka zai iya ceton rayuka fiye da duk wani allurar rigakafi ko maganin da aka hada, rage mutuwar diarrhea da kusan rabi da kuma mutuwar cututtukan numfashi na gaggawa da kusan kashi ɗaya cikin huɗu.
Wanke hannu yawanci ana haɗa shi da sauran hanyoyin tsabtace tsabta a matsayin ɓangare na shirin ruwa, tsabtace tsabta da tsabta (WASH).
Wanke hannu yana iya kuma karewa daga impetigo wanda aka watsa ta hanyar hulɗa ta jiki.
Wani dan kadan na cutarwa na yawan wanke hannu shi ne, wanke hannu sosai zai iya haifar da lalacewar fata saboda bushewar fata.
Wani bincike daga Denmark a shekara ta 2012 ya gano cewa yawan wanke hannu na iya haifar da itching, yanayin fata mai laushi da ake kira hand eczema ko dermatitis na hannu, wanda ya zama ruwan dare a tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sau da yawa kuma ana ganin yana ɗaya daga cikin alamun matsalar damuwa ta damuwa (OCD).
Akwai lokuta masu mahimmanci guda biyar a cikin yini inda wanke hannu da sabulu ke da mahimmanci don rage yaduwar cutar ta bakin: bayan amfani da bayan gida (kayan wanka, wanka), bayan wanke bayan yara (canja kayan wanka), kafin cin hanci da yara, kafin cin abinci da kafin / bayan shirya abinci ko sarrafa naman alade, kifi ko tsuntsaye.
Sauran lokutan da ya kamata a yi wanka da kyau don guje wa yaduwar cuta sun hada da kafin da bayan kula da yanke ko rauni; bayan yin tari, tari, ko hura hanci; bayan taɓa ƙashin dabba ko taɓa dabba; da kuma bayan rike shara.
Yawan wanke hannu da sabulu bai kai na kowa ba a ƙasashe da yawa.
A cikin 2015, binciken wanke hannu a cikin ƙasashe 54 ya gano cewa a matsakaita kashi 38.7% na gidaje suna da al'adar wanke hannu da sabulu. A cikin 2014, binciken ya nuna Saudi Arabiya tana da mafi girman kashi 97 cikin ɗari; Amurka tana kusa da tsakiyar kashi 77 cikin ɗari; da China a mafi ƙarancin kashi 23 cikin ɗari.
Shirin Kula da Lafiya mai mahimmanci da Ma'aikatar Ilimi ta Philippines ke aiwatarwa misali ne na manyan matakai don inganta lafiyar yara da ilimantar da su.
Yin fitsari sau biyu a shekara, tare da wanke hannuwanku kullum da sabulu, da kuma goge haƙoranku kullum da ruwan 'ya'yan itace, sune ainihin shirin na kasa.
An yi nasara a Indonesia.
Za a iya ƙara kawar da ƙwayoyin cuta daga fata ta ƙara sabulu ko na'urar wankewa cikin ruwa.
Babban aikin sabulu da na'urar wankewa shine rage toshewar maganin, da kuma kara narkewa.
Ruwa kaɗai ba zai iya tsabtace fata ba domin kitse da furotin, waɗanda suke cikin ƙasa, ba su narkewa cikin ruwa.
Duk da haka, ruwa mai kyau yana taimakawa wajen tsabtace...
Saboda yadda ake sake amfani da shi, sabulu na iya riƙe kwayoyin da aka samu daga amfani da shi a dā.
Karamin bincike kan kwayar cutar da ke gudana daga gurbataccen sabulu ya gano cewa ba za a iya samun kwayar ba saboda ana zubar da kwayoyin lokacin da ake wanke su da kumfa.
Har ila yau, shafin yanar gizon CDC ya ce "safi mai ruwa da aka cire ba tare da amfani da hannaye ba ya fi kyau".
Sabulu mai guba yana samun tallafi sosai a cikin jama'ar da suke son kiwon lafiya.
Babu tabbaci a yau cewa amfani da maganin kashe ƙwayoyin cuta ko kuma maganin kashe ƙwayoyin cuta ya fi dacewa da kwayoyin da ke da kariya ga maganin rigakafi.
Duk da haka, sabulu na antibacterial yana ƙunshe da magungunan antibacterial na yau da kullun kamar triclosan, wanda ke da jerin abubuwan da ke da tsayayya ga ƙwayoyin cuta.
Saboda haka, ko da yake ba za a iya zaɓan rigakafin rigakafin da sabulun ya yi ba, amma ba zai yi tasiri ba kamar yadda ake tallatawa.
Baya ga surfactants da wakilai masu kare fata, waɗannan ingantattun maganganun na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai daidaita pH, acid benzoate mai aiki da ƙwayoyin cuta da ƙarin kayan shafawa na fata (aloe vera, bitamin, ampoules, tsire-tsire na shuka). Cikakken bincike daga Faculty of Public Health a Jami'ar Oregon ya nuna cewa sabulu na yau da kullun yana da tasiri iri ɗaya da sabulu mai ƙwayoyin cuta mai amfani da ke dauke da triclosan a cikin hana cututtuka da kawar da ƙwayoyin cuta daga hannu.
Ruwa bai yi zafi sosai ba don wanke hannuwanku ba ya isa ya kashe ƙwayoyin cuta.
Kwayoyin cuta suna ninka da sauri a zafin jiki (37 °C).
Duk da haka, ruwan dumi da sabulu ya fi ruwan sanyi da sabulu tasiri wajen kawar da man da ke cikin ƙasa da kuma ƙwayoyin cuta.
Akasin abin da mutane da yawa suka gaskata, bincike na kimiyya ya nuna cewa amfani da ruwan dumi ba shi da wani sakamako a rage ƙwayoyin cuta a hannu.
Mai tsabtace hannu ko kuma maganin kashe cutar hannu shine mai tsabtace hannu wanda ba ya tushen ruwa.
A ƙarshen 1990s da farkon farkon ƙarni na 21, shafawar giya na kayan aikin tsabtace hannu na ruwa (wanda kuma aka sani da shafawar tushen giya, shafawar hannu ta antiseptic, ko tsabtace hannu) ya fara zama sananne.
Yawancin su suna da tushen isopropyl ko ethanol na giya wanda aka tsara tare da kayan ƙanshi kamar Karbomer (polymer na acrylic acid) a cikin gel, ko humektan kamar glycerin zuwa ruwa, ko kumfa don sauƙin amfani da kuma rage tasirin busar da giya.
Ƙara hydrogen peroxide da aka yi narkewa zai ƙara ƙaruwa a aikin rigakafin ƙwayoyin cuta.
Rubbing da barasa yana kashe kwayoyin cuta, kwayoyin cuta masu tsayayya da magunguna (MRSA da VRE), tarin fuka da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccinia, influenza da hepatitis) da fungi.
Ruwan shafawa na giya mai dauke da kashi 70% na barasa yana kashe kashi 99.97% (rage 3.5 log, daidai da rage 35 decibels) na kwayoyin cuta a hannu 30 seconds bayan amfani da kuma kashi 99.99% (rage 4 zuwa 5 log) na kwayoyin cuta a hannu 1 minti bayan amfani.
Maganin tsabtace hannu na barasa kusan ba shi da tasiri ga kwayar cutar Norovirus (ko Norwalk), wanda shine sanadin cututtukan gastroenteritis. Dole ne a yi amfani da maganin kashe wuka ko kuma rubbing na giya don wanke hannu ko kare hannayensu yadda ya kamata.
An shafe gaba da bayan hannaye biyu da tsakanin yatsunsu na kimanin dakika 30 har sai ruwan, kumfa ko gel ya bushe.
Ƙungiyar Kula da Cututtuka da Rigakafin cuta ta Amurka ta ba da shawarar wanke hannaye maimakon shafawa da mai tsabtace hannu, musamman idan hannayen suna da datti.
Amfani da wannan wakili yana ƙaruwa saboda sauƙin amfani da saurin kashe ayyukan ƙwayoyin cuta. Koyaya, ba zai iya maye gurbin wanke hannu daidai ba sai dai idan babu sabulu da ruwa.
Amfani da kayan aikin wanke hannu na barasa akai-akai na iya haifar da bushewar fata sai dai idan an kara emollients da/ko moisturizers a cikin tsari.
Za a iya rage ko kawar da tasirin busassun giya ta hanyar ƙara glycerin da/ko wasu emollients a cikin tsari.
A gwajin asibiti, maganin wanke hannu na barasa wanda ke dauke da emollients ya haifar da raguwar damuwa da bushewa a fata idan aka kwatanta da sabulu ko na'urar wankewa.
Allergic contact dermatitis, contact urticaria syndrome ko kuma hypersensitivity ga shan giya ko kayan shafawa a hannu da giya ba safai ake samu.
Yanayin rage yawan cutar fata ta tuntuɓe mai tsananin damuwa ya zama abin jan hankali fiye da amfani da sabulu da ruwa don wanke hannu.
Maganin da ba ruwa ba, ko da yake yana da tasiri, ba ya wanke hannu daga kwayoyin halitta.
Wannan shi ne dalilin da ya sa mai tsabtace hannu ba ya da tasiri fiye da sabulu da ruwa wajen hana yaduwar cututtukan cututtuka, domin cututtukan suna nan a hannu.
Ingancin mai tsabtace hannu mai ba da barasa ya dogara sosai da abin da aka yi da kuma tsarinsa, kuma a tarihi ya yi kasa da barasa da kuma shafawa.
A kwanan nan, an nuna formulations da ke amfani da benzalkonium chloride suna da ci gaba da aiki na antimicrobial kuma suna tarawa bayan amfani, ba kamar giya ba wanda aka nuna yana rage ingancinsa bayan amfani da yawa, mai yiwuwa saboda rashin dacewar fata a hankali.
Yawancin mutane masu ƙarancin kuɗi ba su iya sayan sabulu ba, maimakon haka suna amfani da toka ko ƙasa.
Ash ko ƙasa na iya zama da amfani fiye da ruwa kawai amma ƙila ba zai yi tasiri ba kamar sabulu.
Akwai damuwa idan ƙasa ko toka ta gurɓata da ƙwayoyin cuta waɗanda za su iya ƙaruwa maimakon rage yaduwar cuta.
Ash kuma yana da maganin kashe cuta kamar sabulu saboda yana samar da maganin alkaline idan ya haɗu da ruwa.
WHO ta ba da shawarar ash ko yashi a matsayin madadin sabulu idan babu sabulu.
Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar cewa hanyoyin da suka dace na wanke hannu don hana yaduwar cuta sun haɗa da waɗannan matakan:
Ka sa hannunka ya yi sanyi ko kuma ya yi zafi.
Ana ba da shawarar ruwa mai gudana saboda ana iya gurɓata kwandon tsaye, a lokaci guda yanayin ruwan ba shi da tasiri.
Wanke hannuwanka da sabulu mai yawa, ciki har da bayan hannu, tsakanin yatsun hannu, da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna da sha'awar wanke hannayensu sosai yayin da suke amfani da sabulu fiye da ruwa kawai.
Aƙalla na tsawon dakika 20.
Yin taƙama yana kawo sauyawa, wanda ke taimakawa wajen kawar da ƙwayoyin cuta daga fata, kuma yin taƙama na tsawon lokaci yana kawar da ƙwayoyin cuta da yawa.
Ka wanke shi da ruwa mai gudãna.
Yin wanka a cikin kwanon rufi zai sa hannayenka su sake zama da datti.
Ka bushe da tawul mai tsabta ko kuma ka bar shi ya bushe da iska.
Hannun da suka yi rigar suna da saukin sake yin datti. Hannun yatsa, wuyan hannu, tsakanin yatsunsu da kuma ƙarƙashin ƙusa sune wuraren da aka manta da su.
Ƙwayoyin cuta na iya kasancewa a cikin ƙusa da kuma zane-zane.
Ana ba da shawarar lotions masu laushi don hana hannaye daga bushewa; fata mai bushewa na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin watsa cututtuka.
Akwai zaɓuɓɓuka masu rahusa don sauƙaƙe wanke hannu idan babu ruwan famfo da/ko sabulu, misali. zuba ruwa daga gwangwani ko gwangwani tare da ramuka masu dacewa da/ko amfani da toka idan ya cancanta a ƙasashe masu tasowa. Idan samar da ruwa ya iyakance (kamar a makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai mafita mai tanadin ruwa kamar "pipi tippi" da sauran zaɓuɓɓuka masu arha.
Fuskar ruwa mai sauƙi ce da ke amfani da igiya da ke rataye da kuma matattarar da ƙafafun mutum suke amfani da ita don zuba ruwa a hannunsa da kuma sabulu.
Wani muhimmin bangare na tsaftace hannu shine bushewar hannu mai inganci, amma akwai muhawara game da mafi kyawun hanyar bushewa a cikin gidan wanka.
Karin bincike na nuna cewa takarda mai wanka ya fi na'urar busar hannu da ake amfani da ita a cikin gidajen wanka.
A shekara ta 2008, wani bincike da aka yi daga Jami'ar Westminster, London, kuma masana'antar tawul ɗin ta tallafa masa, wato, Tissue Symposium na Turai, ya gwada tsabtar da ake samu a lokacin amfani da tawul ɗin takarda, na'urar bushe hannu mai zafi da na'urar bushe hannu mai iska mai iska.
Bayan wankewa da bushewa da mai bushewar iska, an sami karuwar ƙwayoyin cuta a ƙasan yatsunsu da kashi 194% kuma a hannun hannu da kashi 254%.
Drying tare da mai bushe iska yana haifar da ƙaruwa a cikin ƙwayoyin cuta a kan yatsunsu na matsakaici na 42% da kuma a kan hannu na 15%.
Bayan wankewa da bushewa da hannuwan hannu tare da tawul ɗin takarda, adadin ƙwayoyin cuta a ƙasan ƙarshen wanka ya ragu da kashi 76% kuma a hannun hannu har zuwa 77%. Masana kimiyya sun kuma gudanar da gwaje-gwaje don sanin ko yiwuwar gurɓataccen gurɓataccen abu daga sauran masu amfani da gidan wanka da kuma yanayin gidan wanka daga kowane irin hanyar bushewa.
Jirgin iska mai bushewa, wanda ke fitar da iska daga cikin na'urar a cikin saurin 180 m/s (650 km/h; 400 bsj), yana iya fitar da kwayoyin cuta daga hannu da na'urar kuma yana iya gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka har zuwa mita 2.
Amfani da na'urar busar hannu mai zafi yana watsa kwayoyin cuta har zuwa mita 0.25 daga na'urar busar.
Takardar takarda ba ta nuna alamar yaduwar kwayoyin cuta ba. A shekara ta 2005, wani binciken da TÜV Produkt und Umwelt ya yi ya kimanta hanyoyin bushewa na hannu.
An gano canje-canje masu zuwa a cikin ƙididdigar ƙwayoyin cuta bayan bushewar hannu:
Akwai masana'antun bushe-bushe na hannu daban-daban, kuma an kwatanta bushe-bushe da tawul ɗin takarda don bushewa.
Wanke hannu ta amfani da kayan wanke hannu ya zama madadin lokacin tafiya lokacin da sabulu da ruwa ba su da wadata.
Abin sha mai tsabtace hannu ya kamata ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa.
Wanke hannu don magani ya kasance wajibi ne tun lokacin da likitan Hungary Ignaz Semmelweis ya gano tasirinsa (a cikin 1846) a cikin hana cutar a cikin asibiti.
Akwai na'urar lantarki da ke tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya nuna cewa amfani da shi yana rage yawan kamuwa da cuta.
Wanke hannuwanka a magani na akalla dakika 15, ta amfani da sabulu da ruwa mai yawa ko kuma gel don tausa da shafa kowane bangare na hannu.
Dole ne a shafa hannu tare da yatsan da aka saka a cikin hanyar da ba daidai ba.
Idan akwai datti a ƙarƙashin ƙusa, ana iya amfani da goge gashi don kawar da shi.
Tun da yake ƙwayoyin cuta suna iya zama a cikin ruwa a hannayenmu, ya kamata mu wanke su sosai kuma mu shafa su har su bushe da tawul mai tsabta.
Bayan an bushe hannu, ya kamata a yi amfani da tawul ɗin don rufe ruwa (kuma a buɗe ƙofar fita idan ya cancanta).
Wannan yana hana hannayenka daga sake yin datti lokacin da suka taɓa farfajiya.
Wanke hannu a cikin yanayin kiwon lafiya yana nufin kawar da ƙwayoyin cuta ("kuman") da kuma hana su yadawa.
Jaridar New England Journal of Medicine ta ruwaito cewa rashin wanke hannu na yau da kullun ya kai matakin da ba za a iya yarda da shi ba a yawancin yanayin kiwon lafiya, tare da yawancin likitoci da ma'aikatan jinya suna mantawa da wanke hannu kafin su taɓa marasa lafiya, don haka suna yada ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu daidai da wasu matakai masu sauki na iya rage kamuwa da cutar da ke tattare da catheter da kashi 66 cikin dari. Hukumar Lafiya ta Duniya ta wallafa wata takarda da ke nuna yadda ake wanke hannu da kuma shafawa a bangaren kiwon lafiya.
Ana kuma iya samun shawarwari game da tsabtace hannu ta hanyar wannan kungiya a shafinta na yanar gizo don ra'ayoyin jama'a.
Wani bincike da ya dace da wannan binciken shi ne na Whitby et al.
Na'urar kasuwanci na iya auna da tabbatar da tsabtar hannu, idan ana bukatar nuna bin ka'idoji.
Hukumar Lafiya ta Duniya ta ba da "Lokaci Biyar" don wanke hannu:
bayan an yi amfani da jini/ruwa
kafin aikin aseptic, da kuma
Bayan an warkar da marasa lafiya, an ƙara sinadarai masu kashe ƙwayoyin cuta a cikin sabulu (sabulu "mai magani" ko "anti-microbial") wanda ke kashe kayan wanke hannu.
Irin wannan kashe-kashe na iya zama da ake so kafin a yi aiki ko kuma a cikin yanayin da kwayoyin da ke da juriya ga maganin rigakafi suka yadu. Don 'wanke' hannun mutum don aikin tiyata, ana buƙatar bututun da za a iya kunnawa da kashewa ba tare da taɓa hannu ba, wasu chlorhexidine ko iodine wanka, tawul mai tsabta don bushe hannaye bayan wanka, da kuma goga mai tsabta don shafawa da sauran kayan tsabta don tsabtace ƙusa.
Dole ne a cire duk kayan ado.
Wannan aikin yana buƙatar wanke hannaye da ƙananan hannu har zuwa gwiwoyi, yawanci 2-6 minti.
Ba a bukatar dogon lokaci na yin wanka (minti 10).
Lokacin wanka, dole ne a hana ruwa daga hannun hannu daga komawa hannun.
Bayan an gama wanke hannu, sai a bushe hannu da kayan shafawa kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko kuma a yi amfani da maganin kashe ƙwayoyin cuta kafin a yi wa mutum jinya da kuma bayan an gama.
Don sarrafa kamuwa da cutar staph a asibitoci, an gano cewa mafi yawan fa'idodin wanke hannu sun fito ne daga wanke 20% na farko, kuma an sami fa'idodi kaɗan lokacin da yawan wanke hannu ya ƙaru sama da 35%.
Wanke hannu da sabulu na yau da kullun yana haifar da fiye da sau uku na cututtukan cututtukan da aka watsa a cikin abinci idan aka kwatanta da wankewa da sabulu mai hana ƙwayoyin cuta. Kwatanta wanke hannu tare da maganin barasa tare da wanke hannu tare da sabulu mai hana ƙwayoyin cuta na tsawon dakika 30, kowannensu ya nuna cewa wanke hannu tare da barasa yana rage gurɓataccen ƙwayoyin cuta 26% fiye da sabulu mai hana ƙwayoyin cuta.
Amma sabulu da ruwa sun fi tasiri fiye da wankin hannu na barasa don rage kwayar cutar H1N1 da Cystic Fibrosis spores daga hannu. Matsayi don inganta tsabta a cikin yanayin kiwon lafiya na iya haɗawa da ilmantarwa ga ma'aikata game da wanke hannu, haɓaka wadatar wankin hannu na barasa, da rubuce-rubuce da kuma tunatarwa ga ma'aikata.
Akwai bukatar ƙarin bincike kan wane irin sa baki ne ya fi tasiri a cikin yanayin kiwon lafiya daban-daban.
A ƙasashe masu tasowa, wanke hannu da sabulu sananne ne a matsayin kayan aiki mai tasiri da mahimmanci don cimma lafiya mai kyau, har ma da abinci mai gina jiki.
Duk da haka, rashin isasshen ruwa, sabulu ko wuraren wanke hannu a gida, a makaranta da kuma a wuraren aiki ya sanya kalubalen cimma daidaiton wanke hannu a duniya.
Alal misali, a yawancin yankunan karkara na Afirka, wanke hannu a kusa da kowane gidan wanka na jama'a da na masu zaman kansu ba shi da yawa, duk da cewa akwai zaɓuɓɓuka masu arha don gina tashoshin wanke hannu.
Duk da haka, rashin wanke hannu na iya zama sanadiyar al'ada da ta samo asali daga rashin sabulu ko ruwa.
Tallafawa da kuma ba da shawara ga wanke hannu da sabulu na iya tasiri kan yanke shawara, inganta wayar da kan jama'a game da fa'idodin wanke hannu da kuma haifar da sauye-sauyen halayyar jama'a na dogon lokaci.
Don wannan abu ya yi aiki yadda ya kamata, dole ne a yi sa ido da kuma kimantawa.
Binciken da aka yi na nazarin 70 ya gano cewa tsarin da ke kan al'umma yana da tasiri wajen inganta wanke hannu a cikin LMIC, yayin da kamfen na talla na zamantakewa ba shi da tasiri.
Da zarar an cimma matsakaicin matsakaicin, makarantar za ta iya motsawa daga tauraro daya zuwa karshe tauraro uku.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen na inganta wanke hannu da aka yi don rage cututtukan yara da mutuwa.
Ranar Wanke Hannun Duniya wani misali ne na kamfen na wayar da kan jama'a wanda ke kokarin canza halayyar. Sakamakon annobar cutar coronavirus ta 2019-20, UNICEF ta inganta amfani da emojis na wanke hannu.
Wasu nazarin sun yi la'akari da tasirin tsadar wanke hannu gaba ɗaya a cikin ƙasashe masu tasowa dangane da DALY.
Amma wani bincike ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin ruwa da na tsabtace jiki tsada.
Muhimmancin wanke hannu ga lafiyar ɗan adam  musamman ga mutanen da ke cikin yanayi mai rauni kamar uwaye masu haihuwa ko sojoji da suka ji rauni a asibiti  an fara gane su a tsakiyar karni na 19 ta hanyar manyan ma'aikatan tsaftace hannu: likitan Hungary Ignaz Semmelweis wanda ke aiki a Vienna, Austria da Forence Nightingale, "wanda ya kafa aikin jinya na zamani" na Ingila.
A lokacin yawancin mutane suna da tabbaci cewa cutar ta samo asali ne daga ƙanshin ƙanshi da ake kira miasmas.
A cikin shekarun 1980, annobar abinci da cututtukan da suka shafi kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su inganta inganta tsabtace hannu a matsayin hanya mai mahimmanci don hana yaduwar kamuwa da cuta.
Barkewar mura ta alade a shekara ta 2009 da kuma annobar COVID-19 a shekarar 2020 sun haifar da wayar da kan jama'a a kasashe da dama game da muhimmancin wanke hannu da sabulu don kare kai daga irin wannan cuta mai yaduwa.
Alal misali, ana rataye allon "daidaitaccen wanke hannu" kusa da wanka a cikin gidajen wanka na jama'a da kuma cikin gidajen wanka na ofisoshin gwamnati da filayen jiragen sama a Jamus.
Kalmar nan "wanke hannuwan mutum daga" wani abu, tana nufin sanar da rashin yarda da mutum ya dauki alhakin abin ko kuma ya raba hannu a ciki.
Ya fito ne daga ayar Littafi Mai-Tsarki a cikin Matiyu lokacin da Bilatus Babila ya wanke hannunsa daga yanke shawarar gicciye Yesu Kristi, amma ya zama kalmar da ke da amfani sosai a cikin wasu al'ummomin Ingilishi.
A cikin Macbeth na Shakespreare, Lady Macbeth ta fara wanke hannayenta a cikin ƙoƙari na wanke ƙazantar da aka yi tunaninsa, wanda ke wakiltar jin ta laifin laifin da ta aikata kuma ta rinjayi mijinta ya aikata.
An gano cewa mutane, bayan tunawa ko yin tunani game da rashin ɗabi'a, suna da sha'awar wanke hannayensu fiye da sauran mutane kuma suna daraja kayan wanke hannu.
Bugu da ƙari, waɗanda aka ba su izinin wanke hannayensu bayan irin wannan tunani ba su da wataƙila su shiga cikin wasu ayyukan "wanke" biyan kuɗi, kamar yin aikin sa kai.
Addinai sun tsara wanke hannu don dalilai na tsabta da alama. Wanke hannu a alamance, ta amfani da ruwa ba tare da sabulu ba don wanke hannu, wani ɓangare ne na al'adar wanke hannu wanda aka samo a cikin addinai da yawa ciki har da Bahai, Hindu, tevilah da netilat yadayim a cikin addinin Yahudanci, Lavabo a cikin Kristanci da Wudhu a cikin Musulunci. Addinai kuma sun tsara wanke hannu mai tsabta musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun bukaci a wanke hannu bayan an gama wanka.
Addinan Hindu, Buddha, Sikh, Yahudanci da Musulunci ma sun bukaci a wanke hannu kafin da kuma bayan cin abinci.
Gudanar da haɗarin aiki na COVID-19
Gudanar da haɗarin aiki don COVID-19 aikace-aikace ne na hanyoyin kiwon lafiya da aminci na aiki don sarrafa haɗari don rigakafin cutar coronavirus na 2019 (COVID-19).
Kula da haɗari a wurin aiki ya dogara da wurin aiki da aikin, bisa la'akari da haɗarin tushen fallasa, tsananin cutar a cikin al'umma, da kuma haɗarin kowane ma'aikaci wanda zai iya kamuwa da cutar COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aiki ta Amurka (OSHA), ayyukan da ke da ƙananan haɗarin kamuwa da cuta suna da ƙarancin hulɗa da jama'a da sauran abokan aiki, inda aka ba da shawarar matakan rigakafin kamuwa da cuta na yau da kullun da suka haɗa da wanke hannu, ƙarfafa ma'aikata su zauna a asibiti idan suna cikin asibiti, ɗabi'ar numfashi, da kiyaye tsabtace jiki na yau da kullun da kuma aikin kashe ƙwayoyin cuta a wurin aiki.
Ayyuka masu haɗarin haɗarin haɗari sun haɗa da ayyukan da ke buƙatar yawan hulɗa ko kusanci da mutanen da ba a san ko ake zargin suna da COVID-19, amma suna iya kamuwa da cutar saboda yaduwar cikin al'umma ko tafiya ta duniya.
Wannan ya hada da ma'aikata da ke da hulɗa da jama'a kamar a makarantu, wuraren aiki da ke da yawan jama'a, da kuma wasu wuraren sayar da kaya masu yawa.
Kula da haɗari ga wannan rukunin, ban da matakan rigakafin kamuwa da cuta na yau da kullun, sun haɗa da iska ta amfani da mai tace iska mai inganci, mai kula da hanci, da kuma samun kayan kariya na mutum idan aka haɗu da mutumin da ke dauke da COVID-19.
OSHA ta dauki ma'aikatan kiwon lafiya da na gawawwaki da suka kamu da cutar COVID-19 a matsayin masu hadarin kamuwa da cutar, wanda hakan ya kara hadarin kamuwa da cutar idan ma'aikata suka yi aikin samar da aerosol a, ko kuma tattara ko kuma sarrafa samfurori daga mutanen da aka sani ko ake zargin suna da cutar COVID-19.
Kula da haɗari da suka dace da waɗannan ma'aikata sun haɗa da kulawar injiniya kamar su ɗakunan iska tare da matsin lamba mara kyau da kayan kariya na mutum wanda ya dace da aikin aiki.
Cutar COVID-19 na iya yin tasiri a wuraren aiki.
Wataƙila ma'aikaci ba ya zuwa wurin aiki domin rashin lafiya, yana bukatar ya kula da wasu ko kuma yana jin tsoron nunawa.
Yanayin kasuwancin na iya canzawa, duka dangane da abin da ake nema, da kuma yadda ake samun waɗannan abubuwan (kamar sayayya a lokacin da ba a cika lokaci ba ko ta hanyar jigilar kaya ko kuma jagora).
A ƙarshe, jigilar kayayyaki daga yankunan da COVID-19 ya shafa kai tsaye na iya zama mai rikitarwa. Shirye-shiryen cututtukan cututtuka da shirye-shiryen amsawa na iya zama jagora don matakan kariya.
Shirin yana magance matakan haɗari da ke tattare da wuraren aiki da ayyuka daban-daban na aiki ciki har da tushen fallasa, abubuwan haɗarin da ke tasowa daga gida da kuma al'umma, da abubuwan haɗarin kowane ma'aikaci kamar tsufa ko yanayin rashin lafiya na yau da kullun.
Ya kuma bayyana matakan da ake bukata don magance wannan hadarin, da kuma shirin gaggawa don yanayin da zai iya tasowa sakamakon annobar.
Shirye-shiryen kamuwa da cuta da kuma shirin mayar da martani na iya zama abin da ya dace da shirin kasa ko na kasa.
Manufofin maganin cutar sun hada da rage yaduwar cutar a tsakanin ma'aikata, kare mutanen da ke cikin hatsarin kamuwa da cuta, kiyaye ayyukan kasuwanci, da rage tasirin illa ga sauran kamfanoni a cikin sarkar samar da kayayyaki.
Matsayin cutar a cikin al'ummar da kasuwancin ke ciki yana shafar yadda ake amsawa.
Tsarin kula da haɗari tsari ne da aka yi amfani da shi sosai a cikin lafiyar aiki da kiwon lafiya don rarraba kula da haɗari bisa ga tasiri.
Lokacin da ba za a iya kawar da haɗarin COVID-19 ba, mafi ingancin sarrafawa shine sarrafa injiniya, biye da sarrafawa, kuma na ƙarshe shine kayan kariya na mutum.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin haɗari na aiki ba tare da dogaro da halayyar ma'aikata ba, kuma yana iya zama mafi kyawun mafita mai tasiri don aiwatarwa.
Gudanar da aiki shine canji a cikin manufofin aiki ko hanyoyin da ke buƙatar ma'aikaci ko mai aiki.
Kayan kariya na mutum (PPE) ana ganin ba su da tasiri sosai fiye da na injiniyoyi da na gwamnati amma suna iya taimakawa wajen hana wasu fallasa.
Duk nau'ikan PPE dole ne a zaɓi su bisa haɗarin da ke tattare da ma'aikata, a shigar da su daidai gwargwado (cth respirator), a sa su daidai a kai a kai, a duba su a kai a kai, a kula da su kuma a maye gurbin su, idan ya cancanta, kuma a cire su, a tsabtace su kuma a adana su ko a zubar da su yadda ya kamata don kauce wa gurɓata.
Bisa ga Hukumar Kula da Lafiya da Lafiya ta Aikin Amurka (OSHA), ayyukan da ke da ƙananan haɗarin haɗari suna da ƙananan aiki tare da jama'a da sauran abokan aiki.
Matakan rigakafin kamuwa da cuta da aka ba da shawarar ga duk wuraren aiki sun haɗa da wanke hannu akai-akai da kuma sosai, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ɗabi'ar numfashi ta haɗa da rufewa yayin tari da tari, shirya kayan aiki da kwandon shara, shirya don aiki na tebur ko juyawa idan ya cancanta, ba ƙarfafa ma'aikata su yi amfani da kayan aikin wasu ba, da kuma kiyaye tsabtace aiki da aikin kashe ƙwayoyin cuta a wurin aiki.
Ganowa da kuma ware mutane da ke da cutar da sauri matakai ne masu muhimmanci wajen kare ma'aikata, abokan ciniki, baƙi da kuma sauran mutane a wurin aiki.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun ba da shawarar cewa ma'aikata da ke da alamun cututtukan numfashi na gaggawa su zauna a gida har sai sun sami 'yanci daga zazzabi, alamun zazzabi ko wasu alamun aƙalla awanni 24 ba tare da shan maganin rage zazzabi ko wasu magungunan canza alamun ba, da kuma manufofin hutu na rashin lafiya, ba da damar ma'aikata su zauna a gida don kula da dangin da ke rashin lafiya, kuma ma'aikata sun san wannan manufofin.
A cewar OSHA, ayyukan da ke da haɗarin haɗarin haɗari sun haɗa da ayyukan da ke buƙatar haɗuwa da yawa ko kusanci a cikin ƙafa shida (1.8 m) na mutumin da ba a san shi ba ko kuma wanda ake zargin yana da cutar COVID-19, amma yana iya kamuwa da SARS-CoV-2 saboda yaduwar al'umma da ke faruwa a kusa da wurin kasuwancin, ko kuma saboda mutumin ya yi ba da daɗewa ba ya yi balaguron ƙasa da ƙasa zuwa wurin da ke da yaduwar COVID-19.
Wannan ya hada da ma'aikata da ke da hulɗa da jama'a kamar a makarantu, wuraren aiki masu yawan jama'a da wasu wuraren sayar da kaya masu girma. Gudanar da injiniya ga waɗannan rukunin da kuma rukunin masu haɗari sun haɗa da sanya manyan masu tace iska, haɓaka ƙimar iska, sanya shinge na jiki kamar su masu kariya na roba da kuma sanya windows na jagora don sabis na abokin ciniki. Gudanar da gudanarwa ga waɗannan rukunin da kuma rukunin masu haɗari sun haɗa da ƙarfafa ma'aikata marasa lafiya su zauna a gida, maye gurbin tarurrukan fuska da sadarwa akai-akai, ƙirƙirar juzu'i na juzu'i, dakatar da balaguron balaguro zuwa wuraren da ba su da mahimmanci tare da barkewar COVID-19, haɓaka shirin sadarwa na gaggawa gami da dandalin tattaunawa don amsawa ga ma'aikata, samar da ma'aikata tare da ilimin zamani da horo game da abubuwan haɗarin COVID-19 da sauran halaye masu kariya, horar da ma'aikata kan amfani da tufafi da kayan kariya, samar da albarkatun muhalli da inganta yanayin aiki, da kuma ba da izinin shiga, sanya takunkumin rufe fuska ko takunkumin rufe fuska, da wasu matakan kariya na yau da kullun da ma'aikata ke buƙata a wuraren aiki, da sanya takunkumin rufe fuska ko takunkumin rufe fuska.
Ma'aikata a cikin wannan rukunin haɗarin ba sa bukatar yin amfani da na'urar numfashi.
Idan mutum ya yi rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da keɓe mutumin da ke da rashin lafiya daga wasu mutane a nesa da ƙafa 6, sanya ma'aikaci don kula da mai haƙuri, da kuma ba da abin rufe fuska ga mai haƙuri ko kuma ya nemi mai haƙuri ya rufe baki da hanci da takarda lokacin da yake tari ko sneezing.
Ma'aikatan jirgin za su yi amfani da safofin hannu na likita na lokaci-lokaci lokacin kula da matafiya masu rashin lafiya ko taɓa ruwan jiki ko yanayin da ke da lahani, kuma wataƙila ƙarin kayan kariya idan matafiyin mai rashin lafiya yana da zazzabi, ciwon ciwo ko wahalar numfashi.
Don jigilar kasuwanci gami da jiragen ruwa da sauran jiragen ruwa masu jigilar kaya, kula da haɗari ya haɗa da jinkirta tafiya lokacin da mutum ya yi rashin lafiya, keɓe kansa da sanar da cibiyar kiwon lafiya a cikin jirgin nan da nan idan mutum ya sami zazzabi ko wasu alamun bayyanar yayin da yake cikin jirgin.
Zai fi kyau a bi da mutane a cikin gidajen da aka keɓe. Ga makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsabtace ko kuma kashe ƙwayoyin cuta idan mutumin da ke da cutar ya kasance a cikin ginin makaranta ba tare da la'akari da yaduwar al'umma ba.
Lokacin da akwai ƙarancin yaduwar al'umma, ana iya aiwatar da dabarun nisantar zamantakewar jama'a kamar soke ziyarar filin, tarurruka da sauran manyan tarurruka kamar ilimin motsa jiki da azuzuwan mawaƙa ko cin abinci a cafeteria, ƙara sarari tsakanin tebur, lokaci mai zuwa da dawowa, iyakance baƙi marasa mahimmanci, da amfani da wuraren ofisoshin kiwon lafiya daban don yara masu alamun kamar mura.
Idan akwai yawan kamuwa da cuta a cikin al'umma, ban da dabarun nisantar zamantakewa, ana iya yin la'akari da tsawaita dakatar da makaranta.
Jami'an tilasta bin doka waɗanda dole ne su yi hulɗa da mutanen da aka tabbatar ko ake zargi da COVID-19 an ba da shawarar su bi ka'idodin da masu fasahar likitan gaggawa suka bi ciki har da kayan kariya na kai tsaye.
Idan hulɗa ta kusa ta faru yayin kamawa, ma'aikata za su tsabtace da kuma cire belinsu da kayan aikin aikinsu kafin sake amfani da su tare da spray ko mai tsabtace gida, kuma su bi ƙa'idodin aiki na yau da kullun don hanawa da zubar da PPE da aka yi amfani da su da kuma shirya da wanke tufafi.
OSHA ta ɗauki ma'aikatan kiwon lafiya da na gawawwaki a matsayin masu babban ko kuma matsanancin hadarin kamuwa da cutar.
Ayyukan haɗari masu haɗari sun haɗa da isar da kiwon lafiya, tallafi, dakunan gwaje-gwaje da ma'aikatan sufuri na likita waɗanda ke da haɗari ga waɗanda aka sani ko ake zargi da cutar COVID-19.
Yana da haɗarin haɗari sosai idan ma'aikata suka yi aikin samar da aerosol a kan, ko tattara ko sarrafa samfuran daga sanannun ko waɗanda ake zargi da cutar COVID-19.
Hanyoyin samar da aerosol sun hada da intubation, hanyoyin shigar da tari, bronchoscopy, wasu hanyoyin da binciken hakori, ko kuma tarin kwayoyin cuta.
Ayyukan gidan gawa na haɗarin haɗari sun haɗa da ma'aikatan da ke cikin shirya gawawwakin mutanen da aka sani ko ake zargin suna da cutar COVID-19 a lokacin mutuwarsu; yana zama haɗarin haɗari sosai idan sun yi autopsy. Ƙarin sarrafa injiniya ga wannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don sanannun ko ake zargin marasa lafiyar COVID-19, gami da lokacin da aka yi aikin samar da aerosol.
Ana iya yin amfani da iska mai matsi mai guba a wasu wuraren kula da lafiya da kuma gidajen gawa.
Dole ne a sarrafa samfurin tare da matakin tsaro na 3 na Biosafety.
Ƙungiyar Lafiya ta Duniya (WHO) ta ba da shawarar marasa lafiya da za a shigar da su a cikin keɓewa zuwa wuraren jira daban-daban dangane da ko suna da cutar COVID-19 da ake zargi. Baya ga PPE, OSHA ta ba da shawarar masu numfashi ga waɗanda ke aiki a cikin nisan ƙafa 6 daga marasa lafiya da aka sani, ko ake zargi, suna da cutar SARS-CoV-2, da waɗanda ke yin hanyoyin samar da aerosol.
A Amurka, dole ne a yi amfani da masu numfashi na fuska na N95 masu tace NIOSH ko mafi kyau a cikin mahallin cikakken shirin kariya na numfashi wanda ya haɗa da gwajin dacewa, horo da kuma binciken likita.
Wasu nau'ikan na'urorin numfashi na iya ba da kariya mafi girma da kuma inganta jin daɗin ma'aikata. WHO ba ta ba da shawarar sanya abin rufe fuska ba saboda COVID-19 cuta ce ta numfashi da ba a yada ta ta ruwa.
Hukumar Lafiya ta Duniya ta ba da shawarar sanya abin rufe fuska na tiyata kawai ga ma'aikatan da ke sa ido a wuraren da ake shiga.
Ga waɗanda ke tattara samfuran numfashi daga, kula da, ko jigilar marasa lafiya na COVID-19 ba tare da aiwatar da aikin samar da aerosol ba, WHO ta ba da shawarar abin rufe fuska, kariya ta ido, ko kariya ta fuska, rigar kariya da safofin hannu.
Idan an yi aikin samar da aerosol, ana maye gurbin abin rufe fuska da N95 ko FFP2.
Ganin cewa samar da PPE a duniya bai isa ba, WHO ta ba da shawarar rage buƙatun PPE ta hanyar telemedicine, shinge na zahiri kamar su windows masu haske, ta hanyar ba da izinin waɗanda ke cikin kulawa ta kai tsaye don shiga cikin ɗakin marasa lafiya na COVID-19, amfani da PPE kawai da ake buƙata don takamaiman aiki, ci gaba da amfani da na'urar numfashi iri ɗaya ba tare da cire shi ba yayin kula da marasa lafiya da yawa tare da ganewar asali iri ɗaya, saka idanu da daidaita sarkar samar da PPE, da kuma hana inganta amfani da abin rufe fuska ga mutane marasa alamun.
KYAUTA: Katherine Maher, Shugaba na Gidauniyar Wikimedia
KADA: Dukan ma'aikatan Wikimedia Foundation
ABIN DA KE BAYANA: [COVID-19] Saukaka nauyi da kuma shirya don nan gaba
Kwanan wata/Lokaci: 14 ga watan Maris, 2020, 00:24 UTC
Ba a kiyaye duk haƙƙoƙi ba
Mun tsinci kanmu cikin yanayi mai ban mamaki a wannan watan.
Cutar COVID-19 wani abu ne da ya nuna yadda muke da alaƙa a duniya da kuma hakkin da muke da shi ga juna.
Ba mu taɓa fuskantar irin wannan kalubalen ba, amma mun san cewa amsar da za mu iya bayarwa ta dogara ne da irin juyayi da haɗin kai da kuma gina al'umma da ke cikin wannan kungiya.
Abokantaka da damuwa da muka gani a tsakanin dukkan abokan aikinmu ta hanyar imel, waya da hira tabbaci ne na ban mamaki na mutane masu ban mamaki waɗanda muke da sa'a sosai don yin aiki tare.
Ina matuƙar godiya da kuma alfahari da kasancewa abokin aikinku.
A makon da ya gabata, wasu mutane sun nuna mini godiyarsu ga aikin da muke yi.
Wannan ya tunatar da ni yadda duniya take da muhimmanci a yanzu da za a iya danganta ta da Wikipedia, da kuma yadda take da alama ta iko domin wannan muhimmin tushe ya kasance a kan layi kuma yana samuwa ga kowa.
Aikinku ne ya sa duk wannan ya yiwu, ko kun kiyaye shafin yana aiki ko abokan aikinku suna biya ko kuma al'ummarmu tana lafiya.
Duniya na bukatar bayanin da Wikipedia ke bayarwa, fiye da kowane lokaci.
Wannan lokaci ne da ba wai kawai abin da muke yi ba amma yadda muke yi, zai yi tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan aiki da kuma matsayin da kuke da shi, za mu yi wasu muhimman gyare-gyare ga yadda muke aiki tare, daga mako mai zuwa.
Yin aiki da kuma tsara jadawalinmu
Kamar yadda Robyn ta ambata, ƙungiyar C ta taru a daren jiya don tattauna tsarinmu da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A cikin wannan tattaunawar, mun yi tunanin abin da muke tunani zai zama amsar da ta dace da abin da muke fuskanta da kuma yadda za mu tabbatar da cewa wannan kungiya ta tsira a wannan lokacin.
Tare, muna son kawar da damuwa da kuma tallafa wa aikinmu na dogon lokaci.
Idan kana bukatar ka rage gudu kadan, shi ke nan.
Ga dukkan ma'aikata, masu kwangila da ma'aikatan kwangila:
Za mu yi aiki na awa hudu a rana ko kuma awa 20 a mako har sai an gaya mana.
Ba mu sanar da hutu - idan za ka iya aiki a kan al'ada hours, da manufa iya amfani da ku.
Duk da haka, duniya ta zama abin mamaki, ko kuna kula da ƙaunatattunku, ko kuna sayen kayan abinci, ko kuna ganin likita, lafiyarku ita ce fifiko.
Ba za mu yi rikodin lokacinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Bai kamata a gaya masa ba, amma mun gaya masa.
Babu bukatar ranar rashin lafiya ko PTO - kawai ka sanar da manajanka kuma ka taimaki tawagarka ta sake duba kalandarka da kuma jadawalinka don tabbatar da cewa an rufe manyan wuraren aikinka.
(Idan ka kamu da cutar COVID-19, ka sanar da Bryan a T&C Ops domin T&C ta taimaka da tallafi da kuma tabbatar da cewa an kula da yanayinka daga hukumar.)
Waɗanda aka biya su bisa ga sa'a za a biya su cikakke.
Mun sanar da kuma tabbatar da cewa mun amince da alkawarin da aka yi wa 'yan kwangilarmu da kuma ma'aikatanmu na biyan sa'o'i.
Za a biya kowa bisa ga aikinsa na yau da kullum a yanayi na yau da kullum.
Wannan ya haɗa da idan ka yi rashin lafiya kuma ba za ka iya yin aiki ba.
Idan kana son yin aiki, muna goyon bayan ka.
Mutane da yawa suna amfani da aikinsu a matsayin hanyar da za su iya kawar da damuwarsu da duniya.
Abin da muke yi zai iya zama mai gamsarwa, musamman a irin wannan lokaci.
Har yanzu, wannan game da kula da kanka.
Muna so ne kawai ku yi magana da manajanku domin mu san abin da za mu yi tsammani kuma mu daidaita shi yadda ya kamata.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da ya kamata mu ci gaba da.
Ƙungiyar SRE, HR Ops, Trust & Security, da kuma Fundraising (a tsakanin su) suna yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin taimako.
Za mu fara aiki tare da dukkan sassan don tantance manufofinmu na yanzu kuma mu mai da hankali kan tallafawa abin da ke da mahimmanci ga aikinmu.
Akwai abubuwa da yawa da za a yi wa kowa, za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Dakatar da shi yanzu ba zai cutar da shi ba.
Ba mu da shirin yin "biyu don samun abin da ya rage" da zarar annobar ta wuce.
Ba za a sa ran cewa za ka yi aiki na sa'o'i da yawa ba don ka cika wani lokaci da ba zai yiwu ba.
Mun yarda cewa yanayi ya sauya, kuma za mu yi kokarin kafa sabon manufa da kuma lokaci idan ya cancanta.
Me ya faru da APP?
Don daidaitawa da ainihin gaskiyar da ake tsammani na lokutan aikinmu na yau da kullun, muna son daidaita lokacin gabatar da Shirin Mu na Shekarar 2020-2021.
Muna son ba da shawarar tsawaita shirin 2019-2020 wanda ke ba da ƙarin lokaci don kasafin kuɗi don ba da damar ma'aikata su ba da fifiko ga aiki mai mahimmanci, kula da kansu da kula da ƙaunatattun su yayin taimaka wa waɗanda ke buƙatar ko son yin aiki tare da rage lokacin aiki na makonni masu zuwa.
Ƙara lokaci yana rage yawan aiki da kuma matsin lamba na shirin da ake yi a dukan ƙungiyar.
Za mu gabatar da shawarwarinmu ga kwamitin a mako mai zuwa kuma za mu sanar da wakilai da ƙungiyoyi game da matakanmu na gaba da zarar mun sami amincewa.
Godiya ga tawagar APP kan jagorancinku a kan wannan.
Matsayi na ofishi, fallasa da kuma tsabtace
A makon da ya gabata, an sanar da mu cewa wani abokin aikinmu na SF na iya kamuwa da cutar COVID-19.
Amma, a matsayinmu na masu tsaro, mun yi hayar wani rukunin masu tsabtace ƙwayoyin cuta don su kawar da cutar daga dukan ofisoshinmu a San Francisco.
Suna amfani da maganin rigakafin cutar asibiti don kashe kowace farfajiya da kuma tsarin ɗaki da ke kaiwa ga bene.
Ginin ya amince da takamaiman ka'idojin kula da aikinsa na amfani da kayayyakin da ke tallafawa lafiyar mazauna gidan.
Mun ji dadi cewa ofishin zai kasance da kyau samuwa a lokacin da muka yanke shawarar komawa.
Ofishinmu na DC yana kan WeWork, wanda ke raba ka'idojin COVID-19 tare da mu da kuma dukkan ma'aikatanmu da ke DC.
A makon da ya gabata, ofishinmu na D.C. ya koma ga tsarin da ke nesa daidai da jagororin da aka ba San Francisco.
Kamar yadda wasu abokanmu da ke birnin New York suka sani, mun tattauna batun samun wurin zama a Brooklyn.
Wannan tattaunawar tana ci gaba amma za a iya dakatar da ita.
Wasu abokan aikinmu sun fara aiki daga nesa.
Abokan aiki na dogon lokaci mun san cewa zai iya zama mai daidaitawa kuma yana so ya ba ku wasu shawarwari:
Ka ƙayyade lokacin taron don ƙarin sa'a ɗaya ko biyu.
Idan ana bukatar ƙarin lokaci, ka yi tunanin raba shi zuwa kwana biyu.
Ka tsara tarurruka da kyau, ka tsara jadawalin, kuma ka aika da littattafai a gaba.
Ka ƙirƙiri bidiyo ta tsohuwa, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗin kai.
Samun shugaban don gudanar da kowane taro, wani don saka idanu kan tambayoyi da kuma bin diddigin jerin masu magana, kuma wani yana taimakawa wajen yin rubutu (ko yin rubutu tare).
Ka aika imel zuwa ga masu goyon bayan fasaha idan kana bukatar na'urar sauraron sauti mai kyau.
Yi amfani da kuɗin kulawarku don abincin dare.
Shiga tashar #remoties a Slack don tattaunawa da abokan aikinka game da aikin da aka ba ku
Ƙungiyar HR Operations tana kallon jagorar webinar ergonomics don tallafawa haɓaka a cikin aikin da aka rarraba a duk faɗin Gidauniyar.
A cikin 'yan makonnin da suka gabata, mun nemi duk masu karɓar tallafin al'umma su soke ayyukan jama'a da Wikimedia ke tallafawa, kamar su editaton har sai WHO ta sanar da ƙarshen cutar.
Mun gaya musu cewa mun fahimci cewa buƙatarmu ta sokewa da sauran takunkumi na iya zama wani abu da ba zai yiwu ba a kammala ayyukan tallafin da suka amince da shi kuma ba za a ɗauki mataki ba saboda jinkiri ko canza wannan burin.
A mako mai zuwa za mu ci gaba da ƙarin jagorori game da Wikimania da sauran taron yanki da kuma batutuwa.
Halin da ake samu daga dukan al'ummar duniya ya nuna cewa sun yi baƙin ciki da rashin jin daɗi amma sun sami kwanciyar hankali da kuma iyawar su na mai da hankali ga al'ummarsu, Wikimedia da kuma sauran su.
A gaba, CRT tana ƙoƙari ta haɓaka shafi game da Meta-Wiki don samar da sarari ga al'umma don saka idanu kan tasiri da kuma bin hanyoyin sadarwa tare da su.
Ku kasance a cikin hulɗa kan batutuwan da suka shafi COVID-19
Za mu aika muku da gayyatar zuwa kalandarku don ranar Alhamis mai zuwa, a karfe 2:00 UTC zuwa 7:00 PT don taron musamman na ma'aikata.
Za mu yi amfani da wannan lokaci don raba ƙarin sabuntawa, amsa tambayoyinku kuma ku ɗan ɗan ɗauki lokaci don tuntuɓar juna.
Muna cikin wannan tare kuma muna nan don taimakawa duk yadda za mu iya.
A yanzu, za ka iya ci gaba da samun bayanai daga wannan imel ɗin, da kuma duk wasu muhimman bayanai game da COVID-19 a kan Office Wiki.
CRT za ta tabbata cewa duk waɗannan shafuka suna da sabuntawa kuma duk bayanan suna cikin wuri ɗaya.
Muna kuma kokarin tabbatar da sadarwa ta yau da kullum da ma'aikatanmu da ke cikin kasashe da suka fi fama da matsalar a wannan lokaci.
Idan kana da wasu tambayoyi game da tafiye-tafiye, abubuwan da suka faru, wani babban aiki, ko kalubalen da kake fuskanta, ko kuma duk wani taimako da kake bukata, kada ka yi jinkirin sanar da CRT.
Muna nan don taimaka muku wajen samar da tallafi da kuma zama hanyar sadarwa idan an buƙata.
Idan kuna da wani abu mai muhimmanci ko kuma mai muhimmanci, ku aika da imel zuwa ga Bryan Judan, Daraktan Ayyuka na HR na Duniya.
Kada a ɗauki waɗannan canje-canjen a matsayin ƙin yin aikinmu da kuma hakkinmu.
Duk da haka, wannan duk yarda ne cewa a wannan lokacin, aikinmu da alhakinmu na iya buƙatar daidaitawa ta hanyar da ba ta taɓa faruwa ba.
Waɗannan su ne matakan da muka yi imanin wajibi ne mu tallafa wa juna domin mu ci gaba da aiki, samar da motsinmu da tallafin da suke bukata, da kuma hidimar duniya da za su iya tsammani.
Aikin da muka tsara zai kasance a wurin yana jiranmu idan lokaci ya yi.
A yanzu, lokaci ne da za mu tallafa wa juna da kuma samar da sarari ga muhimman ayyuka da za su zo cikin makonni da watakila watanni masu zuwa.
Muna bukatar ku duka ku sa hakan ya zama gaskiya, kuma muna bukatar ku duka ku kula da kanku da kuma iyalanku domin ku kasance a shirye a mafi kyawun hanya idan bukatar ta zo.
Yanzu, don Allah -- wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M da Tony S) da sauran waɗanda ke cikin Leadership Team (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M da Toby N).
Angiotensin-converting enzyme 2 (ACE2) shine enzyme wanda ke haɗuwa da waje (mambran sel) na sel a cikin huhu, jijiyoyi, zuciya, koda da hanji.
ACE2 yana fuskantar aikin enzyme mai canza angiotensin (ACE) wanda ke da alaƙa da rage adadin angiotensin-II da haɓaka Ang ((1-7)) yana mai da shi magani mai yiwuwa wanda za'a yi niyya don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin cibiyar shigar da kwayar halitta ga wasu coronaviruses.
An kira kwayar halitta na ɗan adam hACE2.
Angiotensin 2 mai canza enzyme shine zinc wanda ke dauke da metaloenzyme wanda ke kan endothelium da sauran kwayoyin halitta.
Kwayar ACE2 tana dauke da wani yanki na M2 N-terminal peptidase da kuma wani yanki na C-terminal renal amino acid transporter colectin.
ACE2 shine mai amfani da hanyar 1 na membrane mai amfani da hanya guda, tare da yankin aikin enzyme wanda aka fallasa akan kwayoyin halitta a cikin huhu da sauran kayan.
Yankin waje na ACE2 yana manne da yankin transmembrane ta wani enzyme da ake kira sheddase, kuma an saki samfurin furotin mai narkewa zuwa cikin jini kuma a ƙarshe an sanya shi cikin fitsari.
ACE2 yana cikin yawancin gabobin jiki: ACE2 yana haɗe da membrane na yawancin kwayoyin alveolus na nau'in II na huhu, entrositic na ƙananan hanji, arteries da ƙwayoyin endothelium na veins da ƙwayoyin tsoka na arteries a yawancin gabobin jiki.
Hakanan ana samun bayyanar mRNA ACE2 a cikin cerebral cortex, striatum, hypothalamus da kuma kwakwalwar kwakwalwa.
Babban aikin ACE2 shine yayi aiki azaman mai daidaitawa ga ACE.
ACE tana ɗaure da hormone I na angiotensin zuwa cikin narkewar angiotensin II.
ACE2 a madadin haka yana manne da carboxyl-terminal amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) da kuma hydrolysis zuwa cikin angiotensin vasodilator (1-7), (H-Asp-Arg-Tyr-Ile-His-Pro-OH).
ACE2 na iya kuma manne wa wasu peptides da suka hada da [des-Arg9]-bradikinin, apelin, neurotensin, dinorphine A da ghrelin.
ACE2 kuma yana daidaita rarraba membrane mai ɗaukar amino acid mai tsaka tsaki SLC6A19 kuma an nuna shi a cikin cutar Hartnup.
A matsayin furotin mai wucewa, ACE2 yana aiki a matsayin babban cibiyar shigarwa cikin ƙwayoyin cuta don wasu ƙwayoyin cuta ciki har da HCoV-NL63; SARS-CoV (virus wanda ke haifar da SARS); da SARS-CoV-2 (virus wanda ke haifar da COVID-19).
Musamman, ɗaure ga sunadarai na S1 na SARS-CoV da SARS-CoV2 a kan yankin enzyme na ACE2 a saman ƙwayoyin halitta yana haifar da endosytosis da kuma sauya kwayar cutar da enzyme zuwa cikin endosomes da ke tsakanin ƙwayoyin.
Tsarin shigarwa kuma yana buƙatar ƙirar furotin S ta hanyar gyaran sararin samaniya na TMPRSS2, mai haɓaka wanda ke ƙarƙashin binciken yanzu a matsayin mai yuwuwar magani. Wannan ya haifar da wasu yin hasashen cewa rage matakan ACE2 a cikin sel na iya taimakawa wajen yaƙar kamuwa da cuta.
Koyaya, ƙungiyoyi da ƙungiyoyi masu ƙwarewa da hukumomi masu tsarawa suna ba da shawarar ci gaba da daidaitaccen ACE da maganin ARB.
Binciken tsarin da meta-analysis da aka buga a ranar 11 ga Yuli 2012 sun gano cewa "amfani da magungunan ACE yana da alaƙa da raguwar 34% mai mahimmanci a cikin haɗarin cutar huhu idan aka kwatanta da na sarrafawa".
Bugu da ƙari, "haɗarin ciwon huhu ya ragu ga marasa lafiya da ake bi da su da maganin ACE waɗanda ke da haɗarin kamuwa da ciwon huhu, musamman waɗanda ke da bugun jini da kuma gazawar zuciya.
Amfani da ACE inhibitors an kuma danganta shi da raguwar mutuwar da ke da nasaba da ciwon huhu, ko da yake sakamakon ba shi da daidaito game da haɗarin cutar huhu gaba ɗaya".
Sake hada ACE2 (rhACE2) na mutum ana ganin shi a matsayin sabon magani don raunin huhu na yau da kullun, kuma ya bayyana yana inganta haemodynamics na huhu da kuma satar oxygen a cikin aladu tare da cutar rashin lafiyar hankula na lipopolysaccharide.
Rabin rayuwar rhACE2 a cikin mutum sa'o'i 10 ne kuma farkon aikin sa'o'i 30 ne ban da aikin tasiri (lokaci) na sa'o'i 24.
Wasu binciken sun ba da shawarar cewa rhACE2 na iya zama magani mai yiwuwa ga waɗanda ke da rashin haƙuri ga masu hana tsarin angiotensin renin na gargajiya (RAS inhibitors) ko kuma a cikin cututtukan da ke kewaye da ingantaccen angiotensin II. RhACE2 an yi nazari a cikin gwaji na asibiti don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Aikace-aikacen b'COVID-19 aikace-aikacen software ne na hannu wanda aka tsara don taimakawa wajen bin diddigin alaƙa a cikin martani ga cutar coronavirus ta 2019-20, wanda shine tsarin gano mutanen da (suna da "sadarwa") waɗanda zasu iya kasancewa tare da mutumin da ke da cutar.
An samar da aikace-aikace da yawa ko kuma an ba da shawarar tare da goyon bayan jami'an gwamnati a wasu larduna da kuma yankuna.
An riga an tsara wasu tsarin da za su gina aikace-aikacen bin diddigin sadarwa.
An haifar da damuwa game da sirri, musamman game da tsarin da ya dogara da bin diddigin yanayin yanayin aikace-aikacen mai amfani.
Zaɓuɓɓuka masu saurin katsewa sun haɗa da amfani da siginar Bluetooth don yin rikodin rajistar kusanci na mai amfani a kan wasu wayoyin salula.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa ayyukan don tallafawa aikace-aikacen da ke kan Bluetooth kai tsaye cikin tsarin aikin su na Android da iOS.
A China, gwamnatin kasar Sin, tare da hadin gwiwa da kamfanin Alipay, ta kaddamar da wani manhajar da ke bai wa 'yan kasar damar duba ko sun taba yin hulda da wanda ke dauke da cutar COVID-19.
Ana amfani da shi a birane sama da 200 a kasar Sin, kuma a Singapore, ana amfani da wata manhaja mai suna TraceTogether.
Aikace-aikacen da al'ummar IT na yankin suka haɓaka, an ƙaddamar da shi a matsayin mai buɗewa kuma za a ba da shi ga gwamnati. Arewacin Macedonia ta ƙaddamar da "StopKorona!", aikace-aikacen da ke kan Bluetooth don bin diddigin fallasa tare da mutanen da ke da cutar da kuma ba da amsa mai sauri ga hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka kirkiro manhajar.
Ya zuwa ranar 14 ga Afrilu, 2020, aikace-aikacen yana jiran amincewa ta Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta bayyana cewa aikace-aikacen bin diddigin alaƙa yana cikin matakin ci gaba, kuma zai kasance don ƙaddamarwa a cikin 'yan makonni. Ana shirin irin wannan aikace-aikacen a Ireland da Faransa ("StopCovid").
Australia da New Zealand suna la'akari da aikace-aikace bisa ga aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha na da niyyar gabatar da aikace-aikacen geoborder ga marasa lafiya da aka gano suna da COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba sa barin gida.
Ross Anderson, farfesa a fannin aikin tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli na aiki da tsarin da ke bisa aikace-aikace, ciki har da kuskuren kuskure da kuma rashin tasiri idan an iyakance aikace-aikacen zuwa ƙananan ƙananan mutane.
Da yake magance damuwar da ake yi game da yaduwar aikace-aikacen "coronavirus" masu ɓatarwa ko haɗari, Apple ya sanya iyaka ga nau'in ƙungiyar da za ta iya ƙara aikace-aikacen da suka shafi coronavirus a cikin Shagon Ayyukanta, yana iyakance su ga "masu iko" kawai ko kuma sanannun ƙungiyoyi.
Google da Amazon sun kafa irin wannan takunkumi.
Masu fafutukar tsare sirri sun nuna damuwarsu game da tasirin sa ido kan jama'a ta amfani da aikace-aikacen coronavirus, musamman game da ko za a dakatar da tsarin sa ido da aka kirkira don magance cutar ta coronavirus da zarar barazanar ta wuce.
Kungiyar Amnesty International da kuma kungiyoyi sama da 100 sun fitar da sanarwa suna neman a kawo karshen irin wannan sa ido.
Kungiyar ta bayyana sharudda takwas ga ayyukan gwamnati:
dole ne a yi 'da'awar cewa, idan an yi haka, to, za a yi ta ne bisa doka, idan ya cancanta kuma idan ya dace;
ci gaba da sa ido da kuma kula da dole ne a saka wani sashe;
amfani da bayanai ya zama na COVID-19 ne kawai;
Tsaron bayanai da kuma suna dole ne a kiyaye su kuma a nuna su a matsayin amintattu bisa ga hujja;
Za a yi amfani da tsarin tsaro na zamani don hana ƙarin nuna bambanci da kuma gurɓatawa.
duk wani musayar bayanai da aka yi da wasu mutane na uku dole ne a ayyana shi a cikin doka;
za a kiyaye su daga cin zarafi da kuma hakkin 'yan ƙasa su mayar da martani ga cin zarafi;
Dole ne a bukaci ma'ana ta hanyar "duk masu ruwa da tsaki" ciki har da masana kiwon lafiyar jama'a da kungiyoyin da ba su da 'yanci.
Shawarwarin shirin Google/Apple yana nufin magance matsalar sa ido ta hanyar cire tsarin bin diddigin daga tsarin aiki na na'urorin su da zarar ba a bukatar su.
Wasu ƙasashe suna amfani da hanyar sadarwar wuri maimakon aikace-aikace, suna kawar da buƙata don saukar da aikace-aikace da ikon guje wa bin sawu.
A Isra'ila, an amince da bin hanyar sadarwa.
Maganin da ke kan hanyar sadarwa wanda ke da damar zuwa bayanan wuri mai mahimmanci yana da babbar matsala ta sirri.
Koyaya, ba duk tsarin da ke da sabar cibiyar sadarwa bane ke buƙatar samun damar bayanan wurin mutum; an ƙirƙiri wasu tsarin kiyaye sirri waɗanda ke amfani da sabar cibiyar sadarwa kawai don sadarwa tare (duba sashe a ƙasa).
A Koriya ta Kudu, ana amfani da tsarin da ke bisa aikace-aikace don bin diddigin sadarwa.
Maimakon amfani da takamaiman aikace-aikace, tsarin yana tattara bayanan sa ido daga tushe daban-daban ciki har da bayanan sa ido na na'urar hannu da bayanan ma'amala na katin, kuma haɗa waɗannan duka yana samar da sanarwar saƙon rubutu ga mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da abokan hulɗa, gwamnati ta kuma sanya bayanin wurin a bayyane, abin da aka ba da izini saboda manyan canje-canje a cikin dokokin tsare sirri na bayanai bayan barkewar cutar MERS a ƙasar.
Ana samun wannan bayanin ga jama'a ta hanyar aikace-aikace da shafukan yanar gizo. Kasashe ciki har da Jamus suna la'akari da amfani da tsarin cibiyar sadarwa da kuma kiyaye tsare sirri.
Har zuwa 6 ga Afrilu 2020, ba a buga cikakken bayani ba.
Binciken alaƙar kiyaye sirri shine ra'ayi wanda aka shirya tare da mahimman littattafan nazarin jikin da aka fara tun 2013. Ya zuwa ranar 7 ga Afrilu 2020, sama da gungun masana dozin suna aiki don mafita mai aminci kamar amfani da Bluetooth Low Energy (BLE) don yin rajistar kusanci na mai amfani akan wasu wayoyin hannu.
Duk da haka, PEPP-PT wani shiri ne na daidaitawa wanda ya ƙunshi tsarin da aka mayar da hankali, maimakon yarjejeniya guda. Yarjejeniyar da aka mayar da hankali ta hada da Tsaro na Tsaro na Tsaro (DP-PPT/DP-3T), Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar
A cikin wannan yarjejeniya, bayanan da aka gano da kansu ba sa barin na'urar, kuma duk wani toshewa yana faruwa ne a na'urar.
Kungiyar Sirri ta MIT Media Lab tana haɓaka SafePaths, dandamali don amfani da fasahohin kiyaye sirri yayin tattarawa da amfani da wuri ko bayanan sassan hanyar don bin diddigin yaduwar COVID-19.
Wannan ya dogara ne akan bincike daga takarda fari "Ayyukan da suka tafi Rogue: Kula da Sirrin Mutum a cikin annoba" wanda aka buga a watan Maris na 2020.
SafeTrace yana amfani da fasahar kayan aiki mai aminci don ba da damar masu amfani su raba wurin da ke da mahimmanci da bayanan kiwon lafiya tare da sauran masu amfani da hukumomi, ba tare da lalata sirrin bayanai ba.
A ranar 5 ga Afrilu, 2020, an kafa TCN Coalition na duniya ta ƙungiyoyi da yawa waɗanda suka haɗu kan mahimman hanyoyin haɗin kai da manyan ladabi masu haɗuwa, tare da burin rage rarrabuwa, da kuma ba da damar haɗin gwiwar duniya game da sa ido da aikace-aikacen faɗakarwa, muhimmin al'amari don cimma fa'ida mai yawa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta bude tushen yarjejeniyar BlueTrace da aikace-aikacen gwamnati ke amfani da ita.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na wayar hannu na Android da iOS, sun sanar da wani shiri na bin diddigin alaƙar da suka ce za su kiyaye sirrin, bisa ga haɗin fasahar Bluetooth Low Power da kuma ɓoye sirrin sirri.
Sun kuma wallafa takamaiman fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, tsarin yana son a kaddamar da shi a matakai uku:
ƙaddamar da kayan aiki don bawa gwamnatoci damar ƙirƙirar aikace-aikacen bin diddigin cutar coronavirus don kiyaye sirrin
Haɗa wannan aikin kai tsaye cikin iOS da Android shirin Google da Apple don magance matsalolin aiwatarwa da ci gaba da sa ido ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki, sannan kuma cire shi ta hanyar da ta dace da zarar barazanar ta wuce.
Sake sanya magani (wanda kuma ake kira sake amfani da magani, sake fasalin, sake amfani da shi ko kuma sauya magungunan) shine canza manufar magani da aka amince dashi don magance wata cuta ko yanayin kiwon lafiya daban daga dalilin da yasa aka kirkireshi da farko.
Wannan wani bincike ne na kimiyya da ake gudanarwa don samar da ingantaccen magani na COVID-19.
Sauran hanyoyin bincike sun hada da samar da allurar rigakafin COVID-19 da kuma dawo da kwayar cutar. SARS-CoV-2 yana da kimanin sunadarai 66 masu magani, kowannensu yana da wuraren ɗaure ligand da yawa.
Binciken wuraren da ake ɗaurewa ya samar da ingantaccen aikin samar da maganin rigakafi mai tasiri ga furotin COVID-19.
Daga cikin yawancin sunadarai da SARS-CoV-2 ke niyya mafi mahimmanci sune proteases kamar papain, RNA-dangane da polymerase, helikase, S protein da ADP ribophosphatease.
Hussein A A, et al sun yi nazarin wasu magungunan da aka tsara kuma aka bincika don kamanceceniya da magungunan da aka amince da su don hanzarta haɓaka magungunan anti-SARS-CoV-2 masu ƙarfi a cikin binciken da ke gaban asibiti don ba da shawarar a cikin ƙirar gwajin asibiti.
Chloroquine magani ne na antimalarial wanda kuma ake amfani da shi wajen yaki da wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine masu alaƙa za su kasance cikin magunguna huɗu da ake nazari a matsayin ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin jihar New York akan chloroquine da hydroxychloroquine zai fara ne a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin Amincewa da Amfani da Gaggawa (EUA).
Ba a amince da magani ta hanyar gwajin gwaji na FDA ba kuma an ba da izini a ƙarƙashin EUA kawai a matsayin magani na gwaji don amfani na gaggawa a cikin marasa lafiya da aka shigar da su asibiti amma ba za su iya karɓar magani a cikin gwajin asibiti ba.
CDC ta ce "amfani, sashi, ko tsawon lokacin hydroxychloroquine don rigakafi ko maganin kamuwa da cutar SARS-CoV-2" ba a kafa shi ba tukuna.
Likitoci sun ce suna amfani da maganin ne "lokacin da ba su da wani zaɓi".
Wata ƙungiyar masu bincike na Turkiyya a Istanbul suna gudanar da karamin bincike kan amfani da chloroquine tare da hada zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da kuma Jami'ar Oxford.
Makarantar Lafiya ta NYU Langone tana gudanar da gwaji kan aminci da kuma ingancin amfani da maganin hana cutar hydroxychloroquine.
Gwajin asibiti na kasar Sin a Wuhan da Shenzhen sun ce favipiravir "ya yi tasiri sosai".
35 daga cikin marasa lafiya a Shenzhen sun yi gwajin rashin lafiya a matsakaici na kwanaki 4, yayin da tsawon lokacin rashin lafiya ya kasance kwanaki 11 ga marasa lafiya 45 da ba su karɓa ba.
A wani bincike da aka gudanar a Wuhan kan marasa lafiya 240 da ke fama da ciwon huhu, rabin su sun sha favipiravir, sauran rabin kuma sun sha umifenovir.
Hukumar Magunguna ta Italiya ta tunatar da jama'a cewa hujjojin da ake da su a yanzu na goyon bayan maganin ba su da yawa kuma ba su da wuri.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan don ajiyarta kuma ta yi amfani da sojoji don isar da magunguna zuwa asibitin jami'a, wanda zai yi amfani da su wajen kula da marasa lafiya na COVID-19.
A cewar South China Morning Post, Shinzo Abe ya sauya sheka game da gwamnatin Trump kan sayen magungunan da za su iya zama marasa tasiri a mawuyacin hali idan cutar ta ninka.
Ba zai zama lafiya ba ga mata masu juna biyu ko waɗanda ke ƙoƙarin yin ciki.
Wani binciken lopinavir/ritonavir (Kaletra), wani maganin rigakafi na lopinavir da ritonavir, ya ce "babu wani amfani da za a lura da shi".
An tsara maganin ne don ya kawar da cutar HIV maimakon ya yi koyi da shi ta wajen ɗaure shi da sinadarin protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙari su canza magungunan don gano mahaɗan da za su ɗaure da protease na SARS-CoV-2. Akwai suka a cikin ƙungiyar kimiyya game da karkatar da albarkatu don canza manufar magungunan da aka haɓaka musamman don HIV/AIDS.
WHO ta saka lopinavir/ritonavir a cikin gwajin Solidarity na duniya.
Gilead Sciences ta kirkiro Remdesivir kuma ta bunkasa shi a matsayin magani ga cutar Ebola da kuma kamuwa da cutar Marburg.
Wata matsala da ke tattare da maganin rigakafi ita ce gano ƙwayoyin cuta ta hanyar maye gurbi da zai iya haifar da ƙarin cuta da kuma kamuwa da cuta.
Wasu binciken farko na gwaji sun ba da shawarar remdesivir na iya samun babbar toshewar kwayoyin halitta ga juriya. Akwai wasu gwaji na asibiti da ake gudanarwa ciki har da biyu da ke gudanarwa ta Asibitin Jami'ar Cleveland; daya ga mutane masu rashin lafiya mai sauƙi da kuma wani don waɗanda ke da rashin lafiya mai tsanani.
Akwai gwaje-gwaje uku na asibiti da ake gudanarwa na bitamin C a cikin jijiyoyi ga waɗanda suka yi asibiti kuma suna da matukar rashin lafiya tare da COVID-19, biyu placebo-sarrafawa (China, Kanada) da ɗaya ba tare da kulawa ba (Italiya).
Jihar New York ta fara gwajin maganin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) tana shirin yin gwaji na asibiti don Teijin's Alvesco (ciclesonide), wani maganin rigakafin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Wani nau'i na enzyme mai canza angiotensin 2, wani gwaji na Phase II yana gudana a kan marasa lafiya 200 da aka zaɓa daga asibiti da kuma mummunan yanayin a Denmark, Jamus da Austria don tantance tasirin magani.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada suna nazarin rawar da colchicine ke takawa wajen rage cututtukan kumburi da na huhu a cikin marasa lafiya da ke fama da alamun COVID-19.
An kira binciken COLCORONA, ya ɗauki manya 6,000 masu shekaru 40 zuwa sama waɗanda aka gano suna da COVID-19 kuma suna da ƙananan alamun da ba sa buƙatar asibiti.
Mata masu juna biyu ko masu shayarwa ko kuma waɗanda ba su da hanyoyin hana haihuwa masu inganci ba su cancanci shiga.
Ana gwada wasu maganin hana kumburi a Italiya.
Ana amfani da heparin mai nauyin kwayoyin ƙasa don kula da marasa lafiya, yana motsa Hukumar Magunguna ta Italiya don buga jagororin amfani da shi.
An sanar da wani bincike mai yawa na marasa lafiya 300 kan amfani da enoxaparin sodium a cikin maganin rigakafi da magani a Italiya a ranar 14 ga Afrilu.
Tunda SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai kan sauya manufar maganin rigakafin cutar da aka amince da shi wanda aka samar don cutar kamar MERS, SARS da West Nile virus.
Ribavirin: ribavirin da aka ba da shawarar don maganin COVID-19 bisa ga jagorar China ta 7
Umifenovir: umifenovir da aka ba da shawarar don maganin COVID-19 bisa ga jagororin kasar Sin na 7
An gano wasu kwayoyin cutar da ke da yiwuwar sauya manufa a matsayin maganin COVID-19:
Tocilizumab (Anti-IL-6 Receptor): An amince da shi a kasar Sin.
Har ila yau, gwaji a Italiya da China, kuma duba Tocilizumab #COVID-19.
Allurar rigakafin COVID-19 ita ce rigakafin da aka yi zaton cewa za a yi wa cutar coronavirus na 2019 (COVID-2019).
Ko da yake babu wata riga-kafi da ta kammala gwajin asibiti, akwai gwaje-gwaje da yawa da ake yi don samar da rigakafin.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin allurar rigakafin cutar SARS-CoV-2, kwayar cutar da ke haifar da cutar, za ta samu a cikin ƙasa da watanni 18.
An yi gwajin lafiya na Phase 1 a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
Cutar ta duniya ta 2020 ta ba da damar zuba jari da kuma ayyukan bincike don samar da rigakafi.
Ƙungiyoyi da yawa suna amfani da kwayar halittarsu don samar da yiwuwar allurar rigakafin SARS-CoV-2.
An bayyana a watan Afrilu, muhimmancin shirin CEPI don hanzarta ci gaban allurar rigakafi, ƙarfin masana'antu, aiwatarwa mai girma da samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa dandamali daban-daban na fasaha 10 suna ƙarƙashin bincike da ci gaba a farkon 2020 don ƙirƙirar allurar rigakafin COVID-19.
Babban dandamali da ke da burin ci gaba zuwa binciken tsaro na Phase I sun hada da:
nucleic acid (DNA da RNA) (Mai haɓaka Phase 1 da kuma ɗan takarar rigakafi: Moderna, mRNA-1273)
masu kwayar cutar (Mai tsara Phase I da kuma mai neman rigakafin: CanSino Biologics, masu kwayar cutar adenovirus nau'in 5)
Kamar yadda masana kimiyyar CEPI suka ruwaito a watan Afrilu, adadin masu neman rigakafin 115 suna cikin farkon matakan ci gaba, tare da 78 da aka tabbatar a matsayin ayyukan aiki (79, a cewar Cibiyar Milken), kuma an sanar da wasu 37, amma tare da karancin bayanan jama'a (wanda ake ganin a cikin shiri ko a cikin tsari).
Gwajin Phase I-II yana aiwatar da gwajin farko na aminci da rigakafi, yawanci bazuwar, sarrafawa da wuri-wuri da kuma wurare da yawa, yayin ƙayyade ingantaccen sashi.
Gwajin Phase III yawanci yana da ƙarin shiga ciki har da rukunin kulawa da gwajin inganci akan allurar rigakafi don hana cutar, yayin saka idanu don illolin cutar a mafi kyawun sashi.
Daga cikin masu neman rigakafin 79 da ke cikin ci gaba (wanda aka bayyana a farkon Afrilu 2020), 74 ba su cikin gwajin ɗan adam) har yanzu suna cikin binciken "preclinical".
A ranar 24 ga Janairu 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar allurar rigakafin kwayar halitta wacce zata canza kwayar cutar ta kwayar halitta don karfafa aikin rigakafin.
A ranar 24 ga Janairu, 2020 a Kanada, Cibiyar Alurar riga kafi ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da ci gaba da aikin rigakafin, da nufin fara gwajin ɗan adam a 2021.
An sanar da aikin samar da allurar rigakafin a Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin a ranar 26 ga Janairu 2020 da kuma Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanin Janssen Pharmaceutical Companies, wanda Hanneke Schuitemaker ya jagoranta, ya sanar da cewa ya fara kokarin samar da allurar rigakafi.
Janssen na hada kan maganin da za a iya sha tare da Vaxart wanda abokin aikinsa ne a fannin kimiyyar halittu.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwa tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya buga takarda kan ƙirar allurar rigakafi tare da fasahar kama da wacce ake amfani da ita don maganin rigakafin cutar kansa na neoantigen.
A ranar 25 ga watan Maris, shugaban cibiyar bincike ya sanar da cewa sun kammala aikin samar da allurar rigakafin kuma sun fara gwajin.
A ranar 27 ga Fabrairu, 2020, wani reshen Generex, NuGenerex Immuno-Oncology, ya sanar da cewa sun fara aikin rigakafi don ƙirƙirar li-Key peptide vaccine akan COVID-19.
Suna son su samar da maganin da za a iya gwadawa a kan mutane "a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington da ke St. Louis ta sanar da aikinta na samar da rigakafi.
A ranar 5 ga Maris, 2020, Cibiyar Bincike da Magunguna ta Sojojin Amurka a Fort Detrick da Cibiyar Nazarin Sojoji ta Walter Reed a Silver Spring, duka a yammacin Maryland, sun sanar da cewa suna kan aikin yin allurar rigakafi.
Tsakanin 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa sun haɗu da Novavax Inc.
a cikin samar da allurar rigakafi.
Abokan haɗin gwiwar sun kuma sanar da shirin don gwajin farko da na Phase I na gwaji a watan Yulin 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki tare da keɓewa 11 wanda duk da cewa a kan hanya mai sauri zai ɗauki aƙalla shekara ɗaya da rabi zuwa biyu don haɓaka allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere-kere a Quebec City, Quebec, ya ba da rahoton ci gaban kwayar cutar coronavirus-kamar kwayoyin halitta a karkashin wani bangare na kudade na Cibiyar Nazarin Lafiya ta Kanada.
Ana gudanar da gwajin rigakafin a cikin dakin gwaje-gwaje, tare da shirin gwajin mutum a watan Yuli ko Agusta 2020.
A farkon makon, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba CureVac "wadata mai yawa don samun damar yin rigakafin COVID-19", kuma gwamnatin Jamus ta yi hamayya da hakan.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
Wani takarar rigakafin BNT162 na tushen mRNA, a halin yanzu yana cikin gwajin gwaji yayin da ake sa ran fara gwajin asibiti a watan Afrilu 2020.
A ranar 17 ga Maris 2020 a Italiya, Takis Biotech, wani kamfanin kere-kere na Italiya ya sanar da cewa za su sami sakamakon gwajin rigakafin a watan Afrilu 2020 kuma za su iya fara gwajin ɗan adam a lokacin kaka.
A ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) a Faransa ta sanar da saka hannun jari na dala miliyan 4.9 a cikin wani rukunin bincike na allurar rigakafin COVID-19 wanda ya hada da Cibiyar Pasteur, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburgh, wanda ya kawo jimillar saka hannun jari na CEPI a cikin ci gaban allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi kan wasu magungunan rigakafi guda shida.
Masu bincike na Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris 2020 cewa suna haɓaka rigakafin RNA mai ƙarfi don COVID-19.
An samar da wannan rigakafin ne cikin kwanaki 14 bayan an ba da shi daga kasar Sin.
A ƙarshen Maris, gwamnatin Kanada ta sanar da kudade na dala miliyan 275 don ayyukan bincike kan matakan rigakafin likita kan COVID-19, gami da yawancin masu neman allurar rigakafi a kamfanoni da jami'o'in Kanada kamar Medicago da yunƙurin Jami'ar Saskatchewan.
A lokaci guda, gwamnatin Kanada ta sanar da dala miliyan 192 da aka keɓe don haɓaka allurar COVID-19, tare da shirin kafa "bankin allurar rigakafi" na ƙasa na sabbin alluran rigakafi waɗanda za a iya amfani da su idan wani annobar coronavirus ta sake faruwa.
A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoton gwajin PittCoVacc, yiwuwar allurar COVID-19 a cikin beraye, suna mai cewa "MNA ta ba da allurar SARS-CoV-2 S1 wanda ke haifar da amsawar rigakafin antigen mai ƙarfi [a cikin beraye] wanda aka nuna farawa makonni 2 bayan rigakafin".
A Kanada a ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Pharmacy ta sanar da ƙirar takardar rigakafin da ke bisa DNA a matsayin yiwuwar mai fesa hanci.
Ta hanyar amfani da bacteriophage, za a tsara DNA don yin koyi da kwayoyin halittar ɗan adam don samar da ƙwayoyin cuta kamar ƙwayoyin cuta marasa cutarwa, waɗanda za su iya motsa tsarin garkuwar jiki don samar da ƙwayoyin cuta da ke yaƙi da cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, masana'antu da jami'o'i uku sun tara albarkatu don samun damar supercomputers daga IBM, tare da hada albarkatun sarrafa kwamfuta daga Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako na heterologous, wanda ake kira sakamako mara takamaiman.
Wannan yana nufin cewa suna iya samun fa'ida ban da cutar da suke hanawa.
An yi gwajin da aka yi a Australia da nufin a yi wa ma'aikatan kiwon lafiya 4,170 rajista.
Akwai yiwuwar cewa allurar rigakafin da ake ci gaba da samarwa ba ta da lafiya ko tasiri.
Bincike na farko don kimanta tasirin allurar rigakafin ta amfani da takamaiman samfurin dabbobi na COVID-19 kamar su ACE2 transgenic mice, sauran dabbobi masu aiki da kuma dabbobi na farko, ya nuna buƙatar matakan kiyaye lafiyar 3 na biosecurity don sarrafa kwayar cutar mai rai, da haɗin kai na duniya don tabbatar da daidaitattun hanyoyin aminci.
An gwada allurar rigakafin SARS da MERS a kan dabbobi da ba mutane ba.
A shekarar 2020, babu maganin rigakafi ko rigakafin SARS da aka tabbatar da lafiya da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a shekarar 2005 da 2006, ganowa da kuma bunkasa sabbin alluran rigakafi da magunguna don magance cutar SARS shine babban fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama'a a duk duniya.
Lokacin da MERS ta bazu, ana ganin binciken SARS na iya zama samfuri mai amfani don haɓaka allurar rigakafi da maganin cutar MERS-CoV.
A watan Maris na shekarar 2020, akwai rigakafin MERS (wanda ya dogara da DNA) wanda ya kammala gwajin gwaji na farko a cikin mutane, kuma wasu uku suna kan hanya, dukkansu allurar rigakafin kwayar cutar, biyu adenoviral vectors (ChAdOx1-MERS, BVRS-GamVac), da kuma wani MVA vector (MVA-MERS-S).
Sanarwar da aka wallafa a shafukan sada zumunta na inganta ka'idar da ke nuna cewa an gano kwayar cutar COVID-19 kuma an riga an sami rigakafin cutar.
Takaddun shaida da aka ambata ta hanyar kafofin watsa labarun daban-daban suna nufin takaddun shaida na yanzu don tsarawar kwayar halitta da allurar rigakafi don wasu nau'ikan coronavirus kamar SARS coronavirus.
Cutar b'Coronavirus ta 2019 (COVID-19) cuta ce ta kamuwa da cuta da ake haifarwa ta hanyar cutar coronavirus mai saurin kamuwa da cutar numfashi mai saurin kamuwa da cuta 2 (SARS-CoV-2).
Alamun da suka fi kowa sun haɗa da zazzabi, tari da kuma numfashi.
Sauran alamun na iya haɗa da gajiya, ciwon tsoka, diarrhea, ciwon makogwaro, rashin jin ƙanshi da ciwon ciki.
Lokaci daga bayyanar zuwa farkon bayyanar cututtuka yawanci kwanaki biyar ne amma yana iya farawa tsakanin kwana biyu zuwa goma sha huɗu.
Yayin da yawancin masu cutar ke haifar da rashin ciwo, wasu sun ci gaba zuwa cutar huhu da kuma rashin aiki da gabobin jiki.
Ya zuwa 17 ga Afrilu 2020, an samu fiye da mutane miliyan 2.24 da suka kamu da cutar a kasashe 210 da yankuna, wanda ya yi sanadiyar mutuwar mutane fiye da 153,000.
An samu sama da mutane 568,000 da suka warke. Wannan cuta tana yaduwa musamman tsakanin mutane ta hanyar hulɗa da juna, yawanci ta hanyar ƙananan saukad da da ake samu ta hanyar tari, hancin ko magana.
Yayin da ake fitar da waɗannan ɗigon a lokacin numfashi, yawanci sukan fāɗi ƙasa ko kuma a kan farfajiya maimakon su zama cuta daga nesa.
Mutane na iya kamuwa da cutar ta hanyar taɓawa da gurɓataccen wuri sannan kuma taɓawa idanunsu, hanci ko bakinsu.
Kwayar cutar na iya rayuwa a saman ruwa har tsawon sa'o'i 72.
Mafi yawan cutarwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwar na iya faruwa kafin bayyanar cututtuka da kuma a cikin matakan cutar. Hanyar ganewar asali shine ta hanyar amsawar polymerase chain reaction (cRT-PCR) na lokaci na ainihi daga swab na nasopharyngeal.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda suke tsammanin suna da kwayar cutar da masu kula da su.
Shawarwari game da amfani da abin rufe fuska ta hanyar talakawa sun bambanta, tare da wasu hukumomi suna ba da shawarar kada a yi amfani da su, wasu suna ba da shawarar yin amfani da su kuma wasu suna ba da shawarar yin amfani da su.
A halin yanzu, babu rigakafi ko magani na musamman na cutar COVID-19.
An samu yaduwar cutar a cikin kasashe da dama a duk yankuna shida na WHO.
Wadanda suka kamu da kwayar cutar na iya zama marasa alamun cutar ko kuma su nuna alamun cutar kamar mura kamar zazzabi, tari, gajiya da kuma wahalar numfashi.
Alamun gaggawa sun hada da wahalar numfashi, ciwo ko ciwon kirji na ci gaba, rikicewa, wahalar tafiya da fuska ko bluish lips; ana ba da shawarar kulawar likita nan da nan idan waɗannan alamun sun bayyana.
A wasu lokatai, za a iya lura da ciwon numfashi na sama kamar tari, hanci mai ruwa ko ciwon hanci.
An lura da alamun cututtukan gastrointestinal kamar naƙasa, amai da kuma naƙasa a kashi da yawa.
Wasu daga cikin mutanen da aka samu a kasar Sin sun fara nuna cewa suna da matsalar bayanai da kuma bugun zuciya.
A wasu, cutar tana iya kaiwa ga ciwon huhu, rashin aiki da gabobin jiki da mutuwa.
Ana kiran wannan lokacin lokacin da ake sakawa.
Lokacin da COVID-19 ke kwance yawanci kwanaki biyar zuwa shida ne amma yana iya kasancewa tsakanin kwana biyu zuwa 14.
Kashi 97.5 na masu cutar da ke nuna alamun cutar za su yi hakan ne cikin kwanaki 11.5 da kamuwa da cutar.
Ba a san cikakken matsayin wannan mai dauke da cutar ba a cikin yaduwar cutar; duk da haka, shaidar farko ta nuna cewa yana iya taimakawa wajen yaduwar cutar.
Yawan wadanda suka kamu da cutar ba su nuna alamun rashin sanin su ba a halin yanzu kuma ana nazarin su, tare da Cibiyoyin Kula da Cututtuka da Cututtuka na Koriya (KDCC) sun ba da rahoton cewa kashi 20% na dukkan wadanda aka tabbatar da su sun kasance marasa alamun cutar yayin zaman su a asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada da marasa alamun cutar a cikin adadin masu cutar a ranar 1 ga Afrilu; daga cikin mutane 166 da suka kamu da cutar a ranar, 130 (78%) sun kasance marasa alamun cutar a lokacin gwajin.
Cakulan da kuma hawaye na iya ɗauke da ƙwayoyin cuta masu yawa.
Magana da ƙarfi tana sa ruwa ya yi ruwa fiye da yadda ake magana a al'ada.
Wani bincike a Singapore ya gano cewa tari da ba ya rufe baki zai iya sa saurin motsawa ya kai mita 4.5 (15 feet).
Ko da yake cutar ba ta haifa ba, National Academy of Sciences ta ba da shawarar cewa yiwuwar kwayar bioaerosol da kuma masu tara iska a cikin cikin gidajen da ke cikin gidajen jama'a sun nuna samfurin tabbatacce ga RNA na kwayar cutar.
Wasu hanyoyin kiwon lafiya kamar su intubation da cardiopulmonary resuscitation (CPR) na iya haifar da ɓarkewar numfashi zuwa aerosol kuma hakan na haifar da yaduwar ciki.
Duk da cewa akwai damuwa game da yaduwar ta hanyar fitsari, an yi imanin cewa wannan haɗarin yana da ƙarancin. Kwayar cutar tana da yaduwa sosai lokacin da mutum ba shi da alamun; kodayake yaduwa yana yiwuwa kafin bayyanar cututtuka, haɗarin yana da ƙananan.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce duk da cewa ba a bayyana yadda sauƙin cutar ke yaduwa ba, mutum yana kamuwa da mutane biyu zuwa uku a kullum.
Musamman, an sami cutar ta zama mai ganowa na tsawon kwana ɗaya a kan kwali, har tsawon kwana uku a kan filastik (polypropylene) da bakin karfe (AISI 304), da kuma tsawon awa huɗu a kan 99% na jan ƙarfe.
Amma, wannan ya bambanta dangane da zafi da kuma zafin jiki.
Sabulu da na'urar wankewa ma suna da tasiri idan aka yi amfani da su yadda ya kamata; kayan wanki suna raunana fatar da ke kare kwayar cutar, suna kashe ta da kuma fitar da ita daga fata da sauran wurare.
Sauran magungunan kamar benzalkonium chloride da chlorhexidine gluconate (kayan maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
A cikin marasa lafiya biyar cikin shida, samfurin farko ya nuna mafi yawan kwayar cutar, kuma mai haƙuri na shida ya nuna mafi yawan kwayar cutar a rana ta biyu da aka gwada.
Kwayar cutar coronavirus na 2 (SARS-CoV-2) ita ce sabuwar kwayar cutar coronavirus ta kwayar cutar ta kwayar cuta ta kwayar cuta, wacce aka fara warewa daga mutane uku da ke da ciwon huhu dangane da wani rukunin cututtukan cututtukan kwayar cuta a Wuhan.
Dukkanin halayen kwayar cutar SARS-CoV-2 da ke faruwa a cikin coronavirus suna da alaƙa da juna.
A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida, wanda ke zubar da kumfa mai kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Cutar COVID-19 ta fi shafi huhu saboda kwayar cutar tana samun damar zuwa kwayar cutar ta hanyar maganin angiotensin-converting enzyme (ACE2), wanda ya fi yawa a cikin kwayoyin alveolus na nau'in II na huhu.
Kwayar cutar tana amfani da wani takamaiman farfajiyar glycoprotein da ake kira "pepcoll" (peplomer) don haɗawa da ACE2 kuma ya shiga cikin ƙwayoyin cuta.
An gano raunin zuciya mai tsanani a kashi 12 cikin 100 na mutanen da suka kamu da cutar da aka kwantar a asibiti a Wuhan, China kuma ya fi faruwa a cikin mummunar cuta.
Matsakaicin yanayin cututtukan zuciya, saboda aikin amsawar kumburi na tsarin cuta da cuta na tsarin rigakafi yayin ci gaban cutar, amma raunin myocardial na iya kasancewa yana da alaƙa da masu karɓar ACE2 a cikin zuciya.
ACE2 masu karɓa suna da yawa a cikin zuciya kuma suna da hannu cikin aikin zuciya.
An gano yawan yawan kamuwa da cutar a cikin ICU da ke dauke da cutar COVID-19 kuma ana iya danganta hakan da rashin ciwon. An gano lalacewar alveolus diffuse (DAD) a cikin wadanda suka mutu saboda COVID-19, kuma harin da limfosit ya kunshi kumburi a cikin huhu.
Duk da cewa SARS-COV-2 yana da tropism don bayyanar kwayar halitta na ACE2 a cikin numfashi, marasa lafiya da ke da COVID-19 mai tsanani suna da alamun cutar ta tsarin kumburi.
Musamman, kwayoyin T-cell masu fitar da GM-CSF masu cutarwa an nuna su don daidaitawa tare da haɓakar ƙwayar IL-6 mai fitar da monocytes da kuma cututtukan huhu mai tsanani a cikin marasa lafiya na COVID-19.
An kuma ba da rahoton cewa an yi wani ciwon lymphocytic a lokacin da ake bincike.
Hukumar Lafiya ta Duniya ta wallafa wasu ka'idojin gwaji don cutar.
Hanyar gwajin misali ita ce ainihin lokacin juyawa-transcription polymerase chain reaction (rPT-PCR).
Ana yin gwajin ne a kan samfurin numfashi da aka samu ta hanyar nasopharyngeal swab; duk da haka, ana iya amfani da hanci ko samfurin hanci.
Za a iya samun sakamako a cikin sa'o'i da yawa zuwa kwana biyu.
Ana iya yin gwajin jini amma ana bukatar a dauki gwaje-gwaje biyu na jini makonni biyu da juna kuma sakamakon ba shi da wani muhimmin muhimmanci.
Masana kimiyya na kasar Sin sun sami damar ware kwayar cutar coronavirus da kuma buga takardun halittar ta yadda dakunan gwaje-gwaje na duniya za su iya samar da gwajin polymerase chain reaction (PCR) da kansu don gano kamuwa da kwayar cutar.
Ya zuwa ranar 4 ga Afrilu, 2020, gwajin antibody (mai yiwuwa yana gano kamuwa da cuta mai aiki kuma ko mutumin ya kamu da cutar a baya) yana cikin ci gaba amma ba a amfani da shi sosai.
Kwarewar kasar Sin ta gwajin ta nuna cewa daidaito na kashi 60 zuwa 70 ne kawai.
FDA a Amurka ta amince da gwajin farko na fara kulawa a ranar 21 ga Maris, 2020 don amfani a ƙarshen watan. Jagoran bincike da asibitin Zhongnan na Wuhan University ya bayar ya ba da shawarar hanyoyin gano kamuwa da cuta bisa ga alamun asibiti da haɗarin annoba.
Rashin gilashin multilobar na biyu tare da rarraba na gefe, asymmetric da na baya ya zama ruwan dare a farkon kamuwa da cuta.
Dominance na subpleural, yawan turpan (ƙwaƙwalwar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Akwai wasu bayanai game da cutar monoscopic da kuma pathophysiology na COVID-19.
Babban binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Binciken: ciwon zuciya, ciwon zuciya, ciwon huhu da kuma ciwon huhu
Za a iya lura da nau'ikan nau'ikan cutar cutar huhu guda huɗu:
ciwon huhu mai sauƙi: kumburi na huhu, kumburi, hawan jini, kumburi mai girma, kumburi na sararin samaniya tare da cin zarafin lymphocytic da kuma samar da ƙwayoyin giant multinucleate
mummunar cutar huhu: lalacewar alveolus mai yaduwa (DAD) tare da fitar alveolus mai yaduwa.
DAD tana da nasaba da ciwon numfashi mai tsanani (ARDS) da kuma matsanancin rashin isasshen jini.
warkar da ciwon huhu: kafawar exudate a cikin alveolar cavity da kuma fibrosis na sararin samaniya
Jinin: rarrabawar intravascular coagulation (DIC), ƙwayoyin cuta na leukocytoblast
Matakan kariya na rage yiwuwar kamuwa da cutar sun hada da zama a gida, guje wa wuraren taruwa, wanke hannaye da sabulu da ruwa akai-akai kuma na akalla sakan 20, yin tsaftace numfashi mai kyau da kuma gujewa taɓa idanu, hanci ko baki da hannaye marasa wanke.
CDC ta ba da shawarar rufe baki da hanci da kayan shafawa lokacin da kake yin tari ko tari kuma ta ba da shawarar amfani da kayan shafawa a kafada idan babu kayan shafawa.
Ana ƙarfafa tsabtace hannu bayan wani tari ko tari.
CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a, a wani ɓangare don iyakance motsi ta hanyar mutanen da ba su da alamun cutar. Manufofin nisantar da jama'a suna nufin rage hulɗa da mutane masu kamuwa da cuta tare da manyan rukuni ta hanyar rufe makarantu da wuraren aiki, iyakance tafiye-tafiye da soke manyan tarurrukan jama'a.
Layin jagora na nesa ya haɗa da mutane su kasance aƙalla ƙafa 6 (1.8 m) nesa da juna.
Babu magungunan da aka gano suna da tasiri wajen hana COVID-19. Tunda ba a sa ran samun allurar rigakafi har zuwa farkon 2021 ba, babban abin da ke kula da COVID-19 shine ƙoƙarin rage ƙaruwar annobar, wanda aka sani da "sanya ƙwanƙwasa".
CDC ta kuma bada shawarar cewa mutane su riƙa wanke hannayensu da sabulu da ruwa na akalla sakan 20, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun kasance masu datti, kafin cin abinci ko bayan sun hura hanci, sun yi tari ko kuma sun yi tari.
An sake ba da shawarar yin amfani da maganin tsabtace hannu na barasa tare da akalla 60% na barasa amma kawai lokacin da sabulu da ruwa ba su samuwa. Don yankunan da ba su da tsabtace hannu na kasuwanci, WHO ta samar da nau'i biyu don samarwa na gida.
A cikin wannan tsari, aikin antimicrobial ya fito ne daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da ƙwayoyin cuta a cikin giya; "ba abu ne mai aiki ba don antisepsis na hannu".
An ƙara glycerol a matsayin mai ƙoshin nama.
Ana kula da jama'a tare da kulawa mai taimako, wanda zai iya haɗawa da maganin ruwa, tallafin oxygen, da kuma goyon bayan sauran gabobin da suka shafi.
CDC ta ba da shawarar cewa duk wanda ke da tabbacin cewa yana da kwayar cutar ya sa takunkumin fuska mai sauki.
Ana amfani da oxygenation na membrane na exocorporeal (ECMO) don magance matsalar rashin numfashi, amma fa'idarsa har yanzu tana ƙarƙashin la'akari.
Ana ba da shawarar tsabtace jiki da salon rayuwa mai kyau da abinci don haɓaka rigakafi.
Maganin tallafi na iya zama da amfani ga waɗanda ke da alamun rashin lafiya a farkon matakan kamuwa da cutar.
Masu kula da masu fama da cutar da kuma masu ilimin cututtukan huhu a Amurka sun tattara bayanan kulawar daga hukumomi daban-daban zuwa wata hanyar kyauta, IBCC.
Har zuwa watan Afrilu 2020, babu wani magani na musamman don COVID-19.
Don bayyanar cututtuka, wasu likitocin likitoci sun bada shawarar paracetamol (acetaminophen) maimakon ibuprofen don amfani na farko.
Dole ne a ɗauki matakan kariya don rage haɗarin watsa kwayar cutar, musamman a cikin yanayin kiwon lafiya lokacin aiwatar da hanyoyin da zasu iya samar da aerosol, kamar su intubation ko iska.
Ga ma'aikatan kiwon lafiya da ke kula da waɗanda ke da COVID-19, CDC ta ba da shawarar sanya mutumin a cikin dakin keɓewa na Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar
Kayan da ake bada shawara su ne: rigunan PPE, na numfashi ko abin rufe fuska, kariya ga idanu da safar hannu. Idan akwai, ana fifita na numfashi (a kan abin rufe fuska).
Masarrafar numfashi ta N95 ta amince da tsarin masana'antu amma FDA ta riga ta amince da amfani da abin rufe fuska a karkashin Dokar Amfani da Gaggawa (EUA).
An tsara shi don karewa daga ƙwayoyin halitta kamar ƙura amma yana da tasiri akan ƙwayoyin halitta na musamman ba a ba da tabbacin don amfani da labaran ba.
Idan ba a iya samun abin rufe fuska, CDC ta ba da shawarar yin amfani da abin rufe fuska ko kuma a matsayin zaɓi na ƙarshe, abin rufe fuska na gida.
Yawancin shari'o'in COVID-19 ba su da tsanani har su bukaci yin amfani da iska ta hanyar inji ko kuma na madadin iska, amma wasu kashi suna bukatar hakan.
Ana nazarin nau'ikan tallafin numfashi ga mutane tare da COVID-19 dangane da rashin ƙarfi na numfashi a cikin asibiti tare da wasu shaidu cewa ana iya guje wa intubation tare da babban bututun hanci mai juyawa ko matsin lamba mai kyau na iska mai matsin lamba biyu.
Ko waɗannan biyu suna ba da fa'ida iri ɗaya ga mutanen da ke fama da rashin lafiya ba a sani ba.
Wasu likitoci sun fi son kasancewa tare da iska mai guba idan akwai saboda wannan fasaha ta iyakance yaduwar aerosol fiye da na canon hanci mai gudana.
Yawancin ƙasashe masu tasowa ba su da isassun gadajen asibiti na mutum ɗaya, wanda ke iyakance ƙarfin tsarin kiwon lafiya don ɗaukar ƙaruwar ƙaruwar adadin COVID-19 wanda ya isa ya buƙaci asibiti.
Wani bincike a China ya gano cewa kashi 5 cikin 100 na waɗanda aka kai su sashen kula da gaggawa, kashi 2.3 cikin 100 suna bukatar taimakon na'ura mai sa numfashi, kuma kashi 1.4 cikin 100 sun mutu.
A China, aƙalla kashi 30 cikin ɗari na marasa lafiya da ke asibiti da COVID-19 za a shigar da su cikin ICU a ƙarshe.
Ana samun wahalar yin iska ta hanyar inji yayin da cutar ta COVID-19 ke haifar da ciwon numfashi mai saurin ragewa (ARDS) kuma samun iskar oxygen yana da wuya.
Masu iska suna iya sarrafa matsin lamba kuma ana buƙatar PEEP mai ƙarfi don haɓaka isar da iskar oxygen yayin rage haɗarin raunin huhu da ke tattare da masu iska da pneumothorax.
Mai yiwuwa ba za a iya samun babban PEEP a kan masu motsa jiki ba.
Bincike kan yiwuwar magani ya fara ne a watan Janairun 2020, kuma wasu magungunan rigakafi suna cikin gwajin asibiti.
Remdesivir ya bayyana a matsayin mafi kyau.
Duk da yake sabbin magunguna na iya ɗaukar har zuwa 2021 don haɓaka, wasu magunguna da ake gwadawa an riga an yarda da su don amfani da su wasu kuma suna cikin ci gaba da gwaji.
Ana iya gwada maganin rigakafi a kan mutane da ke fama da cututtuka masu tsanani.
Hukumar ta WHO ta ba da shawarar masu sa kai su shiga gwajin inganci da amincin magani. FDA ta ba da izinin wucin gadi don sake dawo da plasma a matsayin magani na gwaji a cikin yanayin da rayuwarsu ke cikin haɗari ko barazana.
Ba a yi gwajin asibiti da ake bukata ba don nuna cewa yana da lafiya da kuma tasiri ga cututtuka.
A watan Fabrairun 2020, kasar Sin ta kaddamar da manhajar wayar salula don magance annobar cutar.
Ana tambayar masu amfani su shigar da sunansu da kuma ID.
Wannan app zai iya gano 'yan'uwa na kusa' ta amfani da bayanan sa ido kuma hakan zai iya haifar da yiwuwar kamuwa da cuta.
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan aka gano wata barazana, ba wai kawai manhajar ta ba da shawarar keɓe kai ba, har ma ta gargadi hukumomin kiwon lafiya na gida. Ana amfani da nazarin bayanai mai yawa kan bayanan wayar salula, fasahar yin amfani da fuska, bin diddigin wayar hannu da kuma ilimin kere kere don bin diddigin mutanen da ke dauke da cutar da kuma mutanen da suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba wa hukumomin tsaro damar bin diddigin bayanan wayar salula na wadanda ke dauke da cutar coronavirus.
An dauki matakai don tsaurara dokar killacewa da kuma kare wadanda suka yi mu'amala da mutanen da suka kamu da cutar.
Har ila yau, a cikin Maris 2020, Deutsche Telekom ta raba bayanan wurin tarho tare da hukumar gwamnatin tarayya ta Jamus, Robert Koch Institute, don bincika da hana yaduwar cutar.
Rasha na amfani da fasahar gano fuska don gano masu keta dokar killacewa.
Kwamishinan kiwon lafiya na lardin Italiya Giulio Gallera ya ce an sanar da shi ta hanyar wayar salula cewa "kashi 40% na jama'a suna ci gaba da tafiya a ko'ina".
Gwamnatin Jamus ta gudanar da wani taron satar bayanai na tsawon sa'o'i 48 da masu halarta sama da 42,000 suka halarta.
Shugaban Estonia Kersti Kaljulaid ya kuma yi kira ga duniya da ta samar da hanyoyin magance cutar coronavirus.
Mutum na iya fuskantar matsin lamba na keɓewa, takunkumin tafiye-tafiye, sakamakon magani ko kuma tsoron kamuwa da cutar kanta.
BBC ta nakalto Rory O'Connor tana cewa: "Ƙara yawan warewar jama'a, rashin zaman kansu, damuwar kiwon lafiya, matsi da koma bayan tattalin arziki su ne cikakkun abubuwan da ke barazana ga lafiyar mutane da kuma jin daɗin rayuwa".
Cutar za ta haifar da sakamako mai sauƙi tare da ƙananan ko babu alamun bayyanar, kamar yadda cutar numfashi ta sama kamar yadda yake a cikin mura.
Masu rashin lafiya sukan warke cikin makonni biyu, yayin da masu ciwo mai tsanani ko kuma masu ciwo mai tsanani sukan ɗauki makonni uku ko shida kafin su warke.
Mata masu juna biyu na iya samun babban haɗarin kamuwa da cutar COVID-19 bisa ga bayanan da ke tattare da wasu irin wannan ƙwayoyin cuta kamar SARS da MERS, amma ba a sami bayanai masu yawa game da COVID-19 ba. A cikin wasu mutane, COVID-19 na iya shafar huhu wanda ke haifar da cutar huhu.
A cikin mafi yawan waɗanda suka kamu da cutar, COVID-19 na iya saurin lalacewa zuwa matsanancin rikicewar numfashi (ARDS) wanda ke haifar da gazawar numfashi, girgizar kasa ko rashin aiki da gabobin jiki.
Rikicin da ke tattare da COVID-19 ya hada da sepsis, rashin jin daɗi da lalacewar zuciya, koda da hanta.
Rashin daidaituwa, musamman ƙaruwa a lokacin prothrombin, ya bayyana a cikin kashi 6% na waɗanda aka kwantar da su a asibiti tare da COVID-19, yayin da aka lura da rashin daidaiton aikin koda a cikin kashi 4% na wannan rukunin.
Akalla kashi 20-30% na mutanen da ke kamuwa da COVID-19 suna nuna karuwar sinadarin hanta (transaminase).
A wannan rahoton, matsakaicin lokaci tsakanin bayyanar cututtuka da mutuwa kwanaki goma ne, tare da kwana biyar don shiga asibiti.
Duk da haka, marasa lafiya da aka kai ICU suna da matsakaicin kwanaki bakwai tsakanin shiga asibiti da mutuwa.
A cikin binciken farko, matsakaicin lokaci daga bayyanar cututtuka na farko zuwa mutuwa ya kasance kwanaki 14, tare da cikakken ɗaukar hoto na kwanaki shida zuwa 41.
A wani bincike da Hukumar Lafiya ta Kasa (NHC) ta kasar Sin ta yi, maza suna da kashi 2.8% na mace-mace yayin da mata ke da kashi 1.7%.
Binciken ilimin lissafi a kan samfurin huhu na bayan mutuwa ya nuna lalacewar alveolus mai rarrabuwa tare da fibromisoid na salula wanda ya ɓace a cikin huhu biyu.
An lura da canjin kwayar cutar kwayar cutar a cikin pneumocytes.
Hoton da aka yi na huhu ya nuna cewa yana da mummunar cuta.
A cikin kashi 11.8% na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito, an lura da lalacewar zuciya tare da karuwar matakan troponin ko kuma karuwar zuciya.
Bisa ga bayanan Maris daga Amurka, kashi 89% na waɗanda aka kwantar da su asibiti tare da yanayin kiwon lafiya, wadatar albarkatun kiwon lafiya da zamantakewar al'umma na yankin na iya yin tasiri kan yawan mutuwar.
Ƙididdigar yawan mutuwar daga jihohi sun bambanta saboda bambancin yankuna, amma kuma saboda matsalolin da suka shafi tsarin.
Rashin ƙididdigar ƙananan ƙwayoyin cuta na iya haifar da ƙididdigar ƙimar mutuwa.
Duk da haka, gaskiyar cewa mutuwar ta kasance saboda cututtukan da suka gabata na iya nufin cewa yawan mutuwar yanzu ya wuce kima.
Masu shan sigari sun fi sau 1.4 na fuskantar munanan alamun COVID-19 kuma suna da aƙalla sau 2.4 na buƙatar kulawa ta musamman ko mutuwa fiye da waɗanda ba sa shan sigari. An kuma nuna damuwa game da tasirin cutar na dogon lokaci.
Hukumomin Asibitocin Hong Kong sun gano raguwar kashi 20% zuwa 30% a cikin ƙarfin huhu a cikin wasu marasa lafiya da suka warke daga cutar, kuma binciken huhu ya nuna lalacewar gabobin.
Wannan kuma zai iya kai ga ciwo bayan kulawa da ya biyo bayan farfadowa.
Ya zuwa Maris 2020, ba a san ko kamuwa da cutar da ta gabata ta ba da rigakafi mai tasiri da na dogon lokaci a cikin waɗanda suka warke daga cutar ba.
An ga cewa rigakafi zai yiwu, bisa ga halayyar sauran coronavirus, amma a cikin yanayin da aka samu waraka daga COVID-19 an bi da gwajin tabbatacce ga coronavirus a kwanan da aka bayar da rahoton.
An yi imanin cewa waɗannan cututtuka sun fi muni da ciwon da ya daɗe fiye da sake kamuwa da cutar.
An yi tunanin cewa cutar ta samo asali ne daga dabbobi, ta hanyar kamuwa da cutar.
Ba a san ainihin asalin ba amma har zuwa Disamba 2019 kusan dukkanin kamuwa da cuta an yi ta ne ta hanyar yaduwar mutum zuwa mutum.
Wani bincike na farko na 41 na COVID-19, wanda aka buga a cikin Janairu 2020 a cikin The Lancet, ya nuna farkon farkon bayyanar cututtuka a ranar 1 ga Disamba, 2019.
Sanarwar hukuma daga WHO ta ba da rahoton farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da wasu ma'auni don auna yawan mutuwa.
Waɗannan lambobin sun bambanta ta yanki da lokaci kuma suna da tasiri ta yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓin magani, tsawon lokaci tun farkon kamuwa da cutar da kuma halaye na yawan jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambar cutar ta gaggawa ta ICD-10 U07.1 don mutuwar cutar ta SARS-CoV-2 da aka tabbatar da dakin gwaje-gwaje da U07.2 don mutuwar cutar ta SARS-CoV-2 ba tare da tabbatar da dakin gwaje-gwaje na COVID-19 da aka gano ba.
Bisa ga ƙididdigar Jami'ar Johns Hopkins, yawan mutuwar mutane a duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Sauran matakan sun hada da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutanen da suka kamu da cutar (IFR) wanda ke nuna yawan mutanen da suka kamu (da aka gano da wadanda ba a gano ba) da suka mutu daga cutar.
Waɗannan ƙididdigar ba su da lokaci kuma suna bin takamaiman yawan jama'a daga kamuwa da cuta zuwa warwarewar shari'ar.
Duk da cewa ba kowa ba ne ke samar da rigakafi, kasancewar rigakafin na iya ba da bayani game da adadin mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, Castiglione d'Adda, wani karamin ƙauye na mutane 4,600, 80 (1.7%) sun mutu.
A Gangelt, cutar da ake yadawa ta hanyar bikin Carnival, da kuma yaduwar ta ga matasa, ta haifar da karancin mutuwar mutane, kuma ba duk mutuwar COVID-19 ake rarraba su ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai cika ba tukuna.
A Netherlands, aƙalla kashi 3 cikin ɗari na iya samun ƙwayoyin cuta kamar yadda aka kimanta daga mai ba da jini.
An tabbatar da mutuwar 69 (0.004% na yawan jama'a) daga COVID-19.
Annobar ta bambanta tsakanin mata da maza.
Yawan mutuwar maza ya fi na maza a cikin binciken da aka yi a China da Italiya.
Maza suna da haɗari sosai a cikin shekarunsu na 50, tare da bambanci tsakanin maza da mata da ke bayyana a cikin shekaru 90.
A ƙasar Sin, adadin mace-macen da ke mutuwa ya kai kashi 2.8 cikin ɗari na maza da kuma kashi 1.7 cikin ɗari na mata.
Ba a san ainihin dalilin da ya sa ake da bambancin jinsi ba amma za a iya ganin cewa wasu abubuwa da suka shafi hali da kuma kwayoyin halitta ne suka sa.
Bambancin rigakafi bisa jima'i, rashin shan sigari a cikin mata da maza wanda ke haifar da yanayin rashin lafiya kamar hawan jini a cikin matasa fiye da mata na iya ba da gudummawa ga yawan mutuwar maza.
A Turai, kashi 57% na waɗanda suka kamu da cutar maza ne kuma kashi 72% na waɗanda suka mutu saboda COVID-19 maza ne.
Har zuwa watan Afrilu 2020, gwamnatin Amurka ba ta gano bayanan da suka shafi jima'i don kamuwa da COVID-19.
Bincike ya nuna cewa cututtuka irin su Ebola, HIV, mura da SARS suna shafar maza da mata dabam.
Ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, sun fi mata yawa, kuma sun fi kowa kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu 2020 cewa sunan hukuma na cutar shine "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa an gano gajerun kalmomin CO don corona, VI don kwayar cutar, D don cuta da 19 don lokacin annoba: 31 Disamba 2019.
An zaɓi sunaye don kauce wa yin nuni ga takamaiman wurin da ake ciki (misali China), nau'in dabbobi ko rukunin mutane, daidai da ƙa'idodin ƙasashen duniya don ba da suna da nufin kauce wa ƙyama. An kira kwayar cutar da ke haifar da COVID-19 coronavirus mai saurin numfashi mai saurin 2 (SARS-CoV-2).
Bugu da ƙari WHO ta yi amfani da "virus COVID-19" da "virus da ke da alhakin COVID-19) a cikin sadarwa ta jama'a.
Dukkanin cutar da kwayar cutar ana kiranta "coronavirus".
A lokacin da aka fara kamuwa da cutar a Wuhan, China, an yi amfani da kalmar "coronavirus" da kuma "Wuhan coronavirus" wajen kiran cutar da cutar.
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCov da cutar numfashi mai saurin 2019-nCoV a matsayin sunaye na wucin gadi don ƙwayoyin cuta da cuta daidai da jagororin 2015 kan amfani da wuri don cuta da sunayen ƙwayoyin cuta.
An sanar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iyawa a cikin daidaitaccen sarkar samarwa, wasu masana'antun dijital suna fitar da kayan kiwon lafiya kamar su swabs na hanci da sassan masu sanyaya numfashi.
A wani misali, lokacin da asibiti na Italiya ke bukatar bawul din iska na gaggawa, kuma mai samarwa ba zai iya isar da su ba a cikin lokacin da ake bukata, wani dan injiniya ya koma gida ya samar da bawul din 100 da ake bukata cikin dare.
Bayan farkon yaduwar COVID-19, ka'idodin maƙarƙashiya, kuskuren bayani da kuma bayanan da ba daidai ba sun bayyana game da asalin, sikelin, rigakafi, magani da sauran fannoni na cutar kuma sun bazu cikin sauri ta yanar gizo.
Mutane suna iya yada kwayar cutar zuwa wasu dabbobi.
Binciken bai sami tabbacin kwayar cutar ba a cikin naman alade, kifi da kaji.
Babu magani ko riga-kafi da aka amince da shi don magance cutar.
Bincike na duniya game da alluran rigakafin COVID-19 da magunguna suna gudana ta hanyar ƙungiyoyin gwamnati, ƙungiyoyin ilimi da masu binciken masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta fara "Gwaji na SOLIDARITY" don tantance tasirin maganin maganin maganin riga-kafi guda huɗu na yanzu tare da tasirin da za a iya tsammani.
Babu allurar rigakafi amma hukumomi daban-daban suna kan ci gaba da samar da masu neman rigakafi.
An yi amfani da wannan aikin a kan SARS-CoV saboda SARS-CoV da SARS-CoV-2 suna amfani da masu karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Akwai dabarun allurar rigakafi guda uku da ake bincike a kai.
Da farko, masu bincike sun yi niyyar gina rigakafin cutar gaba ɗaya.
Amfani da kwayar cutar ko dai a kashe ko a kashe, an yi shi ne don samun amsawar rigakafin gaggawa a jikin mutum ga sabon kamuwa da cutar ta COVID-19.
Dabara ta biyu, allurar rigakafi, tana nufin samar da rigakafi da ke da saukin kamuwa da cuta a kan wasu ɓangarorin ƙwayoyin cuta.
A cikin SARS-CoV-2, binciken ya mai da hankali ne kan sunadarin S wanda ke taimakawa kwayar cutar ta keta kwayar cutar ACE2.
Dabarar ta uku ita ce allurar nucleic acid (DNA ko RNA, sabuwar dabara ce ta samar da rigakafi guda).
A ranar 16 ga Maris, 2020, an fara gwajin gwaji na farko na allurar rigakafi tare da masu sa kai huɗu a Seattle.
A cikin rigakafin akwai kwafin kwayar halitta mara lahani da aka kwafa daga kwayar cutar da ke haifar da cutar. An ba da shawarar haɓaka dogaro da rigakafin antibody a matsayin wata babbar ƙalubale ga ci gaban allurar rigakafin SARS-COV-2, amma wannan batun ya kasance mai rikitarwa.
Akwai gwaji sama da 300 da ake gudanarwa a watan Afrilu na 2020.
Gwaje-gwaje bakwai da aka yi a ciki an amince da su a matsayin maganin zazzabin cizon sauro, ciki har da gwaje-gwaje huɗu da aka yi a kan hydroxychloroquine ko chloroquine.
Magungunan rigakafin da aka gyara manufarsu sun shafi yawancin binciken kasar Sin, tare da gwajin kashi na uku na tara kan remdesivir ga wasu kasashe da za a bayar da rahoto a karshen watan Afrilu.
An samar da wani bincike na ci gaban asibiti don allurar rigakafin COVID-19 da kuma magungunan da ake so, har zuwa watan Afrilu 2020. Wasu magungunan riga-kafi na yanzu ana kimantawa don maganin COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir tare da interferon beta.
Akwai hujja na ɗan lokaci don inganci ta remdesivir har zuwa Mach 2020.
An lura da ci gaban asibiti a cikin marasa lafiya da aka kula da su tare da amfani da remdesivir.
An gudanar da gwajin gwaji na Phase III a Amurka, China da Italiya. Chloroquine, wanda aka yi amfani da shi don magance zazzabin cizon sauro a baya an yi nazari a China a watan Fabrairun 2020, ya ba da sakamakon farko.
Duk da haka, akwai kira ga sake duba daidai da bincike.
Hukumomin Koriya da na China sun ba da shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayar cuta ta Wuhan, yayin da take ba da shawarar kashi ɗaya na gram a kowace rana, ta yarda cewa ninki biyu na cutar yana da haɗari kuma yana iya haifar da mutuwa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa ga hydroxychloroquine da chloroquine a cikin ikon kulawar likitoci na kula da waɗanda ke kamuwa da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar babban allurai na ribavirin don gano SARS-CoV-2 a cikin vitro.
An ba da shawarar Nitazoxanide don ci gaba da nazarin in vivo bayan nuna ƙarancin ƙarfi a cikin SARS-CoV-2. Nazarin ya nuna cewa gano furotin na farko na haɓaka ta hanyar jerin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Nazarin chloroquine da hydroxychloroquine tare ko ba tare da azithromycin ba yana da manyan ƙuntatawa waɗanda ke hana ƙungiyar likitanci amfani da waɗannan jiyya ba tare da ƙarin bincike ba. Oseltamivir bai gano SARS-CoV-2 a cikin vitro ba kuma babu wani sanannen aiki a cikin maganin COVID-19.
Guguwar cytokine na iya zama rikitarwa a matakin gaba don mummunan COVID-19.
Akwai shaidar cewa hydroxychloroquine yana da halayen antihistamine. Tocilizumab an sanya shi cikin jagororin magani ta Hukumar Lafiya ta China bayan kammala karamin binciken.
Yana cikin gwajin gwaji na kashi na biyu a matakin kasa a Italiya bayan ya nuna tabbatacce ga mummunan cuta.
An haɗa shi da gwajin jini na serum ferritin don gano guguwar cytokine, wannan yana nufin yaƙi da ci gaban, wanda ake ɗauka shine dalilin mutuwa ga wasu mutane da ke kamuwa da cutar.
An yarda da maganin maganin interleukin-6 na FDA bisa la'akari da nazarin yanayin baya don maganin cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut
Ya zuwa yanzu, babu wata hujja da aka sarrafa a kai cewa tocilizumab magani ne mai inganci ga CRS.
Ana binciken canja wurin kwayar cutar da aka yi wa allurar rigakafi da kuma abubuwan da tsarin garkuwar jikin mutum ya samar da waɗanda suka warke daga COVID-19 zuwa ga mutanen da suke bukatarsu a matsayin hanyar da ba rigakafi ba don rigakafin wucewa.
An gwada wannan dabarar a kan SARS ba tare da samun sakamako mai kyau ba.
Rashin tasirin kwayar cutar shine tsarin aikin da ake tsammani wanda maganin rigakafin rigakafi zai iya zama matsakaici na kariya akan SARS-CoV-2.
Sauran hanyoyin, kamar su cytotoxicity na salula, antibody dependence da/ko phagocytosis na iya faruwa.
Wani nau'i na maganin rigakafin rigakafi, alal misali, ta amfani da kwayoyin halitta na monoclonal suna cikin ci gaba.
Za a iya inganta samar da maganin dawo da cutar, wanda ya ƙunshi wani ɓangare na ruwan jini daga marasa lafiya da suka warke kuma ya ƙunshi ƙwayoyin cuta na musamman ga wannan kwayar cutar don saurin aiwatarwa.
Cutar coronavirus, wani rukunin cututtuka da ke da nasaba sosai.
Li Wenliang, likita a Asibitin Tsakiya na Wuhan, daga baya ya kamu da cutar kuma ya mutu sakamakon COVID-19 bayan ya wayar da kan jama'a game da yaduwar cutar.
